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Siderophores are small-molecule iron chelators that many bacteria synthesize and 
secrete in order to survive in iron-depleted environments. In Escherichia coli, 
biosynthesis of the siderophore molecule enterobactin requires the activities of six 
enzymes, EntA-EntF. These enzymes function sequentially to produce enterobactin 
molecule in the cytoplasm. The enterobactin biosynthesis pathway is divided into two 
modules. The first module involves the conversion of chorismate to 2,3-
dihydroxybenzoic acid (2,3-DHB), and requires the activities of EntC, EntB (N-terminal 
domain) and EntA. The second module involves non-ribosomal peptide synthesis (NRPS) 
such that three molecules of 2,3-DHB are condensed with three molecules of L-serine to 
form the siderophore. The NRPS module requires the activities of EntE, EntB (C-
terminal domain), EntD and EntF.  
The overall goal of my research project is characterization of the enterobactin 
biosynthetic enzyme EntE. EntE catalyzes the activation of 2,3-DHB via adenylation 
producing DHB-AMP. I am interested in addressing the following questions: (i) How 
does EntE bind its 2,3-DHB substrate? (ii) How does it interact with its upstream and 
downstream partner proteins: EntA, which produces 2,3-DHB, and EntB, which uses the 
EntE product (DHB-AMP) as a substrate, respectively? My thesis is divided into three 
research-related chapters:  
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The first research chapter focused on the interaction of EntE with its substrate, 
2,3-DHB, as well as the characterization of EntE-EntB interaction in the presence and 
absence of 2,3-DHB. A significant change in EntB conformation was observed upon the 
interaction with EntE when in the presence of 2,3-DHB. In the pull-down assay, EntB as 
bait protein pulled down more EntE in the presence of exogenous 2,3-DHB. We conclude 
from this chapter that the ligand-loaded state of the protein was necessary for efficient 
protein-protein interaction. 
 The second research chapter involves the characterization of a novel 
interaction between EntE and its upstream partner protein EntA. A significant increase in 
EntE activity was observed upon adding EntA. Furthermore, EntA reduces the FRET 
signal of EntE-bound 2,3-DHB in a saturable manner with increasing EntA 
concentrations. Using this fluorescence binding assay at 20 °C revealed a positive 
cooperativity in EntA-EntE interaction with Hill coefficient greater than one. The AUC 
experiments showed that EntA conformation is highly dependent on its concentration. In 
conclusion, the results of this chapter suggest that EntA-EntE interaction likely induces 
remodeling of EntE active site, resulting in the observed increase in EntE catalysis. 
In the third research chapter, the EntA-EntE interaction interface was 
characterized using phage display. Based on the interaction interface predicted by phage 
display data, EntA variants containing single-site and double-site mutations were created 
(Q64A, A68Q, and Q64A/A68Q). Our in vitro biophysical techniques and growth 
phenotype experiments revealed that EntA (Q64A) and EntA (Q64A/A68Q) mutations 
have a more pronounced effect than EntA (A68Q) mutation on disruption of the EntA-
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Statement of the Problem and Significance 
In most bacterial pathogens, low levels of intracellular iron act as a signal to 
upregulate the expression of bacterial iron acquisition genes. The products of these genes 
are believed to contribute to the survival of the pathogenic bacteria inside the host and 
hence the pathogenesis of infection. Therefore bacterial proteins expressed under iron-
limited conditions may be used as essential immuno- or chemotherapeutic targets.  
Enterobactin, an E. coli chatecholate siderophore, is a low-molecular-weight iron 
chelating agent. The activities of six enzymes (EntA-EntF) are required for enterobactin 
biosynthesis in the E. coli cytoplasm. The enterobactin biosynthesis pathway is composed 
of two functional modules. The first module is the DHB biosynthetic module in which 
chorismate is converted into 2,3-DHB. This module involves the activities of EntC, EntB 
(N-terminal domain), and EntA. The second module involves non-ribosomal peptide 
synthesis (NRPS) which is comprised of the activities of EntE, EntB (C-terminal 
domain), EntF, and EntD. In the NRPS module, three molecules each of 2,3-DHB and L-
serine residues are condensed to form  enterobactin. This thesis focuses on the 
enterobactin biosynthetic enzymes EntA, EntE, and EntB which catalyze sequential 
reactions. EntA catalyzes the formation of 2,3-DHB which is then used as a substrate for 
EntE. EntE catalyzes the activation of 2,3-DHB in the form of 2,3-DHB-AMP which acts 
as a substrate for EntB.  
 Relatively little has been reported on the characteristics of these enzymes, and we 
are still far from comprehensively understanding how these enzymes work together in the 
same pathway. An important unresolved question: to what extent are the activities of 
these enzymes coordinated through protein-protein interactions?  Such a network of 
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protein interactions may facilitate the direct channeling of enzymatic intermediates 
between sequentially related activities and increase efficiency of enterobactin 
biosynthesis under the iron-starved condition inside the host. In depth analysis of these 
enzymes and characterization of their interactions will enrich and advance our knowledge 
of the enzymology and molecular mechanisms of this pathway. Understanding of the 
molecular basis and the thermodynamics of complexes formation between those enzymes 
are extremely significant. Furthermore, identification of the interaction interfaces 
between the enzymes studied in this thesis will be crucial to design novel antimicrobial 
drugs.  
All of these studies will guide us to better understand how pathogenic bacteria are 
able to use catecholate siderophores as virulence factors to accomplish their pathogenic 
effect inside the host. Recently, it has been reported that the mammalian cells synthesize 
a siderophore that plays an essential role in intracellular iron homeostasis (1). This 
siderophore uses 2,5-DHB in iron chelation instead of 2,3-DHB in E. coli enterobactin. 
BDH2, the EntA homologue, is responsible for the synthesis of 2,5-DHB. Thus 
mammalian homologues of E. coli EntA and EntE have been discovered for the first time. 
Our studies on the enterobactin enzymes will further shed light on the activities of the 
mammalian homologous enzymes and the possible interaction network between them 



























1.1 Iron Chemistry and Availability 
Iron is an important  nutrient for most microorganisms due to its participation in 
many biological processes, including enzyme catalysis, electron transport, and DNA 




). Thus iron 
functions as a major cofactor in many processes. Under aerobic conditions at pH 7, iron 
is predominantly in the ferric form (3). Ferric ions have high affinity for hydroxyl ions, 
resulting in formation of insoluble ferric hydroxide (Fe (OH)3) ions which have solubility 
constant less than 10
-38
 M (4-5). For this reason, the free ferric ions concentration in 
solution is 1.4×10
–9
 M (6). Most of iron in the living cell is complexed with proteins, 
making the free iron concentration (approximately 10
-24
 M) in the serum insufficient to 
support microbial growth (2, 4, 7-9). Consequently, most pathogens develop different 
strategies to obtain iron inside the host. 
Unavailability of iron in host organisms has one more advantage in addition to 
limitation of microbial life. The very low iron concentration under physiological 
conditions protects the living cells from oxidation effects. This is because ferrous irons 
can react with superoxide and hydrogen peroxide, which are generated by many 
processes giving rise to reactive oxygen species (ROS) via the Fenton reaction (10-11). In 
this reaction, the hydrogen peroxide reacts with ferrous ions, producing very reactive 
hydroxyl radical. Then the oxidized iron (Fe
3+
) is reduced by the cellular reducing 
component such as superoxide. The whole cycle is called Haber Weiss reaction (Figure 1 
(6)).  These ROS can cause harmful damage in the cell, including oxidative damage to 
DNA, membranes, and other cellular biomolecules (12-13). It has also been reported that 





Figure 1:  Haber Weiss cycle.  
(Figure from Ratledge et al (6))  
The superoxide radicals are provided by some reactions such as nitric oxide synthetases 
reactions. 
1.2 Iron-Containing Proteins Used by Microorganisms 
Iron is toxic to cell due its contribution to free radicals generation via Fenton 
reaction. Hence organisms have developed set of protective mechanisms to regulate iron 
homeostasis. 
1.2.1 Extracellular Iron-Binding Proteins: Transferrins and Lactoferrin 
In the mammalian cells, ferric iron is bound to extracellular iron binding 
glycoproteins called transferrin (Tf) and lactoferrin (Lf). Transferrin found in the serum 
while lactoferrin is found in extracellular fluid. Tf is usually partially saturated by iron so 
it has a protective role in addition to its iron delivery role (16). The protection role of Tf 
results from its ability to bind any iron released in the serum. Lf is one of the innate 
immune system that has a protective role in case of infections (17). Tf and Lf have 
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similar structures. Briefly, they have molecular weights of  approximately 80 kDa and 














1.2.2 Intracellular Iron-Binding Protein: Ferritin 
Ferritin is an intracellular iron storage protein that is present in most organsims. 
Ferritin stores and releases iron according to the cell need in a highly regulated way. Thus 
it plays an important role in iron homeostasis. Ferritin is found also in plants 
(phytoferritin) and in microorganisms (bacterioferritin) (19-20). Ferritins have similar 
structures except that bacterioferritins have attached heme (21). Ferritins are constructed 
of 24 protein subunits (each subunit ~ 20 kDa) with a central cavity that is capable of 
binding about 4500 ferric ions (22). In a mammalian cell, these subunits are divided into 
two types, the light (L) and the heavy (H) type. All native ferritins have the ability to 
oxidize Fe
+2
 and to store it as Fe
+3
. Such catalytic centers present only in the H-type chain 
(23). In humans, ferritin holds approximately 30% of the iron pool (24). 
1.3 Heme-Containing Proteins Used by Microorganisms 
Heme is used as a prosthetic group in many enzymes. Plants and animals also 
have many heme-containing proteins, including myoglobin, catalase, and type b 
cytochrome. Heme is required by some bacteria that can not synthesize the tetrapyrole 
ring, including Lactococcus lactis and Haemophilus influenzae. Bacteria require heme in 




Inside the host, free heme is poisonous because its hydrophobicity leads to its 
partitioning in membranes. Hemopexin is a plasma heme binding glycoprotein which has 
a protective role via its binding with high affinity to any heme released into plasma with 
KD ~ 10
-13
 M (26).  Heme-hemopexin binding protein “HxuA” has been identified in 
Haemophilus influenzae  (27). Here, HxuA mutant is deficient in using Heme-hemopexin 
as a source of iron. The heme-hemopexin-HxuA complex is recognized by an outer 
membrane receptor HxuC (28).  
1.3.2 Hemoglobin 
Hemoglobin acts as an oxygen transporter in red blood cells. It is composed of 
two α- and two β- subunits. Each subunit is tightly bound to a heme group that contains a 
penta-coordinated iron (25). Five iron binding sites are offered by the four nitrogen atoms 
in the porphyrin ring and the imidazole of one histidine residue from the protein. 
Hemoglobin can be classified based on the sixth coordination position into: (i) 
methemoglobin when the sixth coordination site is free, (ii) oxyhemoglobin when the 
sixth coordination site is occupied by oxygen, (iii) carboxyhemoglobin when the sixth 
coordination site is filled up by carbon dioxide (25, 29). In human, hemoglobin holds 
about two-thirds of the total  iron in the body (24).  
1.3.3 Hemoglobin- Haptoglobin 
Haptoglobin is a glycoprotein located in the serum. Haptoglobin consists of two H 
chains joined by two smaller L chains. It has a protective role via its interaction with any 
hemoglobin released by hemolysis  in the serum and thereby inhibits its oxidative activity 
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(30). This complex is irreversible and can be only separated after removal by the liver. 
The hemoglobin-haptoglobin complex provides iron for many bacteria, including 
Haemophilus influenzae type b and Neisseria meningitidis (31-32). Studies revealed that 
the TonB-dependent outer membrane receptor, HpuAB, utilizes hemoglobin- haptoglobin 
as an iron source in N. meningitides (33-34).  
1.4 Iron and Heme Uptake Systems  
As mentioned previously, iron is tightly bound to proteins in which it plays an 
essential role in overall structure or function. At the same time, there are many proteins 
that bind iron, heme, or hemoglobin to ensure removal of free iron or these iron-
containing compounds from the circulation.  Such clearance is a protective mechanism 
against the oxidative activity of iron or these iron-containing compounds as explained 
previously. This strict iron homeostasis results in free iron concentration in the serum of 
about 10
-24
 M (35). Hence the poor availability of iron at physiological pH under aerobic 
conditions is a serious obstacle to the growth of most microorganisms. Many 
microorganisms have developed direct and indirect mechanisms to scavenge iron or iron-
containing heme under low-iron conditions.  
However, some members of Lactobacilli can live without iron (36). These 
bacteria do not contain heme compounds and they use the cobalt – containing vitamin 
B12 form of ribonucleotide reductase (RNR) (37). RNR is required for biosynthesis of 
deoxyribonucleotides.  RNR is classified into three classes. Class I is aerobic non haem-
iron dependent RNR (in bacteria and eukaryotes) (38), class II is adenosylcobalamin-
dependent RNR (in Lactobacillus leichmannii) (39), and class III is anaerobic iron-sulfur 
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dependent RNR (in bacteria and eukaryotes) (38). E. coli has class I and class III RNR 
systems, so it can adapt to aerobic and nonaerobic environments (40).  
1.4.1 Direct Iron and Heme Uptake System   
Direct uptake strategies involve direct contact between bacteria and iron or heme 
sources. The drawback of these strategies is that bacteria need specific receptors for each 
iron or heme source. In the direct iron uptake systems, bacteria have different 
mechanisms to release iron or heme upon binding of iron or heme sources by their 
receptors at the bacterial surface.  
Direct Uptake of Iron 
   Bacteria could extract iron upon contact with the host iron source by direct 
removal of iron by its reduction and uptake (6). Anaerobes can get iron by creating their 





bound transferrin and lactoferrin causing release of Fe
2+ 
iron (41). 
Facultative anaerobes E. coli and S. typhimurium have Feo uptake system for soluble 
ferrous ions (42-43). The Feo system is composed of three proteins, FeoA, FeoB, and 
FeoC.  FeoB is an inner membrane protein but FeoA and FeoC are cytoplasmic proteins. 
Fe
2+
 uptake from the periplasm is accomplished by FeoB, probably with the assistance of 
FeoA and FeoC (44). It has also been reported that TbpA protein, TonB-dependent outer 
membrane receptor, serves as a channel to transport ferric iron after its release from Tf 
(45). In Mannheimia haemolytica, a periplasmic Fe
3+
-binding protein called FbpA 
mediates the transport of released ferric iron from Tf to the inner cytoplasmic membrane 
complex FbpB/C (46). This study demonstrated that FbpA adopts two conformations, 
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carbonate anion bound FbpA (closed conformation) and anion unbound FbpA (opened 
conformation). The closed conformation has higher affinity for ferric iron than the open 
conformation, indicating the important role of anion binding in iron uptake and release by 
FbpA.  
Direct Uptake of Heme 
   The high affinity between heme and its heme-binding proteins rules out the 
possibity that bacteria can extract the  heme molecules from these proteins by equilibrium 
displacement with the bacterial outer membrane receptors (25). It has been reported that 
heme could be released after hemoprotein degradation by surface proteinases in some 
microorganisms, such as RgpA and Kgp in Porphyromonas gingivalis (47). After heme 
release in the periplasm, heme will be transported to cytoplasm by the periplasmic-
binding protein-dependent transport (PBT) system (6). Inside the cytoplasm, heme can be 
incorporated directly into enzymes or the iron can be removed by the porphyrin ring 
degredation (48-49). 
1.4.2 Indirect Iron and Heme Uptake Systems   
Indirect iron uptake systems are more common among microorganisms. In such 
systems, microorganisms synthesize and secrete iron-chelating molecules (siderophores) 
or heme-chelating proteins (hemophores) to scavenge iron and heme from various 
sources. 
Indirect Heme Uptake System: Hemophores  
Many bacteria pathogens have the ability to use heme as an iron source, including 
V. cholerae, Shigella dysenteriae, enterohemorrhagic E. coli O157:H7, and H. influenzae 
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(41, 50-53). The indirect heme uptake mechanism to scavenge heme from host heme 
sources involves secretion of soluble proteins called hemophores to interact with 
hemoproteins and bring heme to specific TonB dependent outer membrane receptors on 
the cell surface. HasA/HasR is a heme acquisition system identified in many pathogenic 
bacteria such as Serratia marcescens, and P. aeruginosa (25). HasA is a heme-binding 
protein (hemophore) that binds free heme or pulls out heme from hemoglobin and 
transfers it to the outer membrane receptor HasR. HasA was purified as monomeric 
protein of 19 kDa that binds one heme with high affinity without conformational 




Indirect Iron Uptake System: Siderophores 
Under iron limiting conditions, most microorganisms synthesize and secrete small 
iron-chelating molecules called siderophores (from the Greek term for “iron carrying”). 
Siderophore-dependent iron uptake strategies are widely distributed among   
microorganisms. The number of different siderophores produced by bacteria, yeasts, and 
fungi is more than 500 (56-58).  Siderophores are low molecular weight compounds, less 
than  1 kDa in size (24). Siderophores are characterized by their high affinity for Fe
3+
 and 
generally their stability constant for formation complex with Fe
3+







(57). This high affinity is enough to allow siderophore to extract iron from Tf 
and Lf (59). Ferric-siderophores are then transported into bacteria via specific active 
transport systems. In the  bacterial cytoplasm, iron is used by iron-containing proteins or 
stored in heme-containing bacterioferritin (22). In many pathogenic microbes, 
10 
 
siderophore-mediated iron uptake systems are  considered as important virulence factors 
(60). 
1.5 Regulation of  Iron Metabolism in Microorganisms 
The first regulatory mechanism involves ferric uptake repressor (Fur) or 
diphtheria toxin repressor (DtxR). Fur and DtxR are metalloproteins that bind Fe
2+
. In 
Gram-negative bacteria, the iron metabolism genes are regulated by Fur (61). Iron uptake 
genes are negatively regulated by Fur when iron is available within the bacteria. Under 





complex binds to the Fur box consensus sequence, located near or within the promoter of 
the gene to be regulated, resulting in repression the expression of Fur-regulated genes 
(such as genes involved in siderophore biosynthesis and secretion).  Fe
2+
-Fur complex 
also up regulates the translation of some of the iron-using proteins indirectly via 
inhibition of RyhB gene expression (Figure 2). RyhB is a small RNA that binds to the 
mRNAs of some of the  iron-utilizing proteins and promotes their degradation (62). In 
contrast, under iron-limiting conditions, iron will dissociate from Fur, causing Fur 
inactivation and its release from the Fur box. This leads to upregulation of iron uptake 
genes expression in order to obtain iron from extracellular environment, and down 




Figure 2: Iron metabolism regulation by Fur and RyhB. 
 (Figure from Salvail et al (62)) 
Under iron-limiting condition, Fe
2+
 will break up from Fe
2+
-Fur complex, resulting in 
Fur inactivation. This will allow induction of the iron acquisition genes and the ryhB 
gene expression. Then Fe
2+
 will be taken from the extracellular environment by one or 
more iron acquisition mechanisms.  Concomitantly, RyhB will inhibit the synthesis of the 
non-essential iron-containing proteins, ensuring the best use of Fe
2+ 
by the essential 
iron-containing proteins. Once Fe
2+
 will be available in the cytoplasm, Fe
2+
 will be used 
by iron using proteins. Concurrently, Fe
2+
 will bind Fur, resulting in Fur activation. 
Then active Fe
2+
-Fur complex will inhibit the expression of the iron acquisition genes 
and the ryhB gene.  
 
Gram-positive bacteria produce proteins similar to Fur in order to regulate the 
iron uptake system. DtxR (diphtheria toxin repressor) was recognized as a repressor that 
binds iron as corepressor in Corynebacterium diphtheriae (63). DtxR-like proteins have 
been found in other Gram-positive bacteria such as and S. epidermidis (64) and 
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Brevibacterium lactofermentum (65). There are structural similarities between Fur and 
DtxR proteins in the domain organization and metal binding site (66-67). They are 
composed of DNA binding domain and metal binding domain. The metal binding domain 




.  It was shown that Zn
2+
 binding to Fur has an 
essential role in stabilizing the protein quaternary structure (66, 68). 
 The second mechanism of regulation of bacterial iron metabolism is extra 
cytoplasmic function (ECF) sigma factors. This mechanism is commonly found in Gram-
negative bacteria. Sigma factors are essential components that are able to bind RNA 
polymerase and DNA in order to stimulate transcription (69). Sigma factors are 
cytoplasmic proteins that can be sequestered by cytoplasmic membrane proteins (anti-
sigma factors). However, some anti-sigma factors are cytoplasmic proteins and some 
sigma factors do not have anti-sigma factors. Generally, when an external ligand binds to 
an outer membrane receptor, the signal is transferred to a cytoplasmic membrane protein, 
resulting in degradation of the anti-sigma membrane proteins by inner membrane 
proteases. The released sigma factor then binds to RNA polymerase in order to stimulate 
the transcription of target genes (69). This mechanism is well characterized in the E. coli 
ferric citrate uptake system  (70). In most bacteria, hemophore outer membrane receptors 
are regulated by Fur. HasR regulation involves ECF sigma and antisigma factors (71).  
The third regulatory mechanism involves AraC-like transcriptional regulators. 
AraC-like proteins are located in the cytoplasm.  They have DNA binding domain and 
Fe-siderophore binding domains (24). PchR, an AraC-type regulator, has been identified 
in Pseudomonas aeruginosa (72). PchR functions as activator for the pyochelin 
biosynthetic gene cluster pchDCBA and iron uptake gene expression. PchR requires 
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ferric-pyochelin to exert its action, suggesting that ferric-pyochelin acts as intratracellular 
effector that triggers the PchR-mediated activation. 
1.6 Siderophores 
1.6.1 Thermodynamics of Iron Binding by Siderophores 
As mentioned previously, siderophores bind iron (Fe
3+
) selectively with high 
affinity in order to compete with other iron chelators. In this part we will give more 
insight into the thermodynamics of iron-binding by siderophores.  
Fe
3+ 
is  catagorized as a hard Lewis acid due to its high charge-to-radius ratio 
(73). Therefore, Fe
3+
 ions bind with high affinity to hard donor atoms (Lewis base) such 
as oxygen and amine nitrogen atoms. In contrast, Fe
2+
 ions have low charge-to-radius, 





) in aqueous solution (44). Siderophore donor atoms 
replace the solvent water molecules and bind Fe
3+
 via strong ionic interactions in a 
hexadentate coordination that results in octahedral geometry. The stoichiometry of iron-
siderophore complexes can be 1:1 if the siderophore provides six donor atoms. If the 
siderophore has less than 6 donor atoms, the water oxygen atoms will participate as 
donors or more than one siderophore will be involved in the chelation process. For 
example, pyochelin forms FeL and FeL2 complexes (L is used here to indicate a 
siderophore molecule) (74).  




 compete for siderophore binding. Thus, the 
proton participation must be involved during the calculation of the Fe-siderophore 
complex formation constant (Kf) (59). The stability constant of Fe-siderophore complex 
formation is represented by βmlh for the reaction “mM + lL + hH = MmLlHh”, where M is 
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metal, L is ligand, and H is proton (24). The catecholate siderophore enterobactin has a 
log  βmlh of 49 (75, 76). Another scale used to measure the stability of the Fe-siderophore 
complex is the pFe scale. The pFe value is -log [Fe
3+
]free at fixed Fe
3+
, ligand, and H
+
 
concentrations. At pH 7.4, pFe values of enterobactin and aerobactin are 35.5 and 23.4, 
respectively (24).  
The pKa values of the siderophore donor atoms also affect Fe-siderophore 
complex formation. The pKa values of the hydrogen removal from the catecholate 
siderophores hydroxyl groups are: from 6.5 to 8 for the first hydrogen and around 11.5 
for the second hydrogen (24). The pKa values of hydroxamate siderophores  range from 8 
to 9 and those of  carboxylate range from 3.5 to 5 (24). Thus, pH potentially plays a role 
in the ferric chelation process by siderophores. For this reason, microbes such as fungi 
inhabit acidic environments in which carboxylate siderophores are favored while 
enterobactin is a more effective iron-chelator in higher-pH environments (77).  
1.6.2 Siderophores Structures 
As explained previously, Fe
3+
 is hard Lewis acid and needs a hard donor atom to 
ensure strong interaction. Microbes take advantage of this property by incorporating iron-
chelating molecules with catecholate, amine, hydroxamic acid, and α-hydroxycarboxylic 
acid binding moieties (Figure 3). These siderophores bind Fe
3+
 in hexadentate manner. 
Siderophores could be composed of one type of the chelating group, such as the tris-
catecholate siderophore enterobactin and the tris-hydroxamate siderophore 
desferrioxamine (Figure 4). Alternatively, some siderophores are known as mixed 
siderophores because they have constructed of more than one type of the iron chelating 
groups (Figure 4). This type of siderophores includes the mixed citrate-hydroxamate 
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siderophore (aerobactin) that is produced by many pathogenic bacteria (78-79)  and the 
mixed citrate-catecholate siderophore (petrobactin) that is produced by Bacillus anthracis 
(24, 80). Hydroxamate donor groups are common in fungal siderophores such as 
ferrichrome (81). 
 
Figure 3: Chemical iron-binding groups used by microorganisms to build 
siderophores. 




Figure 4: Chemical structure of some natural siderophores. 
( Figure from Miethke et al (24))   
Iron-binding groups are colored: catecholates (red), phenolate (orange,), hydroxymate 
(yellow), α-hydroxy-carboxylates (green), α-keto-carboxylates (blue-green). 
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1.6.3 Siderophores Biosynthesis 
Non-Ribosomal Peptide Synthesis (NRPS) Processes 
Large multienzyme complexes called non-ribosomal peptide synthetases (NRPS) 
are involved in biosynthesis of many siderophores (24, 82-83). NRPS enzymes catalyze 
amino acid activation and assemble siderophore backbones using specialized domains 
that will be explained later. NRPS mechanisms are used in the synthesis of aryl-capped 
siderophores which have been identified in many pathogenic bacteria, including 
enterobactin in E. coli, Shigella spp., and Salmonella enterica; mycobactin in M. 
tuberculosis; pyochelin and pyoverdin in P. aeruginosa; yersiniabactin in Yersinia spp.; 
vibrobactin in V. cholerae (82). Therefore, NRPS in those pathogens is the focus of much 
research and the target for the development of new chemotherapeutic drugs.   
At the beginning of NRPS biosynthesis of aryl-capped siderophores, the aryl acids 
2,3-dihydroxybenzoate (DHB) or salicylate (i.e., the aryl caps), are synthesized. These 
are then used as precursors for condensation with certain amino acids, resulting in 
production of aryl-capped siderophores. The enzymes that catalyze aryl acid synthesis are 
regulated by Fur in Gram-negative bacteria (82). NRPS assembly lines that condense aryl 
acids with amino acids work by a multiple-thiol templating process (84). An NRPS 
assembly line is composed of multiple domains that work together to catalyze aryl acid 
precursor activation, chain elongation, and finally chain termination (82-83). Furthermore 
NRPS can be composed of extra domains which catalyze substrate modification such as 




 Each NRPS system is constructed of multiple domains (Figure 5) (86) (i) 
adenylation (A) domains for the selection and activation of  the aryl acid and amino acid 
as acyl-AMP conjugate; (ii) peptidyl carrier proteins (PCP) domains that covalently 
tether the activated amino acid or carboxylic acid to their thiol groups of their 
phosphopantetheinyl arms; (iii) condensation (C) domains that are located downstream of 
PCP and catalyze chain elongation and forming peptide bond between the activated aryl 
acid and the activated amino acid. Each C domain has an upstream PCP domain as 
substrate donor and a proximal downstream PCP domain that is bound to the attacking 
substrate acceptor; (iv) thioesterase (TE) domain that is responsible for chain termination 
and release of siderophore. The release of the siderophore by the TE domain could be via 
intermolecular hydrolysis to release free acid or intramolecular cyclization to release a 
cyclic lactone (e.g., enterobactin).  
Many antibiotics are also synthesized by NRPS assembly lines via thiotemplate 
mechanism, resulting in synthesis of effective antibiotics (87). This mechanism is 
different from the synthesis of the peptide backbone in the proteins using mRNAs, 
tRNAs, and ribosomes as explained previously. Examples of antibiotics synthesized by 
NRPS include daptomycin (88) and penicillin (89). Some microbes are able to use their 
NRPS machinery to synthesize nature products that have antimicrobial, antitumor, or 
immunosuppressive activities. These products are considered as extremely important 
source for many pharmaceutical agents (90). A deeper understanding of the proteins 
involved in the NRPS will help in modulation of their activities through the use of small 





Figure 5: Mechanism of nonribosomal peptide elongation and termination.  
(Figure from Marahiel et al (86)) 
 1: Activation the substrate (e.g., amino acids) via A domain, 2: The activated substrate is 
transferred to PCP domain and bound to its phosphopantetheinyl group, 3: C domain 
catalyzes the formation of peptide bond between activated substrate bound to upstream 
PCP (as donor) and the activated substrate bound to the downstream PCP (as acceptor), 
and 4: TE domain catalyzes the termination and release of the nonribosomal peptide. 
NRPS- Independent Siderophore Biosynthesis   
 Many siderophores are not polypeptides and are therefore assembled via non-
ribosomal peptide synthetases-independent mechanisms (83, 91). Most hydroxamate and 
carboxylate siderophores are constructed by NRPS-independent mechanisms. Many 
enzymes are involved in this mechanism, including ac(et)yltransferases,  monoxygenases, 
aminotransferases, and amino acid ligases (91). Aerobactin biosynthesis was the first 
described NRPS-independent pathway (91-92). Siderophores synthesized by NRPS-
independent machinery are widely produced by many pathogenic bacteria, including 
petrobactin produced by B. anthracis (93-94), alcaligin produced by B. pertussis and B. 
bronchiseptica (95), and aerobactin produced by Aerobacter aerogenes (96).  
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Hybrid NRPS/NRPS-Independent Pathway 
Hybrid NRPS/NRPS-independent mechanism can be involved in the biosynthesis 
of some siderophores such as  petrobactin (97). Petrobactin is mixed citrate-catecholate 
siderophore made by B. anthracis (94, 98). Petrobactin is composed of two catecholate 
ligands and an α-hydroxycarboxylate ligand for ferric iron chelation. The B. anthracis 
asbABCDEF gene cluster is responsible for petrobactin biosynthesis as reviewed by 
Barry S. M. and Challis G. L. (99).  
1.6.4 Siderophore Transport Systems 
Siderophore Export Systems 
There are three types of transport systems are identified in the siderophore export 
from the cytoplasm.  
(i) ATP-binding cassette (ABC) transporters are a large family of transporters 
that are invoved in both import and export systems (figure 6) (100-101). Thus these 
transporters are considered as one of the important targets for development of antibiotics 
(102).  They are composed of two transmembrane domains and two cytoplasmic domains  
as reviewed by Miethke and Marahiel (24). The cytoplasmic domains have the nucleoside 
triphosphate binding sites (such as ATP). The hydrolysis of the nucleoside triphosphate 
energizes the transport process. IroC is an example of ABC transporters that transports 
salmochelin, a glucosylated enterobactin produced by pathogenic Salmonella and E. coli 




Figure 6: ABC-transport system diagram.  
(Figure from Garmory and Titball (102))  
OMP:  outer membrane protein, IMP: inner membrane protein, SBP: solute periplasmic 
binding protein, and AF: accessory factor that mediates the transport across the 
periplasm. 
 
(ii) Resistance, nodulation, and cell division superfamily (RND). This 
superfamily of transporters is responsible for the export of many compounds. Most of this 
family uses a transport mechanism that involves a proton antiport system (104). The  
RND transporters are large proteins that are composed of various extracytoplasmic  and 
transmembranne domains (24). One of the RND transporters is the AcrB- AcrA-TolC 
system that mediates the transport of large number of compounds into E. coli  (105).  
AcrB is an RND transporter across the inner cytoplasmic membrane, AcrA is a 
membrane fusion protein (MFP), and TolC is an outer membrane chamnel that is mediate 
the transport across the outer membrane.  
 (iii) The major facilitator superfamily (MFS). The MFS superfamily is one of 
the essential transporter families. The transport by this family involves different 
mechanisms such as solute/cation symport, solute/cation antiport, or solute uniport (106). 
This family is involved in the export of various compounds such as drugs, siderophores, 
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and some metabolites (106). This family of transporters is constructed of 12, 14, or 24 α-
helical transmembrane regions as reviewed by Miethke and Marahiel (24). One of the 
examples of the MFS family involved in siderophore efflux is EntS, which is responsible 
for enterobactin secretion under iron-limited conditions and it is Fur- regulated (107).  
EntS will be discussed in more detail later in this chapter. 
Siderophore Import Systems 
Many outer membranes receptors for different ferrisiderophores have been 
identified, including FhuA for ferrichrome (108) and FepA for Fe-enterobactin (109) in 
E. coli. Generally, they are composed of a 22-β-strand barrel (C-terminal residues~ 600) 
and about 150 residues that comprise an N-terminal folded globular domain inside the 
barrel that form a “plug” domain (110). Transport through the receptor is energized by 
TonB complex. This complex is comprised of three inner membrane proteins (TonB, 
ExbB, and ExbD) (Figure 7). In this complex TonB interacts with the with the inner 
cytoplasmic membrane proteins ExbB and ExbD via its N-terminal domain (111) and  
interacts with the ferrisiderophore outer membrane receptor via its C-terminal domain 
such as is seen in its interaction with FhuA (112). The energy is transferred from the 
proton motive force energy transduction system (TonB complex) to the outer membrane 
receptor in order to mediate ferrisiderophore transport into the periplasm. Then an ABC-
type transporter mediates the ferrisiderophore complex passage throught the bacterial 




Figure 7: TonB-ExbB-ExbD complex.  
(Figure from Chu et al (113)) 
TonB is composed of three domains: N-terminal transmembrane domain that interacts 
with ExbB-ExbD, periplasmic linker domain, and C-terminal domain that interacts with 
TonB-dependent outer membrane receptor. 
1.6.5 Liberation of Iron from Ferric-siderophore Complexes 
There are two mechanisms involved in iron release from siderophores in bacteria.  
Many bacteria have ferri-siderophore ferri-reductases such as E. coli (114)  and Bacillis 
spp. (115-116) . These enzymes use NADH or NADPH as cofactors to reduce Fe
3+
 in the 




 has lower charge-to-radius ratio than 
Fe
3+
. This leads to a decrease in the affinity between Fe
2+
 and the donor atoms in the 
siderophores which involve in the iron chelation (44, 117-118). Fe
2+
 ions are delivered to 
the iron-containing molecules (porphyrin, iron-containing proteins, and iron storage 
proteins).   
The second mechanism is the intracellular hydrolysis of siderophores to release 
iron. In E. coli, ferric enterobactin esterase (Fes) catalyzes enterobactin hydrolysis into 
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2,3-hydrozybenzoylserine  (DHBS) moieties. This results in decrease in the chelation 
affinity and iron release. E. coli Fes was purified as monomer with a molecular weight 43 
kDa (119). It hydrolyzes both free enterobactin and ferric-enterobactin, displaying a 4-
fold higher activity with free enterobactin and similar activities toward ferric-enterobactin 
and aluminum (III)-enterobactin complex hydrolysis
 
(119).   
1.7 Iron Metabolism Inhibition  
One of the essential needs of pathogenic microbes in host cells is iron. Because 
the free iron concentration inside the host is not enough to support microbial life as we 
discussed previously, most microbes synthesize and secrete siderophores in order to 
mobilize and extract iron from its source. The molecular mechanisms of these processes 
provide many targets for antimicrobial drugs to attack siderophore-mediated iron uptake 
at the transport level or at the biosynthesis level. Some antimicrobial antibiotics are based 
on using siderophores as mediators to facilitate the transport of the antibiotic compounds 
into the microbial cell. Such hybrid compounds are called “Trojan Horse” antibiotics. 
“Trojan Horse” Antibiotics 
Antibiotics are chemically linked with siderophores so that siderophore uptake 
systems can be exploited as gates to enter the microbial cell. Because these antibiotics 
use the siderophore as “Trojan Horse” to enter the cell they are called “Trojan Horse” 
antibiotics (120). Upon entry to the cell, antibiotic moiety is then cleaved from the 
siderophore in order to be active and to exert its effect.  Siderophore antibiotic drugs can 
be constructed using a semisynthetic method with naturally occurring siderophores, or 
using a total synthesis method for the whole compound (siderophores and antibiotics) 
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(120). One example of a semisynthesized “Trojan Horse” antibiotic is a β-lactam 
antibiotic that was  linked to pyoverdin from P. aeruginosa (121).  
However, there are also some naturally-produced “Trojan Horse” antibiotics. 
Microcins is one of the naturally-produced “Trojan Horse” antibiotics that are made by 
enteric bacteria.  MccE492 produced by K. pneumoniae is joined to the glucosylated 
linear enterobactin so it can be recognized by enterobactin and salmochelin outer 
membrane receptors FepA and IroN, respectively (122-123). MccE492 is an antibacterial 
peptide that induces pore formation in the bacterial membrane (124). Another example of 
the naturally-produced “Trojan Horse” antibiotics is albomycin, made by streptomycetes 
or actinomycetes.  Albomycin is similar to ferrichromes in that it can also be transported 
by the FhuA  outer membrane receptor (125). Inside the cell, a serine peptidase catalyzes 
the release of thioribosyl pyrimidine moiety, a nucleoside analogue, from the siderophore 
moiety. This  nucleoside analogue will then prevent the protein biosynthesis by inhibiting 
seryl-tRNA synthetases (126).   
Siderophore Biosynthesis Inhibitors  
One of the therapeutic targets against pathogens is the process of siderophore 
biosynthesis. There are many drugs that are synthesized as inhibitors of siderophores 
biosynthetic enzymes, and some examples are discussed below. 
The first part of the aryl-capped siderophore biosynthesis pathway is the 
biosynthesis of salicylate or 2,3-dihydroxybenzoate (DHB), which are then activated by 
adenylation domains using ATP and then used as substrates for the NRPS. Some DHB 
and salicylate analogue drugs were synthesized to act as inhibitors for DHB and 
salicylate adenylation domains. A 5'-O-[N-(salicyl)-sulfamoyl] adenosine (SAL-AMS) 
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blocked the salicylate adenylation domain activities in some microorganisms that use 
salicylate in siderophore biosynthesis (127). In contrast, DhbE, the DHB adenylating 
domain in bacillibactin biosynthesis, has more of a preference to bind 5'-O-[N-(2,3-
dihydroxybenzoyl)-sulfamoyl] adenosine (DHB-AMS) so it exerts a more inhibitory 
effect than SAL-AMS (127). Other substrate analogues have been synthesized in order to 
inhibit biosynthetic enzymes during siderophore biosynthesis. For example, brominated-
enterobactin inhibits IroB,  the enzyme that catalyzes C5-glucosylation of enterobactin in 
most pathogenic E. coli species (128).  
1.8 Enterobactin: the Catecholate Siderophore of E. coli 
 Enterobactin is a cyclic trimer of dihydroxybenzoylserine catecholate 
siderophore that is produced by all E. coli species. Enterobactin was initially discovered  
in Salmonella typhimurium  and termed as enterobactin by Pollack and Neiland (129),  as 
well as in E. coli  where it was termed enterochelin by O‟Brien and Gibson (130). It is 
composed of three 2,3-DHB subunits such that each subunit forms an amide bond with L-
serine, and the three serine residues  form the trilactone backbone (enterobactin 
biosynthesis will be discussed later in more detail). Enterobactin has the highest known 
binding constant (KD ~10
-50
 M) for iron compared with other siderophores under 
physiological conditions (75). It binds Fe
+3
 in hexadentate manner via its catecholate 





Figure 8: Fe-enterobactin structure.  
(Figure from Goetz et al (132)) 
Carbon: gray, nitrogen: blue, oxygen: red; iron: red sphere 
 At the genetic level, enterobactin biosynthetic and transport genes regulated by 
Fur (61). There are six genes (entA-F) that encode enterobactin biosynthetic enzymes in 
E. coli. Furthermore, other seven genes (fepA–G) encode the proteins involved in ferric-
enterobactin uptake and a gene (entS) for enterobactin export across the inner 
cytoplasmic membrane. The enterobactin biosynthetic pathway is broadly divided into 
two functional modules. In the first module, 2,3-DHB is synthesized from chorismate by 
sequential reactions catalyzed by EntC, EntB (N-terminal domain), and EntA. In the 
second functional module (NRPS), enterobactin is constructed from three 2,3-DHB 
molecules and three L-serine molecules via formation of peptide bonds between the 2,3-
DHBs and L-serine residues. This module facilitates NRPS by the activities of the 
sequentially related enzymes EntE, EntD, EntB (C-terminal domain), and EntF. The 
NRPS reactions are similar to those for peptide antibiotic biosynthesis; here three amide 
bonds of enterobactin are made non-ribosomally by the protein thiotemplate mechanism 
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as discussed previously (131). After secretion and subsequent iron chelation Fe-
enterobactin (Fe-Ent) is transported into the bacterial cell via its outer membrane receptor 
FepA. The TonB-ExbB-ExbD complex is required to transport the Fe-Ent across the 
bacterial outer membrane. An ABC transporter then transports Fe-Ent into the cytoplasm. 
In the cytoplasm, a cytoplasmic esterase enzyme (Fes) catalyzes the cytoplasmic 
breakdown of ferric enterobactin at its triester core in order to release iron for cellular 
use. 
1.8.1 Enterobactin Biosynthesis and Uptake Regulation by Fur 
In E. coli, iron is involved in many essential biological processes such as 
respiration, DNA biosynthesis, and amino acid biosynthesis. However the high 
intracellular free iron concentration can lead to serious problems due to its contribution in 
the free hydroxyl radical production via the Fenton reaction as explained previously. 
Hence iron metabolism in E. coli is highly controlled by Fur (see Section 1.5).   
The enterobactin gene cluster is composed of 14 Fur-regulated genes, including 
six genes for biosynthesis (entA-F), seven genes for uptake (fepA-G), and fes gene, which 
encodes an esterase that hydrolyzes intracellular ferric-enterobactin to release iron (82). 
The promoter regions of all enterobactin operons contain the Fur box such that under 
normal conditions in which Fe
2+
 is elevated they are repressed by Fe
2+
-Fur complex. 
Another two genes have been identified in enterobactin-dependent bacteria, ybdA and 
ybdB. The  ybdA gene encodes for the cytoplasmic protein EntS that functions to export 
enterobactin (107). The ybdB gene encodes for the thioesterase EntH that corrects the 
misacylation of EntB during enterobactin biosynthesis (133-134). The enterobactin gene 
cluster has been identified in other bacteria, including Pseudomonas species, Salmonella, 
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Shigella, and Klebsiella (135-136). Hence, all of these species have the ability to use 
enterobactin under condition of iron starvation due to the Fur derepression (137).  
1.8.2 Enterobactin Biosynthesis 
The enterobactin biosynthesis pathway is divided into two modules. In the first 
module, 2,3-DHB is synthesized from chorismate using the activities of three enzymes 
EntC, EntB (N-terminal domain), and EntA. Chorismate is the precursor of enterobactin 
that is converted in the first reaction of the DHB module into isochorismate by the 
isochorismate synthase, EntC (Figure 9A). Chorismate is also the major precursor of 
aromatic amino acid biosynthesis (138). It is also used as a substrate for isochorismate 
synthetase (MenF) in menaquinone biosynthesis. E. coli has two isochorismate synthases 
EntC and MenF, which catalyze the same reaction. EntC is required under aerobic and 
iron-limited conditions whereas MenF is required under anaerobic conditions (44).  
The second enzyme in the DHB module is isochorismatase, EntB (N-terminal 
domain). EntB is bifunctional enzyme that functions as an isochorismate lyase via its N-
terminal domain in the DHB module and as an aryl carrier protein (Ar-CP) via its C-
terminal domain in the NRPS module (139). The EntB N-terminal domain catalyzes 
hydrolysis of isochorismate into 2,3-dihydro-2,3-dihydroxybenzoate (2,3-diDHB) and 
pyruvate (Figure 9A). EntA is 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase that 
catalyzes the oxidation of EntB N-terminal domain product (2,3-diDHB) into 2,3-
dihydroxybenzoate (2,3-DHB) using NAD
+
 as cofactor (Figure 9A) (140).  
In the NRPS module, enterobactin is synthesized from 3 molecules of 2,3-DHB 
and 3 L-serine residues using the activities of EntE, EntB (C-terminal domain), EntF, and 
EntD (Figure 9B). EntE is a 2,3-DHB-AMP ligase that catalyzes the first reaction in the 
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NRPS module. The EntE adenylation (A) domain catalyzes activation of 2,3-DHB (the 
product of EntA) by adenylation, resulting in the formation of DHB-AMP. EntE also 
catalyzes the acylation of holo-EntB Ar-CP domain by 2,3-DHB (141)
 
. EntD is a 
phosphopantetheine transferase that catalyzes the posttranslational modification of EntB 
Ar-CP domain and EntF PCP domain to form holo-EntB and holo-EntF (131). This 
modification activates EntB and EntF to work as aryl and acyl carriers, respectively. The 
Ar-CP domain name of EntB derived from its function to carry aromatic carboxylic acid 




Figure 9: Enterobactin biosynthesis.  
A: DHB module (adapted from: (35)) and B: NRPS module (adapted from: (142)). 
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EntF catalyzes the last reaction in the NRPS module. EntF is composed of four 
domains (Figure 9B): the adenylation domain (A), the condensation domain (C), the 
peptidyl carrier protein (PCP) domain, and the thioesterase (TE) domain (143-144). In 
EntF, the A domain adenylates L-serine residues and this is followed by transfer of the 
activated L-serine residue to the phosphopantetheine group of the PCP domain. The EntF 
C domain receives 2,3-DHB from holo-EntB Ar-CP domain. Then the EntF C domain 
catalyzes amide bond formation between the 2,3-DHB carboxyl group and the L-serine 
amino group, forming DHB-Ser-S-PCP in EntF. This is followed by transfer of the 2,3-
DHB-Ser (DHBS) moiety from the PCP domain to the TE domain. A second cycle of 
DHBS synthesis then occurs on the empty EntF C domain. Then the second DHBS is 
connected to the first DHBS in the TE domain by an ester bond. A third DHBS moiety is 
synthesized in the empty EntF C-domain and then linked by an ester bond to the second 
DHBS in the TE domain. At the end of the third cycle, the linear DHBS trimer is cyclized 
and released from EntF by the TE domain. The NRPS module can be summarized by this 
equation (44): 
3 L-Ser + 3 DHB + 6 ATP                Enterobactin + 6 AMP + 6 PPi 
EntH is encoded by the Fur-regulated ybdB gene. EntH was identified as a 
thioesterase enzyme that catalyzes the cleaving of any misacylated molecule attached to 
the phosphopantetheine group of EntB Ar-CP (133). This study also showed that an E. 
coli strain lacking entH hardly grew under iron-restricted condition in the presence of 
salicylate, which is a DHB-analogue inhibitor. Salicylate was tethered to the EntB Ar-CP 
phosphopantetheine group instead of 2,3-DHB causing inhibition of enterobactin 
biosynthesis.    
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1.8.3 Enterobactin Secretion 
In E. coli, a 43 kDa membrane protein was identified and originally called as P43 
(107). P43 catalyzes the transport of enterobactin across the inner cytoplasmic membrane 
(Figure 10). This protein belongs to the major facilitator superfamily (MFS) class of 
membrane proteins which uses the proton motive force to pump the some metabolites 
through the inner cytoplasmic membrane (106). The ybdA gene, one of the Fur-regulated 
enterobactin genes, encodes this transporter. The transporter name was changed to EntS 
due to its role in enterobactin export as well as the gene ecoded  this transporter was 
changed to entS instead of ybdA (107). EntS mutants have been shown to be defective in 
enterobactin secretion (107).  
In E. coli, a membrane protein called TolC is responsible for enterobactin 
secretion through the outer membrane (Figure 10) (145). It has been shown that deletion 
of tolC or entS resulted in E. coli strains that grew poorly under iron-limited conditions 
(145). It was also suggested in this study that enterobactin secretion occurs in two steps. 
The first step, enterobactin export from the cytoplasm to the periplasm, is mediated by 
EntS. The second step involves the outer membrane channel protein TolC to transport 





Figure 10: Scheme of enterobactin transport systems.  
(Figure adapted from: (35, 145)) 
 Right part represents enterobactin export system and left part represents Fe-Ent uptake 
system 
1.8.4 Fe-Enterobactin (Fe-Ent)  Import  
E. coli has a specific outer membrane receptor for Ferric-enterobactin called FepA 
(146). FepA not only mediates the Fe-Ent transport but also colicins B and D transport 
(147-148). Colicin B and D are cytotoxins that share similar Binding and translocation 
domains but have different C-terminal domains (i.e., Killing domains) so they have 
different mechanisms exerting cytotoxicity. Colicin B kills E. coli by creating a pore in 
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the inner membrane but colicin D works as ribonuclease in the bacterial cytoplasm (149-
150).  The binding stoichiometry of Fe-Ent and colicin B to FepA were studied (151). Fe-
Ent and colicin B interact with FepA with 1:1 stoichiometry. Enterobactin, colicin B, and 
colicin D interact with two arginine residues (Arg 286 and Arg316) in a surface loop of 
FepA (152). E. coli FepA interacts with Fe-Ent with high affinity (KD ~17 nM) (153).  
The crystal structure of FepA has been determined (154).  FepA is composed of 
two domains, a C-terminal domain that forms 22-stranded β-barrel and N-terminal 
domain that forms globular plug inside the barrel. This globular plug occludes the barrel 
pore. The translocation of Fe-Ent from FepA to the periplasm needs energy provided by 
the TonB-ExbB-ExbD complex (Figure 10) (155). TonB is a periplasmic protein that is 
embedded in the inner cytoplasmic membrane via its N-terminus. ExbB and ExbD, the 
inner cytoplasmic membrane proteins, mediate proton entry to cytoplasm and 
consequently energize TonB through conformational changes (156). Energy is then 
transfered from TonB to FepA. This energy induces FepA conformational change leading 
to rearrangement in the globular plug inside the β-barrel channel, allowing passage of Fe-
Ent (146).  
Once Fe-Ent is translocated to the periplasm, FepB, a periplasmic binding protein, 
binds Fe-Ent with high affinity and shuttles it to the cytoplasmic membrane ABC 
transport complex, FepD, FepG, and FepC (Figure 10) (157-159). The purified E. coli 
FepB interacts with Fe-Ent and apo-enterobactin with KD values of 30 nM and 60 nM, 
respectively (157). The transport of Fe-Ent into the cytoplasm is mediated by FepD, 
FepG, and FepC. FepC has two conformations, only one of which possess a active ATP 
binding site (44). When Fe-Ent binds FepB, FepB interacts with FepD and FepG. 
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Consequently the FepD-FepG channel opens, leading to change in the conformation of 
the FepC and forming active ATP binding site. All of these changes mediate the transport 
of Fe-Ent across the inner cytoplasmic membrane (44). ATP hydrolysis by FepC domains 
leads to a change in FepC conformation, closing FepD-FepG channel, and causing release 
of FepB. FepE and FepF are inner cytoplasmic permeases which may be involved in the 
Fe-Ent uptake but there are no details in the literature about the exact roles of FepE and 
FepF in the Fe-Ent uptake. In E. coli cytoplasm, the Fes esterase enzyme catalyzes 
hydrolysis of Fe-Ent into DHBS in order to release iron (Figure 10) (160).  
1.8.5 Enterobactin and Pathogenesis 
Enterobactin has the highest iron chelation capacity of all siderophores. However 
enterobactin hydrophobicity makes it less effective inside the host cell due its membrane 
partitioning, clearance by albumin, and binding by an innate immune protein called 
lipocalin-2 (132, 161). Lipocalin-2 is also called siderocalin or neutrophil gelatinase-
associated lipocalin (NGAL). Siderocalin is a 24 kDa protein that interacts with 
enterobactin, Fe-enterobactin, and related siderophores (162). Siderocalin is part of the 
lipocalins family and functions as a transporter via its binding to small hydrophobic 
molecules followed by binding to cell surface receptors (163). Upon bacterial infection, 
neutrophil cells release siderocalin at the site of infection as a kind of innate immune 
defense. Then siderocalin sequesters the catecholate related siderophores, including 
enterobactin.  
As a result of the host innate immune defence by siderocalin against enterobactin-
producing pathogens, these pathogens have developed a mechanism to modify 
enterobactin to evade siderocalin binding inside the host. The glucosylated versions of 
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enterobactin were termed as salmochelins because they were originally identified in 
Salmonella (164-165). The iroA gene cluster mediates enterobactin glucosylation, 
linearization, and transport as salmochelin (60). Many Gram-negative enteric bacteria 
harbor the iroA cluster, including extraintestinal E. coli, Salmonella spp., and Klebsiella 
pneumoniae (166). Salmochelin S4 is the glucosylated enterobactin at C5 of two catechol 
groups (Figure 11).  
 
Figure 11: The structure of salmochelin S4.  
(Figure from Lin et al (167)) 
The iroA gene cluster products are IroBCDE and IroN. IroB is a 
glycosyltransferase that catalyzes the enterobactin glucosylation at the C5 of its catechol 
moiety using uridine-5′-diphosphoglucose  (Figure 12) (168). It adds the glucosyl group 
at the C5 of one, two, or three catechol units of enterobactin. Most glycosyltransferases 
tether glucose residue to nitrogen or oxygen. The glucosylation at a carbon atom instead 
of oxygen or nitrogen is uncommon. However there are C-glucosylated proteins which 
are related to the mammalian innate immune system (169-171). This glycosidic linkage is 
essential due to its stability against low pH and the glycosidase activities (60). IroB 
catalyzes the first step in the IroA system so it is essential target for the drug 
development. Brominated enterobactin at C5 of its catechol groups acts as an IroB 
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inhibitor (128). IroC is an ABC transporter that functions to pump salmochelin and 
enterobactin across the inner cytoplasmic membrane (Figure 13) (103). IroN is the outer 
membrane receptor that is responsible for Fe-salmochelin uptake (Figure 13). It has 52 % 
identity to FepA, the Fe-enterobactin outer membrane receptor. Recently, IroN 
expression was correlated with a 5- to 10-fold increase in the invasion rate by E. coli 
HB101 (172).  
 
Figure 12: IroB, IroE, and IroD reactions.  
(Figure from Fischbach et al (60))  
 
IroD is an esterase enzyme that catalyzes the hydrolysis of Fe-salmochelin in the 
cytoplasm to release iron  (Figure 12) (173). It can hydrolyze Fe-salmochelin into the 
linear trimer, dimer, and monomer to lower the iron affinity. IroE is a periplasmic 
protein that attaches to the inner cytoplasmic membrane. It catalyzes the hydrolysis of 
enterobactin and salmochelin to produce the linear trimer (Figure 12) (173). The whole 




Figure 13: Schematic of IroA system.  
(Figure adapted from: (60)) 
1.8.6 Enterobactin Biosynthetic Enzymes  
Isochorismate Synthase: EntC 
In E. coli, there are two isochorismate synthases EntC and MenF. These enzymes 
are regulated in a different ways. The entC gene is expressed under aerobic and iron 
starvation conditions and is involved in the enterobactin biosynthesis pathway (174). The 
menF gene is expressed under anaerobic conditions and used in the menaquinone 
biosynthesis (175-176). It has been reported that each isochorismate synthase (MenF or 
EntC) is specific to its pathway (175). In this study, an E. coli mutant with intact menF 
and disrupted entC was able to synthesize only menaquinone. In contrast, an E. coli 
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mutant with intact entC and disrupted menF was able to synthesize enterobactin with 
traces of menaquinone.  
EntC catalyzes the reversible conversion of chorismate to isochorismate, the first 
reaction in the enterobactin biosynthesis pathway. E. coli EntC has been purified as 
active monomer with a molecular weight of 43 kDa (174). The E. coli EntC crystal 
structure has been solved recently (Figure 14) (177). EntC is composed of 9 α-helices and 
18 β-strands. The α-helices are placed in the protein surface. The β-sheet that is 
composed of the β-strands 2, 3, 7, and 11 forms an orthogonal β-sandwich with the β-
sheet that consists of the β-strands β5, β6, β17, and β18. In this study, many EntC 
mutations in active site residues were created to get more insights on the mechanism of 
the catalysis.  
 
 
Figure 14: EntC crystal structure as monomer (PDB code: 3HWO). 
The N-terminal and C-terminal domains were colored from the blue to red respectively. 
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The Bifunctional Enzyme: EntB 
EntB is bifunctional enzyme which works as  an isochorismate lyase  (ICL) (also 
known as isochorismatase) via its N-terminal domain and as an aryl carrier protein (Ar-
CP) via its C-terminal domain (139). Thus, EntB contributes to both enterobactin 
biosynthetic modules. The ICL domain functions in the DHB module and the Ar-CP 
domain functions in the NRPS module. The isochorismate lyase activity of EntB 
catalyzes the hydrolysis of isochorismate produced by EntC to 2,3-dihydro-2,3-
dihydroxybenzoate (the EntA substrate) and pyruvate. The Ar-CP domain of EntB is 
phosphopantetheinylated by EntD, the Fur-regulated phosphopantetheinyl transferase, at 
Ser 245 and then acylated at this site by its upstream partner EntE (131, 139). It had 
previously been reported that enterobactin biosynthesis requires the activity of EntG but 
there is no separate gene or polypeptide for EntG (178-179). Later entG gene was 
identified as the 3' terminus of entB gene that encodes the Ar-CP domain of EntB (180).  
The EntB crystal structure has been solved (Figure 15) (181). EntB crystallizes as 
a dimer (~ 60 kDa). In each monomer, the N-terminal ICL domain composed of a six-
stranded β-sheet, three α-helices face the dimerization interface, a long α-helix faces the 
Ar-CP domain, and a short single-turn helix that is located on the top of one end of the β-
sheet. The Ar-CP domain consists of four helices. Ser245 is the site of the 
postranslational modification by EntD. This residue is placed at the start of the second 




Figure 15: EntB crystal structure as dimer (PDB code: 2FQ1). 
The N-terminal and C-terminal domains were colored from the blue to red respectively. 
2,3-Dihydro-2,3-Dihydroxybenzoate Dehydrogenase: EntA 
EntA is 2,3-dihydro-2,3-dihydroxybenzoate (2,3-diDHB) dehydrogenase that 
catalyzes the oxidation of 2,3-diDHB to 2,3-DHB (182). The EntA crystal structure has 
been solved (Figure 16) (183). The protein was crystallized as tetramer that is formed as a 
dimer of dimers. In each dimer, the two monomer forms tight interactions with each other 
through the four four-helix bundle formed by helices 5 and 6 from each monomer. T88 
and D89 that are located in the loop that precedes α5 are also involved in the dimer 
formation. Residues that involved in the tetramer formation are positioned at β7 and the 
C-terminal loops. EntA has also been purified by gel filtration as an octamer with a native 








Figure 16: EntA crystal structure (PDB code: 2FWM). 
A: EntA monomer. The N-terminal and C-terminal domains were colored from the blue 
to red respectively. B: EntA tetramer with colored subunits. 
2,3-DHB-AMP Ligase : EntE 
EntE is a 2,3-DHB-AMP ligase that catalyzes the first reaction in the NRPS 
module. It catalyzes the ATP-dependent adenylation of 2,3-DHB. EntE was initially 
purified as monomer with a molecular weight of 59 kDa (141). The EntE three-
dimensional structure is currently unknown. EntE is a member of a family of adenylate-
forming enzymes that share similar structure. They are composed of a large N-terminal 
domain of 400–520 residues and a smaller C-terminal domain of approximately 120 
residues (184). The P-loop (phosphate-binding loop or Walker A motif)
 
is a common 




movement during catalysis. DhbE is an EntE homologue which is involved in 
bacillibactin synthesis in Bacillus subtilis. The crystal structure of DhbE with and without 
ligands has been reported (184). Based on the DhbE crystal structure, EntE catalysis 
occurs within its adenylation domain in two steps. The first step is the adenylation of 2,3-
DHB and the second step is the transfer of the 2,3-DHB moiety to holo-EntB ArCP 
domain cofactor (139, 184).  
The release of 2,3-DHB-AMP product from the EntE active site is very slow 
(141). This high affinity of EntE for its product has been exploited in the synthesis of 
EntE inhibitors (186). Here, removal of 2 or 3 hydroxyl group of one of the inhibitors 
was shown to diminish the inhibitory effect. This highlights the importance of these 
hydroxyl groups in the interaction between the EntE and its product.  The inhibition of 
aryl acid adenylating enzymes (MbtA, YbtE, EntE, VibE, BasE, and DhbE) by the 
fluorescent probe 5′-O-[N-(salicyl) sulfamoyl] adenosine (FI-Sal-AMS) has also been 
investigated (187). Here, FI-Sal-AMS was effective to interact and inhibit the aryl acid 
adenylating enzymes that use salicylic acid or 2,3-DHB as native substrates with KD 
values ranging from 9 nM to 369 nM.  
Recent studies showed that EntE can be involved in the biosynthsis of P1, P3-
diadenosine-5-tetraphosphate (Ap4A) in the absence of holo-EntB (188). This compound 
is involved in the regulation of cell division during oxidative stress. This suggests that 
Ap4A may play a role of slowing bacterial growth under iron depleted conditions until 
the bacteria obtain iron. A recent report demonstrated that EntE catalysis occurs via two 
half-reactions, following a bi-uni-uni-bi ping-pong mechanism (189). The first half of 
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EntE reaction is adenylation of 2,3-DHB by ATP with release of pyrophosphate. In the 
second half-reaction, EntE catalyzes the transfer of DHB-AMP to holo-EntB, resulting in 
formation of acylated EntB and AMP as products.  
A Serine-Activating Enzyme: EntF 
EntF is a monomer protein with a subunit molecular weight of 142 kDa (190). 
EntF is responsible for activating L-serine residue via its adenylation domain (A) and 
then the activated serine residue is transferred to EntF thiolation domain (T) 
phosphopantetheine group
 
(144). The EntF condensation domain (C) catalyzes the 
condensation of 2,3-DHB acyl group (received from EntB) and the activated serine 
residue amino group in the T domain
 
(191). The thioesterase domain (TE) of EntF was 
shown to catalyze cyclolactonization and elongation steps in enterobactin biosynthesis
 
(143). Mutation of Ser1138 to Ala in the TE domain was shown to abolish enterobactin 
synthetase activity (131). G1027A and M1030A mutations in the T domain disrupted the 
interaction between T domain and TE domain (192). 
The EntF T-TE di-domain structure has been solved recently (Figure 17) (193). 
The three helical bundle of T domain is impacted between the globular core and two 
helices (α4 and α5) of the TE domain. These α4 and α5 helices work as lid that covers 
both T and TE domains. In this study, it was shown that this lid opens during the 
interaction to accommodate the phosphopantetheine group attached to T domain active 
site Ser 48. It was also shown that the T domain interacts with the C domain and The TE 













Figure 17: EntF T-TE di-domain structure (PDB code: 2ROQ). 
The N-terminal and C-terminal domains were colored from the blue to red respectively. 
Phosphopantetheine transferase: EntD  
EntD is phosphopantetheine transferase enzyme with a molecular weight 
approximately of 24 kDa (194). It catalyzes the addition of phosphopantetheine (P-pant) 
moiety of coenzyme A to EntB and EntF, resulting in the formation of the active holo-
EntB and holo-EntF (131, 139, 195), E. coli has two phosphopantetheine transferases: 
holo-acyl carrier protein synthase (ACPS) and EntD. ACPS catalyzes the transfer of P-
pant group to fatty acid synthase ACP, resulting in formation of active holo- fatty acid 
synthase ACP (196).  EntD is able to transfer the P-pant group to the Ar-CP domain of 











transferring the P-pant group to apo-EntF but not to apo-ACP (195). In contrast, ACPS 
was able to transfer the P-pant group only to apo-ACP (195). These results suggest the 
specificity of each enzyme to its substrate.  
1.8.7 Reported Protein Interactions in the Enterobactin Biosynthesis NRPS Module 
Based on the EntB crystal structure (181)
 
and the DhbE (EntE homologue) crystal 
structure (184), the EntB and EntE interaction interface residues have been probed by 
mutagenesis (181). In this study, five of the mutations on the EntB aryl carrier domain 
surface resulted in an increase in EntE specific activity. This suggests that the EntE-EntB 
interaction might be optimized in vivo through EntB conformational change, allowing 
EntB to interact with other protein partners in the pathway. Such interaction may be 
necessary to optimize NRPS activities, since it has been shown that EntE activity is 
stimulated (10-fold increase in kcat) in the presence of holo-EntB (144). 
The EntB-EntF interaction has been indirectly investigated by mutagenesis in the 
EntB Ar-CP domain. Alanine scanning mutations were performed in helix2 and 
loop2/helix3 of the Ar-CP domain which have many of highly conserved residues. It was 
found that EntB Met 249, Phe 264, and Ala 268 constitute an interface for interaction 
with EntF.  Mutation of these residues affected enterobactin biosynthesis and enzymatic 
coordination of EntB and EntF activities, but they did not affect interaction between EntE 
and EntB, suggesting that EntB has separate interfaces for interaction with EntF and EntE 
(142). It has been shown that EntB Ar-CP domain residues G242 and D244 play 
important role in EntB-EntD interaction (197). The predicted EntB-EntD interaction 
interface in this study is different from the previously identified EntB-EntF interaction 
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interface (142). This suggests that EntB Ar-CP domain has non-overlapping interaction 
interfaces for EntD and EntF. The interaction between EntB Ar-CP domain and EntH was 
disrupted by a mutation in the EntB Ar-CP residue at position 245 (133). In the wild type 
EntB, Ser 245 is the site of Phosphopantetheinylation by EntD. This observation 
suggested that the posttranslation modification of EntB-Ar-CP domain at Ser 245 by 
EntD is essential for the interaction between EntH and EntB Ar-CP domain. 
1.9 Scope of Thesis Research 
The overall goal of my thesis focuses on detailed studies of the enterobactin 
biosynthetic enzyme EntE that adenylates 2,3-DHB. My research addresses how EntE binds 
its DHB substrate, and how it interacts with its partner proteins: EntA, which produces DHB, 
and EntB, which uses the EntE product (DHB-AMP) as a substrate. 
Enterobactin as a siderophore is inactive inside the host due to its elimination by 
serum albumin and siderocalin (161-162). However, enterobactin is used as a substrate 
for iroB in some pathogenic bacteria such as extraintestinal E. coli and Salmonella (165). 
IroB catalyzes the formation of salmochelin, the effective siderophore inside the host as 
explained previously (168). Thus proteins involved in biosynthesis of the salmochelin 
precursor enterobactin are the center of much research.  A comprehensive understanding 
of these proteins and their interactions is critical in development of new antimicrobial 
drugs that could inhibit growth of enterobactin utilizing pathogens in a host. The high 
affinity of EntE to its product DHB-AMP has already been used as a target in the 
synthesis of DHB-AMP analogues in order to inhibit enterobactin biosynthesis (186-
187). Furthermore, identification of the protein-protein interactions in this pathway and 
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the interaction interfaces is also essential. This will assist in the synthesis of peptide 
aptamers imitating the interaction interfaces that could inhibit interactions and thus 
disrupt enterobactin biosynthesis in salmochelin-dependent pathogens.  
The EntE crystal structure is currently unknown. Therefore, detailed 
characterization of EntE by homology modeling and eventually solving its structure will 
provide insights into its function and its catalytic mechanism. Such approaches will also 
help us to better understand the interactions between EntE and other proteins in the 
pathway, as well as to enhance our knowledge about the mechanism of related enzymes. 
Recently, it has been reported that the mammalian cell contains a siderophore similar to 
enterobactin that play a role in iron homeostasis (1). It has been shown in this study that 
the biosynthesis of this siderophore needs the activities of EntA, EntE, and EntF 
homologues. Thus my thesis research will also provide insights into the related 















CHAPTER TWO: LIGAND-INDUCED CONFORMATIONAL 
REARRANGEMENTS PROMOTE INTERACTION BETWEEN THE 










The EntE-EntB interaction was measured in the literature indirectly by two 
approaches.  (i) The first approach is study the effect of EntB Ar-CP domain addition on 
EntE activity (144). This study showed that EntE activity was stimulated (approximately 
10 fold increase in kcat) in the presence of EntB Ar-CP domain suggesting that this 
stimulation resulted from EntE-EntB interaction. (ii) The second approach focuses on 
study of the predicted interaction interfaces involved EntE-EntB interaction by 
mutagenesis followed by enzymatic assays (181).  This study showed that some of the 
EntB mutations in the Ar-CP domain enhanced its acylation by EntE. This suggests that 
EntB interaction interface may be optimized by conformational alterations during the 
interaction with EntE. 
This chapter of my thesis addresses the following research areas for the first time: 
(i) detailed characterization of EntE binding to its substrate 2,3-DHB, (ii) measuring the 
effect of 2,3-DHB binding on EntE-EntB interaction. Techniques used in this chapter are 
AUC, ITC, fluorescence spectroscopy, circular dichroism, and pull down assays. Pull- 
down assays provided the first direct evidence of an EntE-EntB interaction.  
The manuscript corresponding to this chapter was published in the Journal of 
Molecular Biology: “Sofia Khalil and Peter D. Pawelek. (2009) Ligand-Induced 
Conformational Rearrangements Promote Interaction Between The Escherichia coli 






Siderophores are small-molecule iron chelators that many bacteria synthesize and 
secrete in order to survive in iron-depleted environments. Biosynthesis of enterobactin, 
the E. coli catecholate siderophore, requires adenylation of 2,3-DHB by the cytoplasmic 
enzyme EntE. The 2,3-DHB-AMP product is then transferred to the active site of holo-
EntB subsequent to formation of an EntE-EntB complex. Here we investigate the binding 
of 2,3-DHB to EntE, and how 2,3-DHB binding affects EntE-EntB interaction. We 
overexpressed and purified recombinant forms of EntE and EntB with N-terminal 
hexahistidine tags (H6-EntE and H6-EntB). Isothermal titration calorimetry showed that 
2,3-DHB binds to H6-EntE with a 1:1 stoichiometry and a KD of 7.4 µM. Fluorescence 
spectra revealed enhanced 2,3-DHB emission at 440 nm (λex=280 nm) when bound to 
H6-EntE due to fluorescence resonance energy transfer (FRET) between EntE intrinsic 
fluorophore donors and the bound 2,3-DHB acceptor. A FRET signal was not observed 
when H6-EntE was mixed with either 2,5-DHB or 3,5-DHB. The H6-EntE-2,3-DHB 
FRET signal was quenched by H6-EntB in a concentration-dependent manner. From 
these data we were able to determine the EC50 of EntE-EntB interaction to be 
approximately 1.5 µM. We also found by fluorescence and CD measurements that H6-
EntB can bind 2,3-DHB, resulting in conformational changes in the protein. Additional 
alterations in the H6-EntB near-UV and far-UV CD spectra were observed upon mixture 
with H6-EntE and 2,3-DHB, suggesting that further conformational rearrangements occur 
in EntB upon interaction with substrate-loaded EntE. We also found that H6-EntB as a 
bait protein pulled down a higher concentration of chromosomally-expressed EntE in the 
presence of exogenous 2,3-DHB. Taken together, our results show that binding of 2,3-
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DHB to EntE and EntB primes these proteins for efficient complexation, thus facilitating 
direct channeling of the siderophore precursor 2,3-DHB-AMP. 
Introduction 
Iron is an essential element for most bacteria since it is used for many cellular 
processes related to metabolism and signaling (25).   In order to survive in iron-depleted 
environments, many bacteria synthesize and secrete iron-chelating molecules known as 
siderophores that have high Fe
3+
-binding affinities. Siderophores, and the proteins 
involved in their synthesis, secretion, modification, and uptake, are considered virulence 
factors in a number of bacterial pathogens (24).  Escherichia coli K12 synthesizes and 
secretes a single catecholate siderophore called enterobactin, which binds Fe
3+





 (35).  Upon secretion, enterobactin chelates bioavailable Fe
3+
 
from the extracellular environment. Ferric enterobactin is then bound by the E. coli outer 
membrane transporter FepA and imported to the periplasm by a TonB-dependent uptake 
system (146). The ferric siderophore is transported to the inner membrane by the 
periplasmic binding protein FepB, which docks with the inner membrane-embedded 
ABC transport complex FepC-FepD-FepG. Upon transport to the cytoplasm via the ABC 
transport complex, ferric enterobactin is degraded by the Fes esterase in order to liberate 
the iron for various cellular processes. It has recently been reported that extraintestinal 
strains of E. coli, including uropathogenic E. coli (UPEC), possess a five-gene cluster 
known as iroA that is responsible for modifying enterobactin to enhance its virulence (60, 
166). Understanding the molecular mechanisms by which enterobactin is synthesized and 




 Enterobactin is synthesized in the E. coli cytoplasm by seven enzymes: EntC, 
EntB, EntA, EntE, EntF, EntD, and EntH. The five enzymes directly involved in 
enterobactin biosynthesis can be grouped into two functional modules: the DHB module 
(EntC, EntB (N-terminal domain), and EntA) and the non-ribosomal peptide synthesis 
(NRPS) module (EntE, EntB (C-terminal domain), and EntF). In the DHB module, 
chorismate is converted to 2,3-DHB through the sequential activities of EntC, EntB, and 
EntA (140, 178-179, 198-199).  The DHB module functions upstream of the NRPS 
module and the two are intrinsically linked through the involvement of the bifunctional 
EntB protein, in which the N-terminal isochorismate lyase (ICL) domain participates in 
DHB synthesis while the C-terminal aryl carrier protein (ArCP) domain participates in 
NRPS. Enterobactin is ultimately produced during NRPS by the condensation of three 
molecules of 2,3-dihydroxybenzoate (2,3-DHB) and three molecules of L-serine yielding 
the tricatecholate ester. The enzyme EntD catalyzes the phosphopantetheinylation of the 
ArCP domains of EntB and EntF (131, 195).  EntH is a proofreading activity that corrects 
NRPS misacylation events (133-134, 200).  
The enzyme EntE catalyzes the adenylation of 2,3-DHB produced by EntA, thus 
activating it for subsequent steps in the NRPS module (Figure 1). EntE has a subunit size 
of 59 kDa and is reported to be monomeric (141). The EntE product, 2,3-DHB-AMP, is 
directly transferred to the phosphopantetheine cofactor anchored at the S245 residue in 
the active site of holo-EntB (131).  Experiments have shown that the turnover number of 
EntE increases approximately 10-fold in the presence of holo-EntB (144). In the absence 
of holo-EntB, release of 2,3-DHB-AMP from the EntE active site is slow, due to the high 
affinity of binding of the product to the enzyme. Site-directed mutagenesis of residues 
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hypothesized to be at the interaction interface of the EntE - holo-EntB complex was 
reported to have an effect on EntE catalytic activity (181). 
 
Figure 1: Scheme of reaction catalyzed by E. coli EntE. 
Although no three-dimensional structure of EntE is currently available, crystal 
structures of DhbE, a homologous protein involved in the biosynthesis of the B. subtilis 
catecholate siderophore bacillibactin, provide us with some insights into the EntE active 
site.  DhbE has been crystallized in three forms: (i) the apo form (PDB code: 1mdf), (ii) 
with 2,3-DHB-adenylate bound (PDB code: 1mdb), and (iii) with 2,3-DHB and AMP 
bound (PDB code: 1md9) (184). In the substrate-bound structures, 2,3-DHB binds at the 
floor of a hydrophobic cavity and is stabilized by the active site residue DhbE Y236. The 
carboxylate moiety of 2,3-DHB is further stabilized by interactions with DhbE residues 
H234 and K517. The ATP cofactor binds near the entrance of the cavity, proximal to a 
loop known as the „P-loop‟, which closes over the active site during catalysis. 
Comparison of the apo- and holo-DhbE structures indicates that the protein undergoes 
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local conformational changes (i.e., loop movements), but no gross structural 
rearrangements to the overall fold, upon substrate binding.  
EntB is the sequentially-related enterobactin biosynthetic enzyme immediately 
downstream of EntE. The crystal structure of EntB has been reported (181). The 32.5 
kDa EntB subunit is composed of two discrete and independently folded domains: an N-
terminal isochorismate lyase (ICL) domain (residues 26-208), and a C-terminal aryl 
carrier protein (ArCP) domain (residues 214-285). Crystallographic data revealed an 
EntB dimer in the asymmetric unit, with the inter-subunit interface occurring between 
ICL domains in the dimer. The ICL domain comprises most of the subunit mass (183 
residues out of 285 residues in the subunit). Mutagenesis studies revealed that alteration 
of residues in the ArCP domain affected stimulation of EntE activity by EntB, suggesting 
their role in the interaction interface (181). Thus, there is well established, albeit indirect, 
evidence for an interaction between EntE and EntB. 
Here we investigate the nature of EntE substrate binding and its effects on the 
EntE-EntB protein-protein interaction. Isothermal titration calorimetry has provided us 
with unambiguous equilibrium dissociation constant describing binding of 2,3-DHB 
substrate to EntE. Furthermore, we show that 2,3-DHB can act as a fluorescent sensor of 
the EntE active site. We exploited this phenomenon to directly measure the EntE-EntB 
interaction. Our circular dichroism studies and pull-down assays support our fluorescence 
binding data and show that the formation of an EntE-EntB complex is most efficient in 
the presence of 2,3-DHB. Our experimental approaches have provided the first direct 
measurement of the EntE-EntB interaction, and have generated insights into how protein-
protein interactions in the enterobactin biosynthetic machinery may be essential in 
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modulating substrate flux that would result in maximal siderophore production while 
minimizing deleterious consequences of intracellular accumulation of intermediates. 
Materials and Methods 
Reagents   
Unless otherwise noted, all reagents were purchased from BioShop Canada, Inc. 
(Burlington, Ontario). 2,3-DHB, 2,5-DHB and 3,5-DHB were purchased from Sigma-
Aldrich.  
Homology Modeling of EntE   
A homology-based model of EntE was obtained using the crystal structure of B. 
subtilis holo-DhbE (with bound 2,3-DHB and AMP) as a template (PDB code: 1md9) 
(184).  A structure-based alignment of the EntE amino acid sequence to that of DhbE was 
obtained using the FFAS03 server (http://ffas.ljcrf.edu/ffas-cgi/cgi/ffas.pl) (201). This 
alignment was used as input for the modeling software Modeller 9v3 (202). Structural 
superposition of the EntE homology model to the DhbE template structure was performed 
using LSQMAN (203) in order to determine RMSD values. Model quality was assessed 
using the VADAR suite (http://redpoll.pharmacy.ualberta.ca/vadar/) (204).  
Protein Expression and Purification   





)) cells harboring pCA24N plasmids containing the genes encoding EntE and EntB 
with in-frame N-terminal hexahistidine tags (i.e., pCA24N-EntE and pCA24N-EntB) 
were obtained from the ASKA repository (205).
 
The strains were grown at 37 °C in LB 
broth containing 30 µg/ml of chloramphenicol to a final OD600 between 0.5-0.6. 
Overexpression of hexahistidine-tagged EntE or hexahistidine-tagged EntB (henceforth 
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referred to as H6-EntE and H6-EntB, respectively) was induced in log-phase cells with 
the addition of IPTG to a concentration of 1 mM. After an additional 3-hour growth at 37 
°C, cells were harvested by centrifugation (15 min at 5,000 g). Pellets were resuspended 
in BugBuster Master Mix (Novagen) and incubated for 30 min at room temperature with 
constant agitation. Cell lysates were centrifuged (50 min at 10,000 g) and supernatants 
were recovered. Clarified lysates containing H6-EntE or H6-EntB were loaded onto 10-
ml Profinity IMAC columns (Bio-Rad Laboratories) connected to a BioLogic DuoFlow 
FPLC system (Bio-Rad Laboratories). Fractions containing washed H6-EntE or H6-EntB 
were eluted by linear imidazole gradients (10 - 500 mM imidazole) in a buffer containing 
50 mM Hepes (pH 8.0), 100 mM KCl, and 1.0 mM TCEP. We determined that IMAC 
purification yielded near-homogenous (> 95% purity) H6-EntE. However, H6-EntB 
required additional purification on a 1-ml UNOsphere Q anion exchange column (Bio-
Rad Laboratories) to achieve a near-homogeneous (> 95% purity) H6-EntB fraction. 
Pooled fractions containing purified H6-EntE and H6-EntB were dialyzed against Buffer 
A (50 mM Hepes (pH 8.0), 100 mM KCl, 1.0 mM TCEP, and 15% glycerol). Dialyzed 
samples were stored at -20 
o
C. We used the Enzchek pyrophosphate release assay 
(Invitrogen) to measure H6-EntE steady-state enzyme activity and found its specific 
activity to be comparable to that reported earlier for non-hexahistidine-tagged EntE 
(141). Stability of H6-EntE was monitored by enzymatic assays, and no loss of activity 
was observed after extended (> 14 days) storage at 4 
o
C or after long (> 4 weeks) periods 
of storage at -20 
o





Isothermal Titration Calorimetry   
Heat generated by the binding of 2,3-DHB to H6-EntE was measured using a VP-
ITC isothermal titration microcalorimeter (cell volume = 1.36 ml; Microcal, Inc.). 2,3-
DHB dissolved to a concentration of 500 µM in Buffer A was injected into a cell 
containing 50 µM purified H6-EntE dialyzed against Buffer A. Protein concentration was 
determined by absorption at 280 nm as measured on a Thermo Genesys 10 
spectrophotometer and using a molar extinction coefficient predicted from the H6-EntE 




). Data from 24 injections (injection 
volume = 10 µl) were collected at 293 K while the contents of the cell were stirred at 300 
rpm. An initial 2-µl injection was not included in the data analysis. A spacing time of 240 
seconds occurred between each injection. Heats of injection were corrected by 
subtraction of heats of dilution generated by injecting 500 µM 2,3-DHB into the sample 
cell containing Buffer A. Calorimetry data were analyzed using Origin 5.0 (Microcal, 
Inc.) by fitting the corrected heats of injection to an equation describing single-site ligand 
binding. Values of ∆H (in kcal mol-1), S (in cal mol-1 K-1) and KD were obtained from the 
Origin software. 
Fluorescence Spectroscopy  
 Fluorescence emission and excitation spectra of purified H6-EntE and H6-EntB 
in the presence and absence of 2,3-DHB, 2,5-DHB, or 3,5-DHB were collected at room 
temperature using a Shimadzu RF-5301PC spectrofluorometer. For emission spectra, the 
excitation
 
wavelength was fixed at 275 nm, 280 nm, or 295 nm and fluorescence 
emission intensities
 
were recorded from 300 nm to 550 nm. For excitation spectra, the 
emission wavelength was fixed at 440 nm and fluorescence intensities were collected 
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upon changing the excitation wavelength from 200 nm to 350 nm.  Excitation and 
emission slits
 
were set to 3 nm. Measurements were performed using a 0.5 ml quartz 
cuvette (10 mm path length) containing purified H6-EntE or H6-EntB diluted to a final 
concentration of 3 µM in Buffer A. Each reported fluorescence spectrum represents the 
average
 
of three scans (2 nm/sec). Fluorescence intensities were corrected for inner filter
 
effects according to the equation: Fcorr = Fobs x 10
((ODex+ODem)/2)
, where Fobs is the observed 
fluorescence intensity, ODex is the optical density of the solution at the excitation 
wavelength, ODem is the optical density of the solution at the emission wavelength. 
Fluorescence emission spectra of H6-EntE were obtained with varying concentrations of 
2,3-DHB (5, 10, 20, 30, 40, 50, 60, 70, and 80 µM). Half-maximal effective 
concentration (EC50) values describing 2,3-DHB binding to H6-EntE were calculated 
from fluorescence emission data (either intensity increase at 440 nm or decrease at 330 
nm) using the computer program Origin 5.0 and fitting the data to a hyperbolic equation 
to determine EC50 values. The EntE-EntB interaction was measured by fluorescence 
using a solution of H6-EntE (2.5 μM) in Buffer A plus 50 μM 2,3-DHB to which 
increasing concentrations of H6-EntB (0.4- 3.4 μM) were added.  
In this study, the fluorescence spectra of all protein solutions mixed with a given 
concentration of 2,3-DHB, 2,5-DHB, or 3,5-DHB were corrected by subtracting 
fluorescence emission spectra of the appropriate DHB isomer collected at the same 
concentration in the absence of protein. Furthermore, all corrections for dilution factors 





Circular Dichroism  
 Circular dichroism experiments were performed on a Jasco J-815 CD 
spectrophotometer connected to a temperature-controlled circulating water bath. Far-UV 
spectra of H6-EntE (7.5 μM) and H6-EntB (2.5 μM) solutions were collected at 20 °C 
between 200 nm and 260 nm (1 nm bandwidth)
 
in 0.2-nm steps at a rate of 100 nm/min 
(0.25 sec response) using a cell with a path length of 0.2 cm. 
 
Each far-UV spectrum 
presented here is an average of five scans. Near-UV spectra of H6-EntE (25 μM) and H6-
EntB (15.6 μM) were collected at 20 °C between 250 nm and 320 nm (1 nm bandwidth) 
in 0.2-nm steps at a rate of 20 nm/min (2 sec response) using a cell with a path length of 
2.0 cm. Each near-UV spectrum presented here is an average of two scans. Both near-UV 
and far-UV spectra were collected from solutions of individual proteins and of mixtures 
of H6-EntE and H6-EntB. In all cases, protein solutions for CD analysis were dialyzed 
against 25 mM Tris (pH 8.0), 0.5 mM TCEP, 100 mM KCl, and 15% glycerol and then 
diluted to the desired concentration in the same buffer. Spectra were collected in the 
presence and absence of 50 μM 2,3-DHB.  Spectra collected in the presence of 50 μM 
2,3-DHB were corrected by subtraction of signal contribution from 50 μM 2,3-DHB 
dissolved in the same buffer in the absence of protein. 
Pull-down Assays  
Pull-down assays were performed using the ProFound Pull-Down PolyHis 
Protein:Protein Interaction Kit (Pierce, Rockford, IL). Cobalt chelate columns were 
equilibrated with washing solution (1:1 mixture of Tris Buffered Saline (25 mM Tris-HCl 
(pH 7.2), 150 mM NaCl) with ProFound Lysis Buffer, and imidazole to a concentration 
of 40 mM). H6-EntB (130 μg), the bait protein, was immobilized to cobalt chelate 
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columns by incubation for 1 hour at 4 °C with gentle shaking. Cell lysates containing 
prey proteins were prepared from E. coli BW25113 cells grown for 16 h at 37 
o
C in iron-
free M63 minimal media in the presence of 75 μM 2,2‟-dipyridyl. Lysates were added to 
the cobalt columns in the presence or absence of 100 μM 2,3-DHB and then incubated at 
4 °C with gentle shaking for 2 hours. The columns were washed 8 times with washing 
solution. Bait-prey protein complexes were eluted by the addition of imidazole to a final 
concentration of 300 mM. Eluted proteins were separated on 10% SDS-polyacrylamide 
gels. After electrophoresis, gels were stained using the SilverQuest Silver Staining kit 
(Invitrogen). Bands of interest were excised from the gels and proteins were subjected to 
in-gel tryptic digestion.  Recovered samples were subjected to LC-MS/MS analysis using 
Bruker ESI Ion Trap and Agilent LC 1100 mass spectrometers at the McGill Mass 
Spectrometry Core Facility (McGill University, Montreal). Briefly, samples obtained 
from gel slices were dried and then resuspended in 97% acetonitrile (ACN)/0.2% formic 
acid. Resuspended samples were injected in the mass spectrometer, and a gradient of 0-
70% (95% water/0.5% ACN to 9.8% water/90%ACN/0.2% formic acid) was used to 
elute the peptides. The resulting data were searched against the NCBI database using 
MASCOT (Matrix Science). 
Results 
Homology Modeling of E. coli EntE Predicts Positions of Ligand-Binding Residues 
and Intrinsic Fluorophores 
In order to gain insights into the nature of substrate binding to E. coli EntE, as 
well as the spatial distribution of intrinsic fluorophore residues (Tyr, Trp) throughout the 
protein, we generated a homology-based model using the structure of the B. subtilis 
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bacillibactin biosynthetic enzyme DhbE (PDB code: 1md9) as a template. These enzymes 
share 46.5% sequence identity (Figure 2A). The structure-based alignment obtained from 
the FFAS03 server was used as an input for Modeller 9v3, which produced a three-
dimensional model of E. coli EntE as output. The EntE model superimposes well with the 
DhbE structure, with an overall RMSD of 0.271 Å (Figure 2B). The stereochemistry of 
the model was analyzed using the VADAR suite (204). Ramachandran analysis showed 
that 90% of the model‟s residues are in the core region, 47% in the allowed region, 1% in 
the generous region, and no residues were found in the disallowed region. The overall 
general distribution of the intrinsic fluorophores in the model is such that most of the 
tyrosine residues populate the interior of the protein whereas most tryptophan residues 






Figure 2: Homology-based model of E. coli EntE. 
(a) Structure-based alignment of EntE to B. subtilis DhbE primary amino acid sequence. 
Positions of identity shown as white letters with black background. Positions of similarity 
shown as black letters on grey background.  Residues are numbered according to 
primary amino acid sequences.  (b) Structural superposition of EntE homology model to 
DhbE structure (PDB code: 1md9). EntE model shown as blue coil. DhbE structure 
shown as green coil. Position of DHB coordinates from DhbE structure shown as sticks 
and colored according to element. (c) Close-up view of 2,3-DHB in the active sites of 
DhbE (green coil) and superimposed EntE (blue coil). EntE tyrosine residues within 10 Å 
of DHB shown as blue sticks. (d) Close-up view of 2,3-DHB in the active site of the EntE 
homology model (blue coil) showing EntE residues (white sticks, atoms colored 
according to element) predicted to form hydrogen bonds with 2,3-DHB substrate (yellow 
sticks, atoms colored according to element). Molecular graphics were generated using 
PyMOL (http://www.pymol.org).  
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We computationally introduced a 2,3-DHB molecule into the active site of our 
EntE model by using the 2,3-DHB coordinates found in the DhbE active site (Figure 2C). 
The 2,3-DHB molecule was introduced using the same rotation and translation matrices 
determined by LSQMAN for optimal EntE-DhbE superposition. Five tyrosine residues 
were found to be most proximal (distance < 10 Å) to the DHB substrate: Y207, Y226, 
Y236, Y341, and Y389. All five tryptophan residues in the EntE model were found to be 
distal (> 15 Å) to the active site. Four of the five tryptophans in the model are surface-
exposed. The tryptophan most proximal to the modeled DHB position, W286 (distance 
=15.6 Å), was the only buried tryptophan found in the model. The model also identified 
EntE residues that could potentially bind to non-aromatic portions of 2,3-DHB.  Residues 
K519 and H233 are within hydrogen bonding distance of the carboxylate moiety of the 
substrate and superimpose with DhbE residues previously identified from the crystal 
structure as stabilizing the carboxylate of bound 2,3-DHB (Figure 2D) (184). According 
to our model, EntE residues N234 and S239 are within hydrogen bonding distance of the 
2-hydroxyl and 3-hydroxyl groups of 2,3-DHB, respectively. These residues superimpose 
with asparagine and serine residues corresponding to 2,3-DHB hydroxyl groups in the 





EntE Has a Single, Micromolar-Affinity Binding Site for Its Substrate 2,3-DHB 
We used isothermal titration calorimetry (ITC) to directly measure the binding of 
2,3-DHB to purified recombinant hexahistidine-tagged EntE (H6-EntE). 2,3-DHB at a 
concentration of 500 µM was injected into a 50 µM solution of H6-EntE and heats of 
binding were measured over 24 injections (Figure 3, upper panel). Integrated heats of 
injection of 500 µM 2,3-DHB into buffer were subtracted from the integrated heats of 
ligand binding to EntE. The corrected heats were plotted as a function of the molar ratio 
of DHB to H6-EntE (Figure 3, lower panel). These data fit well to the single-site binding 
equation in Origin 5.0, indicating that 2,3-DHB binds to H6-EntE with a stoichiometry of 
0.92 + 0.01, and with an equilibrium dissociation constant (KD) of 7.35 + 0.31 µM. Our 
ITC data revealed the ∆H of 2,3-DHB binding to H6-EntE to be -13.46 + 0.15 kcal/mol 











Figure 3: Isothermal titration calorimetry of H6-EntE in the presence and absence 
of 2,3-DHB.  
Upper panel: Heats of injection of 500 µM 2,3-DHB into a cell containing 50 µM H6-
EntE. Lower panel: Data from upper panel integrated and plotted as a function of molar 
ratio of 2,3-DHB after subtraction of heats generated by injection of 500 µM 2,3-DHB 







Binding of 2,3-DHB to EntE Results in A Substrate-Specific FRET Signal 
We obtained H6-EntE fluorescence emission spectra in the presence and absence 
of 2,3-DHB substrate. Analysis of H6-EntE fluorescence emission upon excitation at 280 
nm revealed a single emission peak at 330 nm (Figure 4A, black circles). Upon addition 
of 50 µM 2,3-DHB to 3 µM H6-EntE, we observed a decrease in the 330 nm emission 
peak along with the appearance of a new emission peak at 440 nm (Figure 4A, green 
circles). This peak coincides with the fluorescence emission maximum of 2,3-DHB 
(Figure 4A, magenta circles), although in the absence of protein the fluorescence 
intensity of an equivalent concentration (50 µM) of the substrate was markedly lower. 
The spectral overlap between tyrosine emission and 2,3-DHB excitation maxima suggests 
that the increase in 2,3-DHB fluorescence intensity at 440 nm in the presence of H6-EntE 
is due to fluorescence resonance energy transfer (FRET). Fluorescence excitation spectra 
(λem= 440 nm) of 2,3-DHB solutions in the presence and absence of H6-EntE indicated 
that the excitation maxima of 2,3-DHB were not significantly altered upon binding to H6-
EntE, and that a prominent peak occurred around 280 nm in the presence of H6-EntE 
(Figure 4B). Fluorescence emission spectra were also collected at 275 nm, a wavelength 
that is closer to that of maximal tyrosine excitation and further from that of maximal 
tryptophan excitation. Excitation at 275 nm was observed to increase the intensity of the 
emission peak at 440nm relative to excitation at 280 nm (data not shown). The addition 
of increasing concentrations of 2,3-DHB (5 µM – 80 µM) to a fixed concentration of H6-
EntE (3 µM) resulted in concentration-dependent increases in fluorescence intensity at 
440 nm with corresponding decreases in fluorescence intensity at 330 nm. These 
concentration-dependent changes in fluorescence intensity reflect 2,3-DHB binding to 
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H6-EntE since the data fit well to hyperbolic plots describing single-site saturable 
binding (Figure 4C and 4D). Hyperbolic fits are consistent with EC50 values of 12.9 µM 
(obtained from the increase in fluorescence intensity at 440 nm; Figure 4C) and 9.2 µM 
(obtained from the quenching of fluorescence intensity at 330 nm; Figure 4D). 
 
Figure  4: Fluorescence measurements 2,3-DHB binding to H6-EntE.  
(A) Fluorescence emission spectra (λex = 280 nm) of solutions containing: 3 µM H6-EntE 
(black circles); 50 µM 2,3-DHB (magenta circles); 3 µM H6-EntE and 50 µM 2,3-DHB 
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(green circles). (B) Fluorescence excitation spectra (λem = 440 nm) of solutions 
containing: 50 µM 2,3-DHB (magenta circles); 50 µM 2,3-DHB and 3 µM H6-EntE 
(green circles). (C) Increase in fluorescence emission at 440 nm as a function of 2,3-
DHB concentration. Fluorescence emission at 440 nm corrected by baseline fluorescence 
emission of H6-EntE in the absence of 2,3-DHB, and by 2,3-DHB emission in the 
absence of H6-EntE (black squares). Fit of data to hyperbolic curve describing single-
site binding (solid line). (D) Quenching of fluorescence emission at 330 nm as a function 
of 2,3-DHB concentration. Fluorescence quenching was calculated as ((Fo-F)/Fo) x 100, 
where Fo is the initial fluorescence intensity observed at 330 nm in the absence of 2,3-
DHB. Fluorescence quenching (black squares). Fit of data to hyperbolic curve 
describing single-site binding (solid line). 
 
We investigated the specificity of binding of DHB isomers to H6-EntE and H6-
EntB. Fluorescence emission spectra were collected for H6-EntB and H6-EntE in the 
presence of equivalent concentrations of 2,3-DHB, 2,5-DHB and 3,5-DHB. We found 
that the H6-EntB emission peak at 330 nm (Figure 5a, black circles) was maximally 
quenched in the presence of 2,3-DHB (Figure 5A, green circles). We also found that H6-
EntB intrinsic fluorescence was quenched upon addition of 2,5-DHB (Figure 5A, red 
circles) and 3,5-DHB (Figure 5A, blue circles), albeit to a lesser extent. When solutions 
of H6-EntE were mixed with the DHB isomers, we found that only 2,3-DHB could 
quench intrinsic H6-EntE fluorescence (Figure 5B, green circles). Furthermore, we only 
observed a 440 nm emission peak when H6-EntE was mixed with 50 µM 2,3-DHB. No 
quenching of H6-EntE intrinsic fluorescence was observed upon addition of equivalent 
concentrations of 2,5-DHB (Figure 5B, red circles) or 3,5-DHB (Figure 5B, blue circles); 
furthermore, neither 2,5-DHB nor 3,5-DHB exhibited a 440 nm emission peak in the 
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presence of H6-EntE upon excitation at 280 nm even though both of these DHB isomers 
also exhibit fluorescence emission maxima at 440 nm (data not shown).  
 
Figure 5: Binding of DHB isomers to H6-EntE and H6-EntB. 
 (A) Fluorescence emission spectra (λex = 280 nm) of solutions containing: 3 µM H6-
EntB (black circles); 3 µM H6-EntB and 50 µM 2,3-DHB (green circles); 3 µM H6-EntB 
and 50 µM 2,5-DHB (red circles); 3 µM H6-EntB and 50 µM 3,5-DHB (blue circles). (B) 
Fluorescence emission spectra (λex = 280 nm) of solutions containing: 3 µM H6-EntE 
(black circles); 3 µM H6-EntE and 50 µM 2,3-DHB (green circles); 3 µM H6-EntE and 





Binding of 2,3-DHB to Both EntE and EntB Results in Conformational Changes 
That Promote Formation of A Transient EntE-EntB Complex 
We investigated the effect of EntB-EntE interaction on 2,3-DHB binding to H6-
EntE using our fluorescence assay. We found that H6-EntB quenched 440 nm 
fluorescence emission of H6-EntE-bound 2,3-DHB in a concentration-dependent manner 
(Figure 6a). Half-maximal quenching of H6-EntE-bound 2,3-DHB by H6-EntB indicates 
that the EC50 of the EntB-EntE interaction is 1.5 µM, assuming that the observed 
decrease in fluorescence is due to the EntB-EntE interaction affecting the positioning of 
2,3-DHB binding in the H6-EntE active site and thus its ability to fluoresce at 440 nm. 
Representative fluorescence emission spectra are shown for mixtures of 2.5 µM H6-EntE 
and 50 µM 2,3-DHB in the absence of H6-EntB (Figure 6b, solid black circles) and in the 









 Figure 6: Binding of H6-EntB to H6-EntE in the presence of 2,3-DHB.  
(a) Percentage quenching of the 440 nm H6-EntE-2,3-DHB FRET signal as a function of 
H6-EntB concentration. Data were fit to a sigmoidal curve describing cooperative 
binding using SigmaPlot. (b) Fluorescence emission spectra (λex = 280 nm) of H6-EntE 
(2.5 μM) and 2,3-DHB (50 μM) in the absence of H6-EntB (black circles) and in the 























Circular dichroism (CD) was used to measure protein structural changes occurring 
upon mixture of H6-EntE and H6-EntB in the presence or absence of 2,3-DHB. All 
spectra in which proteins were mixed with 2,3-DHB were corrected for ellipticity signal 
contributions from 2,3-DHB in the absence of protein. Far-UV CD spectra revealed that 
both H6-EntE (Figure 7A, blue circles) and H6-EntB (Figure 7A, red circles) in solution 
exhibited similar major ellipticity minima at 210 nm and 222 nm. The addition of a 
saturating concentration of 2,3-DHB to H6-EntE (Figure 7B, blue circles) did not 
significantly alter its far-UV CD spectrum, indicating no large changes in secondary 
structure occurred upon substrate binding. A decrease in the ellipticity minima in the H6-
EntB spectrum was observed upon the addition of 2,3-DHB (Figure 7B, red circles). Far-
UV spectra were also obtained for mixtures of H6-EntE and H6-EntB in the presence and 
absence of 2,3-DHB. Spectra of the {H6-EntE+H6-EntB} mixtures in which the H6-EntB 
signals were subtracted revealed no significant changes in H6-EntE far-UV spectra in the 
presence or absence of 2,3-DHB (Figure 7A and 7B, cyan circles). In contrast, a spectrum 
of the {H6-EntE+H6-EntB} + 2,3-DHB mixture in which the H6-EntE signal was 









Figure 7: Circular dichroism spectra of H6-EntE and H6-EntB in the presence and 
absence of DHB. 
 (A) Far-UV circular dichroism spectra of protein solutions in the absence of 2,3-DHB: 
H6-EntE (blue circles); H6-EntB (red circles); mixture of {H6-EntE+H6-EntB} with H6-
EntB signal subtracted (cyan circles); mixture of {H6-EntE+H6-EntB} with H6-EntE 
signal subtracted (magenta circles). (B) Far-UV circular dichroism spectra of protein 
solutions in the presence of 50 µM 2,3-DHB: H6-EntE (blue circles); H6-EntB (red 
circles); mixture of {H6-EntE + H6-EntB} with H6-EntB signal subtracted (cyan circles); 
mixture of {H6-EntE + H6-EntB} with H6-EntE signal subtracted (magenta circles). (C) 
Near-UV circular dichroism spectra of protein solutions in the absence of 2,3-DHB: H6-
EntE (blue circles); H6-EntB (red circles); mixture of {H6-EntE+H6-EntB} with H6-
EntB signal subtracted (cyan circles); mixture of {H6-EntE+H6-EntB} with H6-EntE 
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signal subtracted (magenta circles). (D) Near-UV circular dichroism spectra of protein 
solutions in the presence of 50 µM 2,3-DHB: H6-EntE (blue circles); H6-EntB (red 
circles); mixture of {H6-EntE+H6-EntB} with H6-EntB signal subtracted (cyan circles); 
mixture of {H6-EntE+H6-EntB} with H6-EntE signal subtracted (magenta circles). 
 
 The near-UV CD spectrum of H6-EntE in the absence of 2,3-DHB (Figure 7C, 
blue circles) indicates a dominant positive peak centered between 270 nm and 280 nm, 
indicative of contributions from tyrosine residues. This spectrum did not change when 
H6-EntE was mixed with 2,3-DHB (Figure 7D, blue circles).  In the absence of 2,3-DHB, 
the H6-EntB near-UV spectrum (Figure 7C, red circles) revealed two minor positive 
peaks at 255 nm and 277 nm, and a major negative peak at 290 nm. In the presence of 
2,3-DHB, the H6-EntB near-UV spectrum exhibits a similar overall shape, but with 
altered peak magnitudes compared to the –DHB spectrum (Figure 7D, red circles). As 
with our far-UV experiments, we collected near-UV spectra of {H6-EntE+H6-EntB} 
mixtures in the presence and absence of 2,3-DHB. The spectrum of the {H6-EntE+H6-
EntB} –DHB mixture in which the H6-EntB signal was subtracted (Figure 7C, cyan 
circles) revealed no major change relative to the H6-EntE spectrum (Figure 7C, blue 
circles). We observed a small reduction in overall ellipticity of the {H6-EntE+H6-EntB} 
+DHB spectrum after subtraction of the H6-EntB signal (Figure 7D, cyan circles) when 
compared to the H6-EntE spectrum (Figure 7D, blue circles). In contrast, large changes in 
the peak amplitudes at 255 nm and 277 nm were observed in a spectrum of the {H6-
EntE+H6-EntB} mixture in which the H6-EntE signal was subtracted (Figure 7D, 
magenta circles) compared to the H6-EntB +DHB spectrum obtained in the absence of 
H6-EntE (Figure 7D, red circles).  
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H6-EntB Bait Protein Efficiently Pulls Down Chromosomally-Expressed E. coli 
EntE Only in the Presence of Exogenous 2,3-DHB 
To investigate the ability of our recombinantly expressed H6-EntB to form 
complexes with E. coli partner proteins in situ, we used H6-EntB as a bait protein to pull 
down chromosomally-expressed interacting partners from lysates of E. coli cells grown in 
M63 minimal media in the presence of the iron chelator 2,2‟-dipyridyl. This iron-depleted 
media condition was employed in order to induce expression of chromosomally-encoded 
enterobactin biosynthetic proteins by derepression of Fur. Pull down assays were 
achieved by binding H6-EntB bait protein to Co
2+
-chelate resin, flowing over cell lysates,  
and gently washing away unbound proteins. When exposed to lysates pre-incubated with 
exogenous 2,3-DHB, the H6-EntB bait protein was able to pull down a major protein 
band migrating at approximately 60 kDa as determined by SDS-PAGE analysis (Figure 
8, band „d‟), which corresponds to the molecular weight of E. coli EntE. In the absence of 
exogenous 2,3-DHB, a minor band migrating at this position was observed to be pulled 
down (Figure 8, lane -DHB, band „a‟). Bands migrating at approximately 34 kDa, the 
expected molecular weight of H6-EntB, were observed +/- exogenous 2,3-DHB (Figure 
8, bands „b‟ and „e‟). Below this band, we also observed a second major band migrating 




Figure 8: Pull-down assay of proteins binding to H6-EntB bait.  
Silver-stained 10% SDS-polyacrylamide gel of proteins eluted from Co
2+
-chelate beads. 
Numbers to left of gel represent positions of bands of known molecular weight markers 
(not shown). Lane ‘-DHB’: proteins isolated from beads exposed to lysate of iron-starved 
E. coli BW25113 with no exogenously added 2,3-DHB. Lane ‘+DHB’: proteins isolated 
from beads exposed to lysate of iron-starved E. coli BW25113 cells with exogenously-
added 2,3-DHB (100 µM). The identity of proteins in bands ‘b’-‘f’ were determined by 
LC-MS/MS analysis of bands excised from gel. Bands ‘a’ and ‘d’: E. coli EntE; Bands 
‘b’ and ‘e’: E. coli EntB; Bands ‘c’ and ‘f’: E. coli EntB (proteolysed). 
 
We were able to perform mass spectrometry analysis on tryptic peptides 
recovered from the proteins corresponding to bands „b‟-„f‟; all other bands contained 
insufficient amounts of protein for this analysis. Table 1 shows the peptides recovered 
from bands „d‟, „e‟, and „f‟ shown in Figure 8; all of these peptides were obtained from 
lysates spiked with exogenous 2,3-DHB prior to pull-down. Peptides corresponding to 
EntE in band „d‟ (Table 1, rows 3-21) represent 57% total EntE sequence coverage. 
Peptides corresponding to EntB in band „e‟ (Table 1, rows 22-37) represent 66% total 
EntB sequence coverage. Peptides corresponding to EntB in band „f‟ (Table 1, rows 38-
41) represent 18% total EntB sequence coverage. Peptides were also recovered from 
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bands „a‟-„c‟ obtained from –DHB samples (data not shown). In the absence of 
exogenous 2,3-DHB, no peptides corresponding to EntE could be identified by mass 
spectrometry, although the silver-stained gel shows a faint band (Figure 8, band „a‟) at its 
expected position. The low amount of protein in this band likely resulted in poor peptide 
recovery such that any EntE signals were below the sensitivity threshold of the mass 
spectrometer. Mass spectrometry data of peptides recovered from band „b‟ (-DHB) were 
comparable to peptides recovered from band „e‟ (+DHB) (57 peptides corresponding to 
EntB, representing 78% sequence coverage). Consistent with our analysis of band „f‟, 
twelve peptides corresponding to EntB were also obtained from band „c‟ (-DHB), 













Table 1.:  MASCOT analysis of peptides recovered from pull-down assay of iron-

















d + EntE   8 – 14  0.2490 2 
d + EntE 20 – 33  0.2722 20 
d + EntE 34 – 47  0.3206 7 
d + EntE 53 – 66  0.2264 16 
d + EntE   96 – 109  0.6179 8 
d + EntE 110 – 128 0.3726 11 
d + EntE 129 – 150 0.2852 1 
d + EntE 203 – 212 0.1955 3 
d + EntE 213 – 225 0.4819 1 
d + EntE 271 – 296 0.2850 5 
d + EntE 312 – 343 0.4175 1 
d + EntE 320 – 343 0.4190 33 
d + EntE 351 – 382 0.4925 2 
d + EntE 397 – 430 0.4962 2 
d + EntE 442 – 453 0.2739 39 
d + EntE 454 – 473 0.2801 3 
d + EntE 474 – 481 0.2641 1 
d + EntE 503 – 520 0.4018 2 
d + EntE 507 – 520 0.2502 5 
e + EntB   6 – 21 0.4196 2 
e + EntB 22 – 30 0.2724 5 
e + EntB 69 – 81 0.4872 2 
e + EntB   89 – 101 0.3311 15 
e + EntB 112 – 123 0.3618 15 
e + EntB 112 – 125 0.2588 1 
e + EntB 132 – 139 0.2146 1 
e + EntB 144 – 167 0.2988 3 
e + EntB 168 – 183 0.2271 7 
e + EntB 200 – 215 0.4174 17 
e + EntB 220 – 247 0.4461 18 
e + EntB 220 – 254 0.6332 1 
e + EntB 257 – 269 0.2950 2 
e + EntB 257 – 269 0.2950 2 
e + EntB 258 – 269 0.2689 2 
e + EntB 270 – 278 0.2102 3 
f + EntB   6 – 21 0.2932 1 
f + EntB 22 – 30 0.2004 1 
f + EntB 112 – 123 0.2211 2 
f + EntB 200 – 215 0.2270 1 
a
 see Figure 8; 
b
 exogenous 2,3-DHB added to lysate prior to pull-down; 
c
 |(observed 
peptide mass) – (expected peptide mass from sequence)|; d frequency of observed peptide 




The E. coli enzyme EntE is an essential component of the enterobactin 
biosynthetic pathway. Recently this protein has been the focus of studies probing ligand 
binding specificity (134, 200) as well as identifying novel compounds that can act as 
tight-binding EntE inhibitors (127). From previously reported kinetic characterizations 
we know that the release of the product 2,3-DHB-AMP is slow and rate-determining. By 
isothermal titration calorimetry we determined a direct, unambiguous measurement of the 
equilibrium binding constant (KD) of 2,3-DHB binding to EntE (7.3 µM). This value is 
approximately three-fold higher than the reported 2,3-DHB Km value (2.7 µM) (141). It 
should be noted that the reported Km value was determined in the presence of ATP 
substrate as well as 2,3-DHB. If we assume that the reported Km reflects 2,3-DHB 
binding affinity during the EntE-catalyzed reaction in the presence of all substrates, then 
our higher KD value for 2,3-DHB binding (obtained in the absence of ATP) suggests that 
ATP binding and subsequent closure of the P-loop reduces 2,3-DHB dissociation, thus 
potentiating formation of the 2,3-DHB-AMP product. Although an equilibrium binding 
constant has not been reported for 2,3-DHB-AMP binding to EntE, it has been found to 
be a competitive inhibitor of the substrate, with a Ki value of 4.5 nM (186). It is clear 
from our data, in conjunction with these previous findings, that the binding affinity of 
EntE for the 2,3-DHB substrate is much lower than that for the 2,3-DHB-AMP product. 
High-affinity binding of the 2,3-DHB-AMP product to EntE ensures its efficient 
channeling to the holo-EntB ArCP domain. That the affinity of binding of the 2,3-DHB 
substrate is lower than that of the product suggests that considerable dissociation of the 
substrate to the bulk phase might occur prior to its adenylation. However, it is likely that 
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subsequent binding of the ATP co-substrate with closure of the P-loop would prevent this 
dissociation.  
Our fluorescence emission spectra of H6-EntE showed that in the absence of 2,3-
DHB there is a single emission maximum at 330 nm upon excitation at 280 nm. When we 
added 2,3-DHB to H6-EntE, we observed a new and large emission peak at 440 nm upon 
excitation at 280 nm, the wavelength of maximal tyrosine excitation. Based on our 
experimental observations coupled with insights from our EntE homology model, we 
conclude that this emission peak is due to fluorescence resonance energy transfer (FRET) 
between EntE intrinsic fluorophore donors and the bound 2,3-DHB acceptor. In the 
absence of H6-EntE, we observe that 2,3-DHB emits maximally at 440 nm with a 
maximal excitation wavelength of 306 nm. Thus there is a spectral overlap between EntE 
intrinsic tyrosine fluorescence emission (λem = 305 nm) and our observed 2,3-DHB 
excitation maximum. Our fluorescence excitation spectra did not reveal a significant shift 
in the 2,3-DHB excitation maxima when the substrate is bound to EntE (there is a slight 3 
nm red shift in 2,3-DHB λex to 309 nm) indicating that observed fluorescence at 440 nm 
is not due to an alteration in the fluorescence properties of 2,3-DHB itself when bound to 
the EntE active site. When we collected spectra at an excitation wavelength of 275 nm 
instead of 280 nm, we observed an increase in the 440 nm peak, not a decrease. This 
suggests that the FRET signal we observe is mostly due to excitation by instrinsic 
tyrosine donors proximal to the EntE active site, although we cannot rule out some 
contribution to the FRET signal by more distal tryptophan donors. Regardless of the 
exact nature of the EntE FRET donor residues, it is clear that the increase in observed 
fluorescence emission at 440 nm is due to 2,3-DHB binding to H6-EntE. This increase is 
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saturable with increasing 2,3-DHB concentrations and follows hyperbolic single-site 
binding behavior that allowed us to obtain an EC50 value of 2,3-DHB binding to H6-EntE 
that agrees with our ITC outcomes.  
Until now, our knowledge of the exact residues involved in EntE substrate 
binding has been limited. According to our EntE homology model, 2,3-DHB binds in an 
active site cavity proximal to five tyrosine residues. The closest of these residues is EntE 
Y236, which appears to be able to form a stacking interaction with the aromatic moiety of 
2,3-DHB. In the DhbE structure, Y236 does indeed stack with bound 2,3-DHB. In our 
EntE model the Y236 aromatic ring is orthogonal to the 2,3-DHB aromatic moiety, 
although the model indicates that the tyrosine side-chain has sufficient rotational degrees 
of freedom to facilitate stacking. In addition to Y236, our homology model reveals 
additional EntE residues that we predict to be involved in 2,3-DHB binding. In the DhbE 
structure, residues H234 and K517 stabilize the carboxylate moiety of the substrate (184). 
In our model, the side chains of EntE residues H233 and K519 superimpose with these 
DhbE carboxylate-binding residues, predicting their role in substrate binding in the EntE 
active site. In addition, our model predicts that EntE residues N234 and S239 bind the 2- 
and 3-hydroxyl groups of 2,3-DHB. Here it is worth noting that our ITC data show that 
binding of 2,3-DHB to EntE has a negative entropy component. Binding of 2,3-DHB to 
EntE is therefore enthalpy driven, and not primarily due to hydrophobic stacking 
interactions with Y236. This is supported by our fluorescence studies that clearly show 
that EntE specifically binds 2,3-DHB. Neither 2,5-DHB nor 3,5-DHB upon mixture with 
H6-EntE cause a quenching of intrinsic H6-EntE fluorescence, nor do these isomers 
generate a FRET signal at 440 nm upon excitation at 280 nm. The selectivity of H6-EntE 
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binding to 2,3-DHB can be explained by the side-chain positions of the hydrogen bond 
donors N234 and S239 relative to the bound substrate as predicted by our model. In 
contrast, C5 of the bound 2,3-DHB is proximal to a loop containing EntE residues V306, 
G307, G308. None of these residues could stabilize a DHB isomer containing a hydroxyl 
group at position C5. Based on our model, in conjunction with our experimental data, we 
propose that EntE residues N234 and S239 are essential for determining EntE substrate-
binding specificity.   
Two recent studies have suggested that misacylation of EntB may occur due to 
the ability of EntE to adenylate non-physiological DHB isomers. In the one study, a ~ 
30% reduction in in vitro enterobactin biosynthesis was observed when 1,500 µM 2,4-
DHB and 3,4-DHB were mixed with 2,3-DHB in a cell-free assay, showing that 
misacylation interfered with downstream NRPS processes (200). In the other study, it 
was found that holo-EntB could be acylated with 2,4-DHB and 3,4-DHB when in the 
presence of EntE and 500 µM of either DHB isomer (134). In these experiments, the 
concentrations of DHB isomers used was far in excess of the KD of 2,3-DHB binding to 
EntE as determined by ITC in this study. Our fluorescence experiments do not indicate 
any binding of 2,5-DHB or 3,5-DHB to EntE at what is likely to be a more 
physiologically relevant concentration (50 µM), although the possibility remains that 
binding of these isomers may have occurred in a manner such that a FRET signal was not 
generated. While H6-EntE is selective for 2,3-DHB binding under our experimental 
conditions, we found that all DHB isomers examined (2,3-DHB, 2,5-DHB, and 3,5-DHB) 
were able to quench H6-EntB intrinsic fluorescence to some degree.  It is significant that 
2,3-DHB was found to quench H6-EntB intrinsic fluorescence most efficiently, 
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suggesting a binding preference for this isomer. Our far-UV and near-UV circular 
dichroism data also established that 2,3-DHB can bind to H6-EntB, resulting in 
conformational changes to the enzyme. These results were unexpected, since 2,3-DHB is 
not a substrate for the ICL domain of EntB nor the ArCP domain. Based on our results, 
we propose that EntB may possess an allosteric site that binds 2,3-DHB to regulate 2,3-
DHB synthesis by feedback inhibition. It is reasonable that EntB would be a target for 
such regulation, since EntC, the first enzyme in the pathway, has been shown to be highly 
reversible (174). Given its reversibility, it is unlikely that the conversion of chorismate to 
isochorismate is the committed step of enterobactin biosynthesis, which would make the 
EntB-catalyzed conversion of isochorismate to 2,3-dihydro-dihydroxybenzoate the likely 
first committed step of the pathway. Our data suggest that not only could the 2,3-DHB 
module be feedback-attenuated in the presence of excess intracellular 2,3-DHB binding 
to EntB, but also that interaction with EntE would be promoted through ligand-induced 
conformational changes in EntB, thus enhancing NRPS and enterobactin formation 
further decreasing intracelluar 2,3-DHB levels.  
We used the FRET signal generated by 2,3-DHB binding to the EntE active site 
as a tool to measure interaction of H6-EntE with H6-EntB. We found that addition of H6-
EntB to a solution of H6-EntE saturated with 2,3-DHB resulted in significant quenching 
of the observed 2,3-DHB-EntE FRET signal. We conclude that this quenching reflects a 
conformational change in the EntE active site upon interaction with EntB, resulting in 
alterations to the geometry and distance of the bound 2,3-DHB substrate relative to 
intrinsic EntE FRET donor residues and a subsequent decrease in the FRET signal. We 
observed that upon increasing EntB concentration, the 2,3-DHB-EntE FRET signal 
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decreases until apparent saturation is achieved. Saturation of the quenching effect cannot 
be simply due to sequestration of 2,3-DHB as a result of its binding to H6-EntB, since the 
concentration of 2,3-DHB (50 µM) was far greater than the concentration of H6-EntB (3 
µM) used in this assay. Our fluorescence data describing the EntE-EntB interaction fit to 
a sigmoidal curve, suggesting positive binding cooperativity. The EntB concentration at 
which quenching of the FRET signal is half-maximal gives us an EC50 value of the 
interaction affinity, which is in the low micromolar range, suggesting that EntE and EntB 
interact transiently.  Since EntB must deliver acylated 2,3-DHB to EntF during NRPS, 
low-affinity protein-protein interactions would allow EntB to interact in an asynchronous 
manner with both upstream and downstream partners in the NRPS assembly line. We also 
found that mixture of H6-EntB with H6-EntE in the presence of 2,3-DHB resulted in 
additional changes in near-UV CD signal intensities at wavelengths corresponding to 
contributions from aromatic chromophores in each protein. Such changes in the near-UV 
CD signal is generally due to alterations in the local environment of aromatic amino acids 
contributing to the signal. We therefore conclude that our observed changes in the near-
UV CD signals of H6-EntE and H6-EntB upon their mixture in the presence of 2,3-DHB 
are due to conformational rearrangements upon formation of the EntE-EntB interaction 
interface. These rearrangements may include conformational alterations of surface-
exposed aromatic residues at the interface upon entering a more symmetric and ordered 
environment, and/or gross structural rearrangements in the EntB protein upon interaction 
with EntE. 
Our pull-down assays establish that the EntB-EntE interaction can occur in situ 
between H6-EntB and chromosomally-expressed E. coli EntE. Furthermore, the presence 
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of exogenously added 2,3-DHB greatly enhances the efficiency of EntE pull down by 
H6-EntB. This is consistent with our CD data, which show gross EntB conformational 
rearrangements upon mixture with EntE only when 2,3-DHB is present. The binding of 
2,3-DHB to EntE appears to subtly alter the surface of EntE in such a way that an EntB-
EntE interaction interface is optimized. The conformational rearrangements in H6-EntB 
observed by circular dichroism at both secondary- and tertiary-structure levels occur as a 
consequence of its interaction with substrate-loaded EntE.  Our pull-down data show that 
binding of chromosomally-expressed EntE to H6-EntB bait is greatly enhanced in the 
presence of exogenously added (100 µM) 2,3-DHB, confirming that efficient formation 
of the EntE-EntB complex depends on ligand-loaded EntE and EntB.  
That efficient pull-down did not occur in the absence of exogenously added 2,3-
DHB strengthens our argument that the pool of free intracellular 2,3-DHB is normally 
low, presumably due to its direct channeling through the enterobactin biosynthetic 
machinery. Some further insights into EntB conformational flexibility may be obtained 
from our pull-down data. On our SDS-polyacrylamide gel of pull-down products, we 
observed bands at approximately 25 kDa (Figure 8, bands „c‟ and „f‟) containing EntB 
peptides. We conclude that this is the result of EntB proteolysis. The ArCP domain of 
EntB resides between residues 214 – 285. The most C-terminal EntB peptide that we 
observed by mass spectrometry comprises residues 200 – 215 (Table 1, row 41). 
Although only five peptides were recovered from the 25-kDa band obtained in the 
presence of exogenous 2,3-DHB, we also recovered 12 peptides from the 25-kDa band 
pulled down in the absence of DHB (Figure 8, band „c‟, -DHB). The most C-terminal 
EntB peptide from this dataset also corresponded to residues 200 – 215. Band „c‟ 
87 
 
therefore corresponds to the ICL domain of EntB, with proteolysis likely occurring in the 
linker region between the EntB ICL and ArCP domains. This suggests that in solution the 
interdomain region of EntB is solvent-exposed and flexible, and may thus play a role in 
EntB conformational rearrangements. It is also worth noting that we have measured 
EntE-EntB interaction in the absence of ATP, implying that ATP can still access the EntE 
active site subsequent to formation of the EntE-EntB complex. This opens up some 
intriguing lines of inquiry regarding the order of substrate binding and protein interaction.  
  In this study we have shown that binding of 2,3-DHB to the E. coli enterobactin 
biosynthetic enzyme EntE can be measured in a rapid and sensitive manner using 
fluorimetry. Observed changes in intrinsic EntE fluorescence upon binding of 2,3-DHB 
can be clearly explained by the spatial distribution of tyrosine and tryptophan residues 
predicted by our homology model of the EntE structure. EntE and homologous AMP 
ligases from pathogenic bacteria are becoming targets for the development of novel 
synthetic inhibitors that rely on the high affinity of binding of DHB-AMP product
 
(186-
187). Fluorescence-based assays of the binding of DHB-like analogues, or of the 
inhibition of 2,3-DHB binding in the case of non-fluorescent inhibitors could result in a 
more high-throughput approach to the development of such drugs. The fluorescence 
phenomenon that we have reported here also allows us to use 2,3-DHB as a reporter of 
the EntE active site environment. Most importantly, we used this fluorescence 
phenomenon to measure the interaction of EntE with its immediate downstream 
enzymatic partner EntB. Taken together, our data show that EntE only interacts 
efficiently with EntB in the presence of 2,3-DHB. This transient complex is formed 
presumably to facilitate channeling of 2,3-DHB-AMP. Our results lead us to hypothesize 
88 
 
that the enterobactin biosynthetic machinery has evolved to minimize free intracellular 
2,3-DHB, which may be toxic to the bacterium (e.g., by inhibiting chorismate-dependent 
cellular processes such as aromatic amino acid biosynthesis), or which may inhibit other 
aspects of enterobactin biosynthesis and secretion (e.g., competing with enterobactin for 


















CHAPTER THREE: A PROTEIN-PROTEIN INTERACTION FACILITATES 
CONFORMATIONAL REMODELING OF THE ESCHERICHIA COLI 2,3-
DIHYDROXYBENZOATE-AMP LIGASE (ENTE) ACTIVE SITE BY 2,3-







The previous chapter focused on EntE interaction with its downstream partner 
protein EntB. In this chapter, a novel EntE interaction with its upstream partner protein 
EntA was characterized. All the protein-protein interactions involved in enterobactin 
biosynthesis up to this point were localized to the NRPS module (142, 181, 195, 197, 
206).  Here, for the first time the EntA-EntE interaction was detected, establishing a 
direct link between the functional modules of enterobactin biosynthesis (the DHB and the 
NRPS modules). Methods used in this chapter included AUC, fluorescence spectroscopy, 
fluorescence polarization, crosslinking, pull-down assays, and enzymatic assays. In this 
chapter, we also revealed that EntA-EntE interaction is likely dependent on EntA 
conformation.   
The manuscript of this chapter has been accepted for publication in Biochemistry 
under the title: “Enzymatic Adenylation of 2,3-Dihydroxybenzoate is Enhanced by a 
Protein-Protein Interaction Between Escherichia coli 2,3-Dihydro-2,3-
Dihydroxybenzoate Dehydrogenase (EntA) and 2,3-Dihydroxybenzoate-Amp Ligase 














The E. coli siderophore enterobactin is synthesized in response to iron starvation. 
EntA produces 2,3-dihydroxybenzoate (2,3-DHB), an enterobactin biosynthetic 
intermediate. EntE then adenylates 2,3-DHB, activating it for attachment to EntB. Using 
sedimentation velocity analytical ultracentrifugation we found that H6-EntA undergoes 
concentration-dependent dimer-tetramer self-association (KD = 12.3 μM). We further 
found that EntA can form a specific complex with its downstream partner EntE. Pull-
down assays revealed that recombinant H6-EntA bait could pull down EntE from E. coli 
lysates, whereas recombinant H6-EntE bait could pull down both EntA and EntB from 
lysate in the presence of 2,3-DHB. Addition of the crosslinker SMCC to a mixture of H6-
EntA and H6-EntE resulted in a crosslinked product with a size greater than 250 kDa, 
suggesting a complex stoichiometry of one EntA tetramer and four EntE monomers. The 
effect of EntA on EntE activity was also examined. Addition of a 4-fold excess of H6-
EntA to an H6-EntE assay mixture resulted in a 6-fold stimulation of H6-EntE activity. 
H6-EntA was also found to perturb the FRET signal between H6-EntE donor residues 
and H6-EntE-bound 2,3-DHB. By following the EntA-dependent decrease in the H6-
EntE–2,3-DHB FRET signal, EntA–EntE binding behavior was found to be sigmoidal, 
suggesting positive cooperativity in the interaction  (Hill coefficient = 3.66; K0.5 = 1.94 
μM). Taken together, our results establish that EntA and EntE form a complex that 
optimizes EntE catalysis by active site remodeling. The observed sigmoidal binding 




Under iron-limiting conditions, most bacteria synthesize and secrete small 
molecules known as siderophores in order to obtain iron from the extracellular 
environment (24). Siderophores, and the proteins involved in their synthesis, secretion, 
and modification are considered virulence factors in many pathogenic bacteria (60, 166, 
207-209).
 
In extraintestinal environment, Escherichia coli obtains ferric iron 
predominantly via the biosynthesis and secretion of enterobactin, a catecholate-type 
siderophore (35, 130).
 
Enterobactin consists of three 2,3-dihydroxybenzoic acid (2,3-
DHB) moieties linked by amide bonds to three L-serine subunits cyclized in a triserine 
trilactone core (Scheme 1A). High-affinity chelation occurs through the hexadentate 
coordination of the three 2,3-DHB catechol groups of enterobactin to one Fe
3+
 atom 




) (75). This extraordinary affinity for ferric iron is 
needed to effectively scavenge low-abundance extracellular Fe
3+
, and to compete with 
high-affinity chelators such as mammalian serum transferrin (210). 
The biosynthesis and secretion of enterobactin requires the proteins expressed 
from eight genes (entA-F, entH, and entS). Proteins encoded by the genes fepA-G then 
facilitate TonB-dependent uptake of ferric-enterobactin from the extracellular 
environment. These genes are all under the control of the Fur repressor, such that 
expression is only up-regulated when levels of intracellular iron are low (137, 211-212).
 
Enterobactin biosynthesis involves six enzyme activities that can be broadly grouped into 
two major arms that are functionally distinct. The DHB synthesis arm includes the 
activities of EntC (199), EntB (N-terminal isochorismate lyase (ICL) domain) (213), and 
EntA (140); these activities function sequentially to catalyze the conversion of 
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chorismate into 2,3-DHB. The NRPS arm includes the activities of EntD (194), EntE  
(214), EntB (C-terminal aryl carrier protein (ArCP) domain), and EntF  (215); activities 
in the NRPS arm function in concert to condense the three molecules each of 2,3-DHB 
and L-serine into one enterobactin molecule  (82, 142).
 
EntH has been shown to be a 
proofreading activity that ensures proper acylation of EntB during the NRPS process 
(134, 200).
 
The inner-membrane protein EntS secretes enterobactin from the cytoplasm 
into the periplasm, and is necessary for efficient enterobactin export (107). 
 
Scheme 1: (A) Chemical structure of enterobactin. (B) Reaction catalyzed by E. coli 
EntA. (C) Reaction catalyzed by E. coli EntE. 
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 We now know that the majority of proteins in a cell form specific complexes 
with one or more partner proteins in order to carry out their biological activities, and 
many such interactions are now targets in the development of novel chemotherapeutics 
(216-219). To what extent do protein-protein interactions play a role in enterobactin 
biosynthesis? Protein interactions within the NRPS arm have already been reported (142, 
144, 181, 197, 206). EntE activity has been shown to be significantly enhanced (~10-fold 
increase in kcat) in the presence of phoshopantetheinylated EntB (i.e., holo-EntB) (144). 
Residues comprising the EntB–EntE interaction interface have been identified through 
mutagenic studies (181).
 
We have recently reported that EntE–EntB complexation is 
optimal in the presence of exogenous 2,3-DHB, and that the EntE–EntB interaction was 
of relatively low affinity (EC50 ~ 1.5 µM) (206). Evidence of an EntB–EntF interaction 
has also been reported involving the participation of the EntB C-terminal aryl carrier 
protein (ArCP) domain (142).  
    The enzymes EntA and EntE are found at the interface of the two major arms 
of enterobactin biosynthesis. EntA (2,3-dihydro-2,3-dihydroxybenzoic acid 
dehydrogenase; E.C. 1.3.1.28) catalyzes the final reaction in the DHB synthesis arm 
(Scheme 1B). EntA has a subunit molecular mass of 26,249 Da (140).
 
The EntA crystal 
structure revealed EntA to be tetrameric, being composed of a dimer of dimers (183). 
EntE (2,3-dihydroxybenzoic acid-AMP ligase; E.C. 2.7.7.58) catalyzes the first reaction 
in the NRPS arm by activating 2,3-DHB, the product of EntA, through ATP-dependent 
adenylation (Scheme 1C). EntE has a subunit molecular mass of 59,112 Da and is 
monomeric, being a member of the adenylate-forming family of enzymes (131, 141, 184, 
187).
 
The EntE-catalyzed activation of 2,3-DHB facilitates its attachment to the 
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phosphopantetheine moiety of the downstream NRPS enzyme holo-EntB. The EntE 
catalytic mechanism has been elucidated in a recent report showing that EntE catalyzes 
two half-reactions in a bi-uni-uni-bi ping-pong mechanism: (i) in the first half reaction 
2,3-DHB binds to EntE followed by the co-substrate ATP. 2,3-DHB is then adenylated 
followed by release of pyrophosphate (PPi); (ii) in the second half-reaction, EntE-2,3-
DHB-AMP binds to holo-EntB resulting in transfer of 2,3-DHB to the 
phosphopantetheine group on EntB Ser245, thus producing acyl-holo-EntB, and this is 
followed by release of AMP from EntE  (189). Interestingly, it has also shown that in the 





tetraphosphate (Ap4A), a molecule that is involved in modulation of cellular stress  
(188). This highlights not only the importance of the EntE–EntB interaction during 
normal enterobactin biosynthesis, but also a potential protective role for EntE when 
expressed in the absence of EntB. 
    Here we report the first evidence of a protein-protein interaction between the 
sequentially related enzymes EntA and EntE, thus establishing a direct, physical link 
between the DHB synthesis and NRPS arms of enterobactin biosynthesis. Through the 
use of various in vitro assays, we show that EntA and EntE specifically interact to form a 
protein-protein complex. The nature of this interaction appears to be significantly 
affected by the oligomeric structure of EntA, which undergoes a concentration-dependent 
transition from dimer to tetramer at low-micromolar concentrations. Reminiscent of the 
effect of EntB interaction on EntE activity, we report here that the EntA–EntE interaction 
also results in stimulation of EntE activity through a conformational remodeling of the 
EntE active site. EntA exerts an activating role in first half-reaction (2,3-DHB 
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adenylation), similar to how EntB exerts an activating role in the second half-reaction 
(2,3-DHB transfer to holo-EntB). EntE activity therefore appears to be optimal when the 
enzyme is assembled into a protein complex, either EntA–EntE or EntE–EntB. The 
discoveries reported here further highlight the integral role of protein-protein interactions 
in networking the enterobactin biosynthetic pathway. 
Materials and Methods 
 Reagents   
Most reagents were purchased from Bioshop Canada, Inc. (Burlington, Ont.). 2,3-
dihydroxybenzoic acid (2,3-DHB) was purchased from Sigma-Aldrich (St. Louis, Mo.). 
Inorganic pyrophosphatase was purchased from Invitrogen (Carlsbad, Ca.). 
Protein Expression and Purification   
Hexahistidine-tagged EntA  (H6-EntA) and EntE (H6-EntE) were purified from 
Escherichia coli AG-1 cells (obtained from the ASKA repository (205) harboring 
appropriate pCA24N-based expression constructs. Each protein was expressed with an 
in-frame hexahistidine tag and spacer region at the N-terminus 
(MRGSHHHHHHTDPALRA...), and a short extension at the C-terminus 
(...GLCGR[STOP]). Recombinant H6-EntA and H6-EntE were overexpressed and 
purified using immobilized metal affinity chromatography as reported previously (206). 
In this study, all protein concentrations were determined by measuring absorbance at 280 
nm and using molar extinction coefficients predicted from primary amino acid sequences 








 for EntE and EntA, respectively). Protein 




Analytical Ultracentrifugation   
Sedimentation velocity experiments were performed
 
in a Beckman XL-I 
analytical ultracentrifuge with a four-place An-60Ti rotor. Runs were initiated after 
extensive thermal equilibration (> 5 hr) of the rotor and sample-containing cells at 20 
o
C. 
Solutions containing 50 mM Tris (pH 7.5), 150 mM NaCl, 0.5 mM TCEP, and varying 
concentrations of H6-EntA or H6-EntE were centrifuged at 40,000 rpm over 
approximately 10h. A total of 250 absorbance scans were collected per run in which 
optical density at 280 nm was measured. Sedimentation velocity data were fit to g(s*) 
and g^(s*) distributions using the computer program DCDT+ (v2.2.1) (220). A number of 
scans (~ 17 scans per analysis) from each run were selected. Fits to g(s*) distributions 
were used for qualitative graphical comparison of concentration-dependent sedimentation 
behavior. Fits of g^(s*) distributions (in which concentration distributions were not based 
on zero-time extrapolations), were used to quantitatively determine weight-averaged 
sedimentation coefficients. The program SEDPHAT (221) was used for global analysis of 
concentration-dependent EntA oligomerization. SEDPHAT global analysis was 
performed using four sedimentation velocity runs (H6-EntA at 2 μM, 4 μM, 8 μM, and 18 
μM; 250 scans per run). The data were fit to the monomer-dimer self-association model 
of SEDPHAT, in which EntA dimer was modelled as the 'monomer' and EntA tetramer 
was modelled as the 'dimer', assuming that the H6-EntA dimer sedimented as a stable 
non-dissociating species over the concentration range examined, consistent with the 
reported EntA crystal structure in which EntA subunits are arranged as a dimer of dimers 
(183). Estimations of S20,W values for EntA dimer and EntA tetramer, which are required 
in the SEDPHAT global analysis, were obtained by hydrodynamic bead modeling using 
98 
 
the computer program HYDROPRO (222) with the EntA PDB structure (2FWM) as 
input (either all 4 chains of the tetrameric biological assembly, or the 2 chains from the 
structure that comprise the physiological dimer). The fit to the SEDPHAT self-
association model was optimized using both simplex and Marquardt-Levenberg 
algorithms. For both DCDT+ and SEDPHAT analyses, the program SEDNTERP (v1.09)  
(223) was used as appropriate for estimation of the following parameters at 20 
o
C: 
solution viscosity, solution density, protein partial specific volumes (as predicted from 
primary amino acid sequences). 
 Pull-Down Assays  
The ProFound Pull-Down PolyHis Protein:Protein Interaction Kit (Pierce, 
Rockford, IL) was used to study in situ interactions formed between hexahistidine-tagged 
recombinant bait proteins (H6-EntA or H6-EntE) and chromosomally-expressed prey 
proteins from E. coli lysates in the presence or absence of exogenous 2,3-DHB (100 µM). 
Pull-down assays were performed at room temperature as described previously (206). 
Bait proteins and co-eluting proteins were recovered and separated on 10% SDS-
polyacrylamide gels. Proteins in bands excised from the gel were trypsinized and 
analyzed by LC-MS/MS at the McGill Mass Spectrometry Core Facility (McGill 
University, Montreal) as described previously (206).  
Chemical Crosslinking   
Recombinant proteins were covalently crosslinked using the Controlled Protein-
Protein Crosslinking Kit (Pierce). In a typical crosslinking reaction, H6-EntA was 
dialyzed against phosphate-buffered saline (pH 7.2) and then incubated with a 50-fold 
molar excess of the heterobifunctional crosslinker sulfo-SMCC for 30 minutes at room 
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temperature. Purified maleimide-activated H6-EntA-SMCC conjugate (22 μM) was then 
incubated with purified H6-EntE (2.5 μM) for 60 minutes at room temperature. 
Crosslinking reactions were concentrated using Microcon YM-30 centrifugal filter units 
(Millipore). Concentrated proteins were then denatured and separated on a 10 % SDS-
polyacrylamide gel. Peptides recovered from bands containing crosslinked proteins were 
analyzed by LC-MS/MS as described above. 
 Enzyme Activity Assays   
A pyrophosphate release assay adapted from Rusnak et al.  (141, 144) was used to 
monitor the effect of H6-EntA on H6-EntE activity. Reaction mixtures (100 μL total 
volume) containing H6-EntE (1 μM) and H6-EntA (0.25 μM and 4 μM), 0.2 units of E. 
coli inorganic pyrophosphatase, 75 mM Tris (pH 8.0), 10 mM MgCl2, 5 mM ATP, 5 mM 
DTT, and 2 mM salicylate were incubated at 37 
o
C and aliquots were withdrawn at 30 sec 
time intervals. Inorganic phosphate produced by the coupled enzyme reactions was 
measured spectrophotometrically by mixture with an ammonium molybdate–malachite 
green solution, resulting in the formation of a chromophore that maximally absorbs at 
620 nm (224). A control experiment was also performed in which EntE activity was 
assayed as above, but in the presence of 4 μM bovine serum albumin instead of H6-EntA. 
H6-EntE initial velocities were measured as the production of inorganic pyrophosphate as 





Fluorescence Spectroscopy   
Fluorescence emission spectra ( ex = 280 nm) were collected at 20 
o
C using a 
Shimadzu RF-5301PC spectrofluorimeter. Solutions of H6-EntE (3 μM) plus 2,3-DHB 
(60 μM) in Buffer A (50 mM Hepes (pH 8.0) and 1.0 mM TCEP, 15% glycerol) with or 
without H6-EntA (3 μM) were supplemented with KCl to a final concentration of either 
100 mM or 300 mM. Slit widths (excitation and emission) were set to 3 nm. Each 
spectrum presented is the average of 3 scans. Fluorescence emission data were corrected 
for background, dilution, and inner filter
 
effects as appropriate.  
Fluorescence Anisotropy   
Fluorescence anisotropy measurements were performed on a Varian Cary Eclipse 
spectrofluorimeter equipped with automated polarizers. Measurements were collected for 
solutions containing Buffer A plus 100 mM KCl and supplemented with various 
combinations of 2,3-DHB (20 μM), H6-EntA (15 μM) and H6-EntE (7 μM). 
Measurements of 2,3-DHB fluorescence anisotropy in the presence and absence of 
proteins were collected in triplicate at 20 °C at wavelengths of maximal 2,3-DHB 
excitation and emission (310 nm and 440 nm, respectively). Anisotropy (r) values were 
calculated according to the following equation (adapted from Lakowicz (225)): 
 
r = (IVV - IVH) / (IVV + 2IVH)                 (1) 
 
where IVV is the fluorescence emission intensity read at 440 nm with polarizers positioned 
in a parallel orientation, and IVH is the fluorescence emission intensity read at 440 nm 
with the polarizers in a perpendicular orientation.  
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Fluorescence-Based Equilibrium-Binding Assay   
The 2,3-DHB–H6-EntE FRET signal  (206) of solutions containing Buffer A plus 
100 mM KCl, 3 μM H6-EntE, 60 μM 2,3-DHB, and varying concentrations of H6-EntA 
(0.5 μM to 7 μM) was measured as the fluorescence emission intensity of the solution 
monitored at 440 nm upon excitation at 280 nm. Fluorescence emission data were 
collected at 20 °C using a Varian Cary Eclipse spectrofluorimeter equipped with a Peltier 
temperature controller. Fluorescence emission intensities were corrected for inner-filter 
effects, dilutions, and background. To analyze equilibrium-binding data collected in these 
experiments, [EntA]bound and [EntA]free at a given [EntA]total were calculated from 
changes in H6-EntE-bound 2,3-DHB fluorescence emission intensity (ΔF) measured at 
440 nm in the presence of varying concentrations of H6-EntA: 
 
ΔF = F0 – F               (2) 
 
where F0 is the corrected fluorescence emission intensity of 2,3-DHB bound to H6-EntE 
in the absence of H6-EntA, and F is the corrected fluorescence emission intensity of 2,3-
DHB bound to H6-EntE at a given H6-EntA concentration. 
    Binding assays were performed in triplicate in order to determine mean values 
for changes in fluorescence intensities as a function of [EntA]. To normalize for slight 
variations in Fo between replicates, we expressed the change in fluorescence intensity 
(ΔF/F0) at a given [EntA]total by dividing this value by the maximal change in 
fluorescence intensity observed in a given replicate at a saturating concentration of H6-
EntA ((ΔF/F0)max). We define the resulting ratio as fractional binding: (ΔF/F0)/ 
102 
 
(ΔF/F0)max , where (ΔF/F0)max was obtained from plotting (ΔF/F0) as a function of 
[EntA]total and fitting the plotted data to the equation describing a dose-response curve in 
Origin 8.1 (OriginLab Corp., Northampton, Mass.); the curve maxima obtained from 
these fits were used to determine (ΔF/F0)max. We used fractional binding to directly relate 
the observed decrease in 2,3-DHB fluorescence emission at 440 nm to the fraction of H6-
EntE in complex with H6-EntA, as shown below:  
 
[EntA]bound  = [EntE]total  x (ΔF/F0)/ (ΔF/F0)max                  (3) 
 
In all fluorescence titration experiments in this study, [EntE]total was 3 µM. Since 
[EntA]total was experimentally determined by measuring OD280, we derived the 
concentration of H6-EntA in the free fraction as follows: 
 
[EntA]free = [EntA]total – [EntA]bound       (4) 
  
Equilibrium binding data were fit to the Hill equation: 
 
(ΔF/F0)/ (ΔF/F0)max = [EntA]free
n




)              (5) 
 
where n is the Hill coefficient, and K0.5 is the concentration of [EntA]free at which 50% 
binding is observed. Non-linear fits of equilibrium-binding data to the Hill equation were 





Protein Expression and Purification  
 Preparations of recombinant, H6-EntA and H6-EntE were each expressed in E. 
coli AG-1 cells and purified by a single IMAC affinity chromatography step. The purity 
of proteins eluted from the IMAC columns were assessed by SDS-polyacrylamide gel 
electrophoresis and found to be near-homogeneous (purity > 95%). Yields obtained were 
typically in the range of 20-30 mg of purified protein per litre of culture. 
Analytical Ultracentrifugation  
We performed sedimentation velocity analytical ultracentrifugation (AUC) 
experiments on solutions of purified H6-EntA and H6-EntE in order to gain insights into 
the oligomeric state of these proteins as a function of concentration. We employed the 
program DCDT+ to perform model-independent, time-derivative g(s*) analyses of our 
sedimentation velocity data, resulting in a graphical representation of the abundance of 
sedimenting species as a function of S20,W (Figure 1). We observed that H6-EntE 
consistently sedimented as a monomer with a S20,W value of approximately 4.0, 
independent of H6-EntE concentration between 2.5 µM and 13 µM (Figure 1A). In 
contrast, large changes in H6-EntA sedimentation behavior were observed upon 
alteration H6-EntA concentration. Over a concentration range of 2 µM to 18 µM, H6-
EntA sedimented as a single peak, but that peak position shifted significantly with 
increasing concentration (Figure 1B). Concentration-dependent changes in sedimentation 
coefficients of sedimenting species are indicative of reversible self-association occurring 
between sedimenting species during the AUC experiment. In such a situation, the g(s*) 
distribution reflects an averaged reaction boundary of the reversible association and not 
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to discrete sedimenting species (226). We used the g^(s*) analysis function of DCDT+ to 
quantitatively determine S20,W values for H6-EntE and H6-EntA at different 
concentrations (Table 1). Consistent with our g(s*) analyses, the S20,W of H6-EntE did not 
change significantly over the concentration range examined (Table 1, rows 1-3). The H6-
EntA S20,W increased from 3.87 + 0.35 at a total loading concentration of 2 µM to 5.70 + 
0.09 at 18 µM (Table 1, rows 4-7). A plot (not shown) of H6-EntA S20,W vs. loading 
concentration revealed that the sedimentation coefficients followed a hyperbola-like trend 
with H6-EntA concentration, indicative of self-association over the observed 








Figure 1: Sedimentation velocity analytical ultracentrifugation of H6-EntE and H6-
EntA. 
 (A) g(s*) distributions fit to sedimentation velocity data obtained at 20 
o
C from H6-EntE 
solutions at the following concentrations: 2.5 µM (black circles); 4.5 µM (blue circles); 
13 µM (red circles). (B) g(s*) distributions fit to sedimentation velocity data obtained at 
20 
o
C from H6-EntA solutions at the following concentrations: 2 µM (black circles); 8 
µM (blue circles); 18 µM (red circles). For clarity, the g(s*) distribution of H6-EntA at 4 
µM is not shown in this figure, but the S20,W for H6-EntA at this concentration is reported 
in Table 1. The left vertical line represents the S20,W of dimeric EntA calculated by 




























EntE   2.5 3.93 + 0.17 0.859 n/a 
EntE   4.5 4.04 + 0.07 0.879 n/a 
EntE 13.0 3.93 + 0.04 0.869 n/a 
EntA   2.0 3.87 + 0.35 0.866 0.01057 
EntA   4.0 4.48 + 0.23 0.869 0.01054 
EntA   8.0 4.97 + 0.15 0.883 0.01077 
EntA 18.0 5.70 + 0.09 0.864 0.01553 
a
 Protein concentration determined by A280 and expressed as 
micromolar concentration of monomer subunits. 
b
 Weight-average sedimentation coefficients determined by fits to 
g^(s*) distributions using DCDT+. Standard errors to fits also 
shown.  
c
 Ratio of absorbance contribution of sedimenting species identified 
by g^(s*) analysis to total absorbance in cell.  
d
 Local root mean square deviations of fits to self-association model 




We used SEDPHAT to assess the fit of our sedimentation velocity data to a model 
describing dimer-tetramer self-association (given that the H6-EntA sedimenting species 
at 2 µM had an S20,W similar to that of the 60 kDa H6-EntE monomer and that H6-EntA 
also adopts a globular fold, we concluded that at this concentration H6-EntA was 
predominantly in the dimeric (~ 56 kDa) form). For SEDPHAT global analysis we 
required sedimentation coefficients for EntA dimer and EntA tetramer. Since our 
sedimentation velocity data indicated that our samples contained mixtures of H6-EntA 
dimer and tetramer over the concentration range examined, we could not experimentally 
determine sedimentation coefficients for discrete H6-EntA dimer or tetramer. We 
therefore employed hydrodynamic bead modelling using the program HYDROPRO, with 
the published X-ray crystallographic structure of EntA (PDB code: 2FWM) as input. 
According to our HYDROPRO analyses, the EntA dimer was predicted to have an S20,W 
value of 4.23, and the EntA tetramer to have an S20,W value of 6.71. These positions are 
shown in Figure 1B as vertical lines. The HYDROPRO-predicted S20,W of the EntA dimer 
is consistent with our experimental S20,W of H6-EntA determined by g^(S*) analysis at the 
lowest concentration that we examined (2 µM), indicating that H6-EntA is mostly dimer 
at this concentration. At the upper boundary of our concentration range (18 µM), our 
experimentally-derived S20,W value of 5.70 is significantly less than that predicted for 
homogeneous EntA tetramer, suggesting that at this concentration H6-EntA was present 
as both dimers and tetramers, with the majority of the protein being in the tetrameric 
form. Sedimentation velocity data from the four runs (250 absorbance scans per run) 
collected between 2 µM and 18 µM H6-EntA fit well to the SEDPHAT monomer-dimer 
self-association model (here H6-EntA dimer was modelled as 'monomer' and H6-EntA 
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tetramer was modelled as 'dimer', assuming no dissociation of dimer to monomer over 
this concentration range). The reduced chi-squared ( r
2
) value of the global fit was 1.46, 
which is acceptable given that a r
2
 value of 1.00 represents a perfect fit to the model 
(221). The root mean square deviations of fits of local datasets to the global SEDPHAT 
self-association model were also found to be acceptable (each R.M.S.D. was less than 
0.016; Table 1, column 5). The KD of the H6-EntA dimer-tetramer equilibrium was 
determined by SEDPHAT global analysis to be 12.30 µM (or 6.15 µM if total H6-EntA 
is expressed as dimer equivalents).  
 Pull-Down Assays   
We previously showed that recombinant H6-EntB when used as a bait protein 
could pull down chromosomally-expressed EntE from E. coli lysates, and further that 
pull-down efficiency increased substantially in the presence of exogenous 2,3-DHB 
(206). Here we used purified, recombinant H6-EntE and H6-EntA bait proteins in pull-
down experiments to identify respective binding partners from E. coli lysates in the 
presence and absence of exogenous 2,3-DHB. Bait proteins were immobilized to Co
+2
-
chelate beads and then incubated with lysates from E. coli BW25113 cells grown under 
iron-restricted conditions (M63 minimal medium plus 75 μM 2,-2'-dipyridyl), resulting in 
expression of the enterobactin biosynthetic machinery by derepression of Fur. We 
initially used H6-EntA as a bait protein to determine what partner proteins could be 
pulled down from E. coli cell lysates in the presence and absence of 2,3-DHB (Figure 
2A). We found that H6-EntA bait was able to pull down a protein migrating at 
approximately 60 kDa by SDS-PAGE analysis independent of whether or not exogenous 
2,3-DHB (100 µM) was added to the cell lysate (Figure 2A, band 'a', -DHB and +DHB, 
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respectively). Trypsinized proteins recovered from these bands were analyzed by LC-
MS/MS, and the recovered peptides were found to correspond to E. coli EntE (Appendix 
Table1, rows 1-41). The bands visible above the 'a' (-DHB and +DHB) bands were also 
present in a control experiment (in which the lysate was applied to the empty column) 
and therefore do not represent a prey protein that specifically binds to H6-EntA (data not 
shown). In a second pull-down experiment, we used H6-EntE as a bait protein to pull 
down partner proteins from iron-restricted E. coli cell lysates with or without 
exogenously added 2,3-DHB (Figure 2B). H6-EntE bait was also able to pull down a 
protein migrating at approximately 30 kDa (Figure 2B, band 'd', +DHB) that was 
determined by LC-MS/MS to be E. coli EntB (Appendix Table1, rows 42-57). This band 
was only observed when exogenous 2,3-DHB was added to the lysate prior to 
equilibration with immobilized H6-EntE bait. We also found that H6-EntE pulled down 
in a DHB-independent manner a protein migrating at approximately 26 kDa (Figure 2B, 
band 'e', -DHB and +DHB, respectively). Mass spectrometry of proteins extracted from 
the 'e' (-DHB) and 'e' (+DHB) bands confirmed that they contained peptides 






Figure 2: Pull down assays of EntA–EntE and EntE–EntB complexes formed in situ.  
(A) Silver-stained 10% SDS-polyacrylamide gel of E. coli proteins co-eluted from Co
+2
-
chelate beads when H6-EntA was used as bait. (B) Same as (A), but with H6-EntE being 
used as bait. -DHB: proteins eluted from beads exposed to iron-restricted E. coli 
BW25113 lysate in the absence of exogenous 2,3-DHB. +DHB: proteins eluted from the 
beads exposed to iron-restricted E. coli BW25113 lysate in the presence of exogenous 
2,3-DHB (100 μM). Positions of migration of protein molecular weight standards 
(Kaleidoscope Pre-Stained Markers, Bio-Rad Laboratories) are shown on the left side of 
each gel. Labels a-e indicate bands in which proteins were extracted and identified by 
LC-MS/MS: (a) E. coli EntE from lysate, (b) EntA (bait), (c) EntE (bait), (d) E. coli EntB 
from lysate, (e) E. coli EntA from lysate. Peptide sequences identified by LC-MS/MS for 








A solution of H6-EntA was incubated with the heterobifunctional crosslinker 
SMCC resulting in covalent attachment of the n-hydroxysuccinimide moiety of the 
crosslinker to primary amines on H6-EntA. Maleimide-activated H6-EntA (22 μM) was 
then mixed with a solution of H6-EntE (2.5 μM) in order to form crosslinks between H6-
EntE cysteine residues and the H6-EntA-SMCC conjugate. Resolution of crosslinked 
products on an SDS-polyacrylamide gel revealed the presence of a single band 
corresponding to a large (> 250 kDa) complex in addition to bands corresponding to 
uncrosslinked H6-EntA and H6-EntE. This additional band was observed in the presence 
of SMCC, but not in the absence of SMCC (Figure 3). The size of the +SMCC band is 
consistent with a crosslinked product containing four EntE monomers and four EntA 
monomers. Analysis of tryptic peptides from proteins recovered from the > 250 kDa band 
revealed that it contained both E. coli EntA and EntE sequences (Appendix Table 2), 








Figure 3: Covalent crosslinking of maleimide-activated EntA to EntE using the 
heterobifunctional crosslinker SMCC.  
Left lane: Mixture of purified EntE and SMCC-activated EntA. Right lane: Mixture of 
purified EntE and untreated (-SMCC) EntA. Proteins were separated by SDS-PAGE and 
sizes were estimated by co-electrophoresis with molecular weight standards 
(Kaleidoscope Precision Plus, Bio-Rad Laboratories). Positions of standards are shown 
as numerals on the right side of the gel. Labels on the left side of the gel correspond to 
proteins identified by LC-MS/MS mass spectrometry from excised bands (see Appendix 
Table 2). Although the crosslinking reaction was performed with 22 M maleimide-
activated EntA and 2.5 M EntE, the abundance of the bands on the gel do not reflect 
this ratio. This is likely due to loss of protein during concentration in Microcon YM-30 
centrifugal filtration units, as well as aggregation of a portion of maleimide-activated 
EntA due to self-crosslinking. 
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EntE Activity Assays   
Since we found that H6-EntE can form a complex with H6-EntA, we were 
interested in determining the effect of H6-EntA interaction on H6-EntE activity. It was 
previously reported that EntE turnover increases approximately 10-fold in the presence of 
its downstream partner protein, holo-EntB (144), suggesting that protein interactions 
could remodel the EntE active site. Here we found that addition of purified H6-EntA at 
concentrations of 0.25 μM and 4 μM to a solution containing 1 μM of purified H6-EntE 
resulted in 3-fold (Figure 4, black inverted triangles) and 6-fold (Figure 4, black 
triangles) increases in H6-EntE initial velocity, respectively, relative to the initial velocity 
of H6-EntE-catalyzed production of pyrophosphate product in the absence of H6-EntA 
(Figure 4, black squares). We did not observe any significant change in H6-EntE activity 
upon the addition of a control protein (bovine serum albumin at a concentration of 4 μM 
(Figure 4, black circles), demonstrating that the observed increase in H6-EntE activity 





Figure 4: Stimulation of H6-EntE activity by H6-EntA.  
Initial velocities of H6-EntE (straight lines) fit to the production of pyrophosphate as a 
function of time.  H6-EntE alone (black squares); H6-EntE plus 0.25 μM H6-EntA (black 
inverted triangles); H6-EntE plus 4 μM H6-EntA (black triangles); H6-EntE plus 4 μM 
bovine serum albumin (black circles). Data shown are averaged values of triplicate 











Effect of H6-EntA on the H6-EntE–DHB FRET Signal  
The observed stimulatory effect of H6-EntA on H6-EntE activity led us to 
investigate if conformational changes at the H6-EntE active site did indeed occur upon 
formation of the EntA–EntE complex. We used fluorescence spectroscopy to further 
investigate the EntA–EntE interaction by observing the effect of H6-EntA on the H6-
EntE–2,3-DHB FRET signal that we reported previously (206). The corrected 
fluorescence emission spectrum of the H6-EntE (3 µM) plus 2,3-DHB (60 µM) solution 
containing 100 mM KCl in the absence of H6-EntA is shown in Figure 5 (dashed line). 
The maximum at 440 nm corresponds to 2,3-DHB fluorescence emission upon excitation 
of H6-EntE intrinsic fluorophores at 280 nm. When the experiment was repeated with the 
addition of 3 µM H6-EntA, the observed corrected spectrum exhibited a 1.75-fold 
decrease in the peak maximum at 440 nm (Figure 5, solid line). We performed a similar 
experiment with H6-EntA present, but increased the concentration of KCl from 100 mM 
to 300 mM (Figure 5, dotted line). We found that this increase in ionic strength almost 
restored the H6-EntE–2,3-DHB FRET signal to its initial intensity, even in the presence 
of H6-EntA. We did not observe any KCl-dependent effect on the H6-EntE–2,3-DHB 
FRET signal in the absence of H6-EntA. This specificity suggests that the restoration of 





Figure 5: Perturbation of the 2,3-DHB– H6-EntE FRET signal by H6-EntA.  
Fluorescence emission spectra collected at 20 
o
C show 2,3-DHB fluorescence emission 
around 440 nm upon excitation of mixtures of 2,3-DHB with H6-EntE plus or minus H6-
EntA at 280 nm. 3 µM H6-EntE, 60 µM 2,3-DHB (dashed line); 3 µM H6-EntE, 60 µM 
2,3-DHB, 3 µM H6-EntA in a buffer containing 100 mM KCl (solid line); 3 µM H6-EntE, 
60 µM 2,3-DHB, 3 µM H6-EntA in a buffer containing 300 mM KCl (dotted line).  
 
Fluorescence Anisotropy Experiments   
 In order to determine the binding status of 2,3-DHB during EntA–EntE 
interaction, we measured the fluorescence anisotropy of 2,3-DHB in the absence and 
presence of H6-EntA and/or H6-EntE. We observed that in the absence of protein, 
fluorescence anisotropy (r) of 2,3-DHB at a concentration of 20 µM was near zero, 
indicating a rapid rate of rotational diffusion in solution (Figure 6, black bar). The 
addition of 15 µM H6-EntA to the 2,3-DHB solution did not result in a significant 
increase in 2,3-DHB anisotropy (Figure 6, dark grey bar). The addition of H6-EntE (7 
µM) to 2,3-DHB results in a relatively large increase in 2,3-DHB anisotropy, consistent 
with its ability to bind 2,3-DHB as a substrate (Figure 6, light grey bar). The addition of 
both H6-EntA (15 µM) and H6-EntE (7 µM) (Figure 6, white bar) resulted in observed 
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2,3-DHB anisotropy similar to that of 2,3-DHB plus H6-EntE, showing that H6-EntA 
binding to H6-EntE does not cause dissociation of 2,3-DHB from H6-EntE. 
 
Figure 6: Fluorescence anisotropy of 2,3-DHB.  
Fluorescence anisotropy measurements ( ex = 310 nm; em = 440 nm) collected at 20 
o
C 
of 2,3-DHB alone and in the presence of H6-EntE and/or H6-EntA. Black bar: 20 µM 
2,3-DHB; dark grey bar: 20 µM 2,3-DHB, 15 µM H6-EntA; light grey bar: 20 µM 2,3-
DHB, 7 µM H6-EntE; white bar: 20 µM 2,3-DHB, 15 µM H6-EntA, 7 µM H6-EntE.     
 
Fluorescence-Based Equilibrium-Binding Assay   
Having found that the change in the H6-EntE–2,3-DHB FRET signal by H6-EntA 
was due to the EntA–EntE interaction, we followed the decrease in this signal as a 
function of H6-EntA concentration to measure the equilibrium-binding behavior of 
EntA–EntE complexation. By varying the concentration of H6-EntA relative to a fixed 
concentration of H6-EntE plus 2,3-DHB, we found that H6-EntA was able to decrease 
the H6-EntE–2,3-DHB FRET signal in a saturable, concentration-dependent manner. At 
20 
o
C the decrease in the FRET signal was initially shallow followed by a transition to a 
steeper decrease commencing at an H6-EntA concentration of approximately 4 µM 
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(Figure 7A). We used our SEDPHAT-derived equilibrium association constant for the 




 when total H6-EntA is 
expressed as dimer equivalents) to estimate the fraction of tetrameric EntA at a given 
[EntA]total. The following equation, adapted from Cole (227), was used to relate the 
concentration of EntA dimer at a given [EntA]total (here expressed as dimer equivalents): 
 
[EntA]dimer =  (-1 + (1 + 8KA[EntA]total_as_dimer)
1/2
) / 4KA    (6) 
   
 We were thus able to estimate at each H6-EntA concentration used in our 
fluorescence-based equilibrium-binding assay the fraction of EntA occurring in the 
tetrameric form (Figure 7A, inset). According to these calculations, the amount of 
tetrameric H6-EntA found when [EntA]total is at a saturating concentration (7 µM) in our 
fluorescence assay is about 2.8 µM (i.e., fraction of H6-EntA as tetramer at this 
concentration was estimated to be 0.4), which is approximately equimolar with the fixed 
concentration of H6-EntE in our binding assay (3.0 µM). H6-EntA-dependent changes in 
the 2,3-DHB–H6-EntE FRET signal were used to determine fractional binding 
((∆F/Fo)/(∆F/Fo)max). Fractional binding values were then used to calculate [EntA]bound 
and [EntA]free at a given [EntA]total (see Experimental Procedures). At 20 
o
C the observed 
change in fractional binding as a function of [EntA]free was sigmoidal in character (Figure 
7B). These data fit well (R
2
 = 0.975) to the Hill equation. The Hill coefficient (n) 
determined from the non-linear fit was 3.66, and the K0.5 value was determined to be 1.94 
µM. A Scatchard replot of our binding data revealed a concave-down trend (Figure 7B, 




Figure 7: Fluorescence-based equilibrium binding assay of the EntA–EntE 
interaction.  
Binding of H6-EntA to H6-EntE corresponds to the decrease in the 2,3-DHB– H6-EntE 
FRET signal at 440 nm upon increasing concentration of H6-EntA. (A) Decrease in 
fluorescence emission at 440 nm ( ex = 280 nm) as a function of [EntA]total at 20 
o
C 
(black circles). Data shown are averaged values of readings taken in triplicate and 
normalized to correct for small changes in Fo between replicates; error bars represent 
standard deviations from averaged values. Fluorescence emission at 440 nm is due to 
2,3-DHB emission resulting from FRET via H6-EntE donor residues excited at 280 nm. 
Inset: Estimate of the fraction of [EntA]total occurring as tetramer at concentrations used 
in the fluorescence assay. Fractions as tetramer were determined using the KA of dimer-
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tetramer equilibrium determined by SEDPHAT global analysis of H6-EntA sedimentation 
velocity AUC data in an equation relating [EntA]dimer concentration to total loading 
concentration expresed as EntA dimers. Fraction as tetramer = ([EntA] total_as_dimer - 
[EntA]dimer) / [EntA]total_as_dimer ). The solid line represents a non-linear fit of the data to a 
second-order polynomial describing Equation (6) (see Results). (B) Hill plot showing the 
change in fractional binding ((ΔF/F0)/ (ΔF/F0)max) as a function of [EntA]free (black 
squares). Error bars along the y-axis reflect standard deviations of averaged fractional 
binding determinations from three experiments; error bars along the x-axis reflect 
standard deviations of averaged [EntA]free determinations from three experiments. Inset 
shows Scatchard replot of same data, in which [EntA]bound = fractional binding x 
[EntE]total. See Experimental Procedures for details on how [EntA]bound and [EntA]free 
were determined.  
 Discussion 
Protein-protein interactions are now recognized to play a key role in many 
metabolic processes mediated by sequential enzyme activities (228-230). Such 
interactions may facilitate the direct channeling of metabolic intermediates, resulting in 
optimization of catalysis, sequestration of intermediates to protect against diversion to 
other pathways, or to protect against degradation of labile intermediates (231-233). The 
biosynthesis of the E. coli siderophore enterobactin is a cytoplasmic enzyme-mediated 
process in which protein-protein interactions are now recognized to be essential. Prior to 
this study, all protein-protein interactions relevant to enterobactin biosynthesis had been 
localized to proteins involved in the NRPS arm (EntE, EntB, EntF, EntD) (142, 181, 195, 
197, 206).
  
Here we report the first experimental evidence of a protein-protein interaction 
between EntA and EntE, thus establishing a direct link between the DHB synthesis and 
NRPS arms. Formation of an EntA–EntE complex during enterobactin biosynthesis could 
serve to facilitate substrate channeling, thus minimizing dissociation of 2,3-DHB into the 
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bulk medium and favoring direct, rapid entry of this intermediate into the NRPS arm. 
Such channeling would be advantageous since excessive accumulation of intracellular 
2,3-DHB during enterobactin biosynthesis in E. coli under iron-limiting conditions could 
interfere with iron uptake processes potentially requiring molecular recognition of 
enterobactin 2,3-DHB moeities as part of their function (e.g., Fes, EntS).  
    Here we found through our enzyme assays that H6-EntE activity increased 
significantly upon addition of H6-EntA, and in a manner dependent on H6-EntA 
concentration. We propose that our observed stimulation of EntE activity is due to 
optimization of the EntE active site through conformational changes occurring upon 
EntA binding. Our finding that H6-EntA perturbs the FRET signal between 2,3-DHB and 
H6-EntE intrinsic fluorophore donor residue(s) supports this. Complexation of EntA with 
EntE therefore likely results in conformational changes at the EntE active site causing 
translocation of bound 2,3-DHB towards the ATP co-substrate and away from FRET 
donor residues such as Tyr236 predicted to be found at the floor of the EntE active site, 
consistent with the structure of the EntE homologue DhbE (184, 206). Our fluorescence 
anisotropy experiments clearly show that 2,3-DHB is not dissociated upon formation of 
the EntA–EntE complex, thus excluding this as an alternate explanation for EntA-induced 
reduction in the observed FRET signal. Taken together, our data show that EntA induces 
a conformational remodeling of the EntE active site upon EntA–EntE complex formation, 
resulting in a re-positioning of 2,3-DHB within the substrate-binding cavity of EntE such 
that the rate of EntE-catalyzed 2,3-DHB adenylation in the first half-reaction of the EntE 












Scheme 2:  Proposed model of the attenuation of the EntE–2,3-DHB FRET signal 
upon EntA interaction.  EntE Y236 is shown as a putative FRET donor at the base 
of the EntE active site. 
 
    We also found that the decrease in the 2,3-DHB–H6-EntE FRET signal was 
dependent on the concentration of H6-EntA, and we exploited this phenomenon to gain 
insights into the equilibrium-binding aspects of EntA–EntE complexation. Our 
equilibrium-binding data at 20 
o
C fit well to the Hill Equation, with a Hill coefficient 
greater than one (n = 3.66; Figure 7B). A Hill coefficient of that magnitude, along with 
the concave-down behavior observed in the Scatchard replot of our binding data, suggests 
positive cooperativity in the EntA–EntE interaction (i.e., EntE affinity for EntA increases 
as a function of EntA concentration). Concordant with this binding behavior, our AUC 
data show that the oligomeric structure of EntA changes over the concentration range 
used in our equilibrium-binding assay. We found that EntA exists as a mixture of dimers 




predominantly dimer at 2 µM to being predominantly tetramer at 18 µM. The sigmoidal 
binding behavior observed in the EntA–EntE interaction is therefore likely due at least in 
part to EntE binding with higher affinity to EntA in the tetrameric form. However, it 
appears that EntE can also interact with EntA in non-tetrameric forms (i.e., dimer) since 
we observed stimulation of EntE activity in the presence of EntA at a concentration of 
0.25 µM, where the concentration of EntA tetramer would be negligible according to our 
analysis of EntA self-association.  
When taken together, our experimental data demonstrate that the EntE interacts 
with EntA, and appears to form a higher-affinity complex with EntA in the tetrameric 
form compared to EntA in the dimeric form. Our crosslinking experiment detected only a 
large (> 250 kDa) crosslinked species that contained both H6-EntA and H6-EntE (Figure 
3), consistent with a complex comprised of four EntE monomers binding to one EntA 
tetramer (~ 360 kDa). The effect of intracellular concentration on the oligomeric state of 
EntA may play a regulatory role during enterobactin biosynthesis, with activation of the 
process occurring upon EntA tetramerization only at sufficiently high intracellular 
concentrations. Our pull-down assays also showed that recombinant H6-EntE bait could 
pull down both chromosomally-expressed EntA and EntB in situ from E. coli lysates 
when exogenous 2,3-DHB was present. This supports our previous study (206) where we 
showed that the EntE–EntB interaction affinity increases significantly in the presence of 
exogenous 2,3-DHB, due to 2,3-DHB binding to EntB as an allosteric regulator. The 
most likely explanation for our pull-down data is that EntA and EntB formed discrete and 
independent complexes with the immobilized H6-EntE bait during the pull-down 
experiment. Consistent with this, we observed that H6-EntA bait could pull down EntE 
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but not EntB, and in our previous study that H6-EntB bait could pull down EntE but not 
EntA. An alternative explanation for our pull-down data could be that H6-EntE in the 
presence of 2,3-DHB pulled down both EntA and EntB as an EntA–EntE–EntB complex. 
Although this is enticing, we currently do not have further evidence to support the 
existence of such a ternary complex.  
 To summarize our findings in the context of what is currently known about EntA, 
EntE, and EntB, we propose in Scheme 3 a model outlining the roles of dynamic protein-
protein interactions in enterobactin biosynthetic steps involving EntE. In this model, EntE 
initially forms a complex with tetrameric EntA, facilitating direct channeling of 2,3-DHB 
from EntA to the EntE active site. ATP would then enter the EntE active site and the first 
half-reaction (adenylation of 2,3-DHB) would occur at an optimal rate along with release 
of pyrophosphate. Assuming partial channeling of 2,3-DHB between EntA and EntE 
active sites, some free 2,3-DHB would be released into the cytoplasm that could then 
bind at an allosteric site on holo-EntB, thus activating it for interaction with EntE. EntA 
would then dissociate from EntE (perhaps as a result of ATP hydrolysis), thus allowing 
EntE–DHB–AMP to interact with holo-EntB. The resulting EntE–EntB complex would 
allow for direct transfer of the 2,3-DHB moiety to PPant-Ser245, thus forming acyl-holo-
EntB along with the release of AMP. Dissociation of acyl-holo-EntB from the EntE 
would then occur such that the 2,3-DHB moiety could be delivered to the NRPS scaffold 
protein EntF for condensation with activated L-serine. Upon dissociation of acyl-holo-
EntB, the EntE–EntA complex would be regenerated, resulting in turnover of the process. 
This model is consistent with recent reports elucidating the EntE mechanism in the 
context of its two half-reactions (188-189), such that the EntA–EntE interaction 
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optimizes the first half-reaction (2,3-DHB adenylation), and the EntE–EntB interaction 
optimizes the second half-reaction (transfer of 2,3-DHB to holo-EntB). 
 
Scheme 3: Proposed mechanism of EntA–EntE and EntE–EntB complex assembly 
during enterobactin biosynthesis.  
This model proposes that protein-protein interactions enhance the two EntE half-
reactions in a manner consistent with what is known about the EntE catalytic mechanism. 
First half reaction: Four EntE monomers (red ellipsoids) bind with optimal affinity to 
one EntA tetramer (blue circles indicate EntA monomers). Partial channeling then occurs 
in which some 2,3-DHB (small circles) produced by EntA is directly transferred to the 
EntE active site, while some is released into the cytoplasm that will act as a signal to 
recruit holo-EntB to EntE. Subsequent to 2,3-DHB binding, ATP will then bind at the 
EntE active site. While in complex with EntA, EntE catalyzes the production of 2,3-DHB-
AMP, followed by release of pyrophosphate (PPi) and EntA. Second half reaction: holo-
EntB (subunits shown as green elliposids; dimerization occurring through isochorismate 
lyase (ICL) domains, consistent with the EntB structure), with 2,3-DHB bound at an 
allosteric site, forms a complex with EntE–DHB–AMP. 2,3-DHB is then directly 
transferred to the phosphopantetheine (PPant) group attached to EntB Ser245, resulting 
in the production of acyl-holo-EntB. EntE and AMP dissociate from acyl-holo-EntB, 
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allowing it to participate in downstream NRPS steps. Dissociated EntE complexes with 
EntA, followed by another round of DHB adenylation upon binding of 2,3-DHB (via 
transfer from EntA) and ATP.  
 
Here we have shown that E. coli enterobactin biosynthesis is even more highly 
networked by protein-protein interactions than previously thought. We have established 
that there is a direct link between the DHB synthesis and NRPS arms of enterobactin 
biosynthesis as facilitated by the EntA–EntE interaction. Our study, in conjunction with 
previous reports, provides strong evidence that EntE has evolved such that its enzymatic 
activity is only fully optimized when the protein is participating in a protein-protein 
interaction that facilitates conformational remodeling of the EntE active site. 
Significantly, it has recently been reported that an endogenous catecholate siderophore 
occurs in mammals, with a homologue of E. coli EntA (BDH2) being essential for its 
biosynthesis; furthermore, a mammalian homologue of E. coli EntE has also been 
identified (1). Our elucidation of the protein-protein interaction network necessary for E. 
coli enterobactin biosynthesis therefore provides not only further insights into a 
biological process that is essential for bacterial survival under iron-limiting conditions, 
but also provides insights that will be useful in interpreting the newly identified BDH2-

















CHAPTER FOUR: IDENTIFICATION OF ESCHERICHIA COLI ENTA 
RESIDUES NECESSARY FOR INTERACTION WITH ENTE:  TARGETED 













Continuing our characterization of the EntA-EntE interaction that was the focus 
of the last chapter, the EntA-EntE interaction interface was mapped and characterized in 
this chapter for the first time. Here, phage display was used to identify the EntE 
interaction interface on the EntA surface. Site-directed mutagenesis was then used to 
measure the contribution of two of the identified interface residues of EntA in the 
interaction with EntE. Techniques used to study EntA variants predicted to differentially 
interact with EntE compared to wild-type include: AUC, circular dichroism, fluorescence 
spectroscopy, cross-linking experiments, and growth phenotype assays. The manuscript 


























Enterobactin biosynthesis needs the activities of six enzymes (EntA-EntF). The 
activities of EntC, EntB (N-terminal domain), and EntA are required for biosynthesis of 
2,3-dihydroxybenzoate (2,3-DHB). The activities of EntE, EntB (C-terminal domain), 
EntD, and EntF are required for the condensation of 2,3-DHB with L-serine via non-
ribosomal peptide synthesis (NRPS). We previously showed that the DHB biosynthesis 
and NRPS processes are directly linked by EntA-EntE interaction. Here we performed a 
fine-mapping of the EntA-EntE interaction interface by phage display. We localized 
EntE-interacting residues to an alpha helix near the N-terminus of EntA, proximal to the 
EntA dimerization interface. H6-EntA variants containing single-site mutations (Q64A 
and A68Q) and a double-site mutation (Q64A/A68Q) were created. Our cross-linking 
experiments demonstrated a weak interaction between H6-EntE and H6-EntA (Q64A) 
variant. Near-UV CD spectra did not display any changes in the H6-EntE and H6-EntA 
(Q64A) or H6-EntA (Q64A/A68Q) spectra upon mixing. Our fluorescence assays 
showed a weak interaction between H6-EntE and H6-EntA variants (Q64A and 
Q64A/A68Q), supporting our CD results. Growth phenotype experiments revealed that 
an E. coli entA-knockout strain transformed with gene encoding H6-EntA (Q64A) variant 
or H6-EntA (Q64A/A68Q) variant grew more poorly in iron-free M63 minimal media in 
the presence of 2,2-dipyridyl. Taken together, our results show that EntA residues Q64 
and A68 are necessary for efficient formation of the EntA-EntE complex. Disruption of 
the EntA-EntE interaction by mutations at these positions appears to be due a 
combination of direct disruption of the EntA-EntE interaction interface as well as an 




Most microorganisms have developed different ways to get iron from the 
extracellular environment under conditions of iron starvation. One of such strategy 
involves the synthesis and export of low-molecular-weight compounds named 
siderophores that have high affinity for ferric iron. More than 500 siderophores have so 
far been identified (57). Siderophores compete with other iron chelators to sequester iron 
from the extracellular environment. Iron is an essential micronutrient for most 
microorganisms. It is involved in many important biological processes, including enzyme 
catalysis and electron transport. Since iron availability inside a host cell is limited, 
siderophores from pathogenic bacteria are considered virulence factors. For example, 
siderophores have been identified as virulence factors in a number of diseases inflicted by 
pathogenic microorganisms: cystic fibrosis pathogenesis (234), pulmonary infections 
caused by Klebsiella pneumonia (235), Pseudomonas aeruginosa pathogenesis (236), 
Escherichia coli k1 in neonatal meningitis (207), extraintestinal Escherichia coli 
pathogenesis (172), and avian pathogenic Escherichia coli infection (237). Much work 
has been done to gain understanding of siderophore biosynthesis and transport systems. 
E. coli and other enteric bacteria synthesize and secrete the catecholate 
siderophore, enterobactin, which is a cyclic triester of 2,3-dihydroxybenzoylserine 
(DHBS). Enterobactin is secreted in response to iron deficiency in the cell. It has the 
highest affinity for ferric ions (KD ~ 10
-50
 M (75)). The outer membrane protein FepA 
binds ferric enterobactin and transports it to the periplasm (146) where FepB shuttles the 
ferric siderophore to the multisubunit inner membrane permease complex FepCDG (44, 
157-159). In many bacteria, the iron uptake and homeostasis pathways are down-
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regulated by ferric uptake regulator (Fur) protein in response to iron availability (238).   
Several pathogens including
 
E. coli (130), Salmonella typhimurium (239), and Klebsiella
 
pneumoniae (240), produce enterobactin by derepression of Fur in response to iron-
limiting conditions. Thus enterobactin biosynthesis, export, and import pathways are a 
crucial target in the development of novel antimicrobial drugs.  
The biosynthesis of enterobactin needs the activities of six enzymes: EntC, EntB, 
EntA, EntE, EntD, and EntF. The first three enzymes in the pathway (EntC, EntB (N-
terminal domain), and EntA) comprise the DHB biosynthesis module that involves the 
formation of 2,3-dihydroxybenzoate (2,3-DHB) from  chorismate (140, 177, 213). EntE, 
EntB (Ar-CP domain), EntD, and EntF comprise the non-ribosomal-peptide synthesis 
(NRPS) module (131, 139, 141, 143). In the NRPS module three molecules of 2,3-DHB 
are condensed with three L-serine residues to form enterobactin. EntH has been shown to 
be a proofreading activity to prevent or reverse misacylation of EntB and EntF during 
NRPS (133). Enterobactin can be further modified by iroA system in extraintestinal E. 
coli in order to evade the host innate immune system (241). 
EntA is a 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (E.C. 1.3.1.28). It 
catalyzes the last reaction of the DHB biosynthesis module, which is the oxidation of 2,3-
dihydro-2,3-dihydroxybenzoate (2,3-diDHB) to 2,3-dihydroxybenzoate (2,3-DHB) (140). 
The crystal structure of EntA has been determined (183).  EntE, 2,3-DHB-AMP ligase 
(E.C. 2.7.7.58), catalyzes the first reaction of the NRPS module, which is the activation 
of 2,3-DHB (i.e., the product of EntA) via adenylation to form 2,3-DHB-AMP (141). The 
crystal structure of EntE is currently unknown. The crystal structure of DhbE, an EntE 
homologue from Bacillus subtilis, was determined in the presence and absence of bound 
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DHB and AMP (184). In our previous work (Chapter 2), we generated an EntE homology 
model using DhbE as a template (206). This model provided insights into the nature of 
binding of the 2,3-DHB substrate to the EntE active site. We also previously 
demonstrated that the functional modules involved in DHB biosynthesis and NRPS are 
directly linked by a protein-protein interaction between EntA and EntE (Chapter 3) (242). 
In that study we demonstrated that EntA quaternary structure is dependent on its 
concentration. EntA in solution is in equilibrium between dimeric and tetrameric forms, 
with conversion to the tetrameric form occurring with increasing EntA concentration. At 
low micromolar EntA concentrations the dimeric form is predominant, with a transition 
to predominantly tetrameric EntA occurring at a concentration greater than 20 µM. We 
also demonstrated that EntE has a higher affinity for EntA in the tetrameric form at 20°C. 
Thus EntA oligomerization likely plays a regulatory role in enterobactin biosynthesis, 
such that EntA tetramerization enhances EntA-EntE interaction.    
In this report, we used phage display to identify EntA residues involved in 
interaction with EntE. Based on our phage display results, we generated EntA variants to 
observe the effects of EntA mutagenesis at these positions on EntE interaction in vitro 
and in vivo. The effect of EntA mutations on the interaction with EntE was characterized 
in vitro using cross-linking experiments, fluorescence spectroscopy, and circular 
dichroism. Here we found that single-site mutation at EntA residue 64 and double-site 
mutation at EntA residues 64 and 68 had a significant effect on the ability of variants 
harboring these mutations to interact with EntE in solution. We also studied the effect of 
EntA mutations in vivo by conducting growth phenotype experiments in which we 
transformed genes encoding EntA variants with mutations at residues 64 and 64/68 into 
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an E. coli entA-knockout strain. Growth of resulting transformants under iron-restricted 
conditions was found to be very poor relative to entA-knockout cells transformed with a 
gene encoding wild-type EntA.  
Materials and Methods 
Reagents 
 All chemicals were purchased from Bioshop Canada, Inc. (Burlington, Ontario) 




 phage display peptide library kit (New England Biolabs) was 
used to pan a phage library containing random 12-mer peptide sequences (~ 1 x 10
13
 
pfu/ml) against immobilized H6-EntE. Panning was carried out by incubating 10 μl of a 
library of phage-displayed peptides (~1 x 10
11
 pfu/ml) in a well of a plastic tray coated 
with approximately 100 μg of purified H6-EntE. Unbound phage were washed away 
using a buffer containing 50 mM Tris (pH 8.6), 150 mM NaCl, and 0.1% (v/v) Tween 20. 
Bound phages were eluted by the addition of a solution containing 0.2 M glycine-HCl 
(pH 2.2) and bovine serum albumin (1 mg/ml). Eluted phages were amplified in E. coli 
ER2738 cells, and two additional binding/amplification cycles were performed. After 
three rounds, clones were selected by picking individual plaques containing amplified 
phage developed on plated lawns of E. coli ER2738 cells. Each plaque represented a 
clonal phage population containing a single 12-mer peptide sequence. Single-stranded 
DNA was isolated from phage amplified from plaque picks using the QIAGEN M13 Kit 
(QIAGEN Inc, Chatsworth, CA) and sequenced at the McGill University and Génome 
Québec Innovation Centre. Amino acid sequences of 12-mer peptides from isolated 
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phage particles were predicted from DNA sequence data. The dataset of unique peptide 
sequences isolated from H6-EntE-bound phage particles was analyzed using the RELIC 
server (http://relic.bio.anl.gov/) that employs algorithms developed from statistical 
analyses of published phage display outcomes (243). 
Site-Directed Mutagenesis 
 Single-site mutagenesis of H6-EntA was performed on the construct obtained 
from the ASKA repository (205) used previously for expression and purification of wild-
type, recombinant hexahistinde-tagged EntA (henceforth referred to as H6-EntA) (242). 
This construct was used as a template in site-directed mutagenesis experiments 
employing the Quik-Change Site-Directed Mutagenesis Kit (Stratagene) along with two 
mutagenic oligonucleotide primers for each mutant generated. The mutagenic 
oligonucleotides were designed to substitute EntA Gln64 to Ala (Q64A) (forward primer: 
5'-GGT CGC GCA AGT GTG TGC GCG ACT GTT AGC TGA AAC G-3'; reverse 
primer: 5'-CGT TTC AGC TAA CAG TCG CGC ACA CAC TTG CGC GAC C-3') or 
EntA Ala68 to Gln (A68Q) (forward primer: 5'-TGT CAG CGA CTG TTA CAG GAA 
ACG GAG CGA CTG G-3'; reverse primer: 5'-CCA GTC GCT CCG TTT CCT GTA 
ACA GTC GCT GAC A-3'). The reaction mixture contained the pCA24N-H6-entA 
construct (5-50 ng), mutagenic forward and reverse primers (125 ng each), 1 μl of dNTP 
mixture (10 mM), and DNA polymerase (0.05 U/μl). The number, duration, and 
temperature of the PCR cycles were performed according to the manufacturer's 
instructions. Double-stranded plasmids obtained from site directed mutagenesis were 
purified using QIAGEN DNA Mini Prep Kit and verified by sequencing. Plasmids 
containing the mutations were transformed into competent E. coli AG-1 cells (Stratagene) 
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for expression and purification of H6-EntA mutants. An EntA double mutant 
(Q64A/A68Q) was created by TOP Gene Technologies (Montreal, Canada) using the 
pCA24N-H6-entA construct. 
Expression and Purification of EntA Wild-Type and Variant Proteins  
Constructs containing DNA sequences encoding in-frame N-terminal 
hexahistidine tagged EntE, EntA, or EntA variants (Q64A, A68Q, or Q64A/A68Q) were 
transformed into competent AG-1 cells. Transformants were grown in LB broth 
containing 30 μg/ml of chloramphenicol at 37 °C to an OD600 of 0.6. Protein expression 
was induced with the addition of IPTG to a final concentration of 1 mM followed by 
further incubation at 37 
o
C for 3 hours. Cell lysis was performed using the BugBuster 
Master Mix lysis buffer (Novagen). Clarified lysates were applied to a 10-ml Profinity 
IMAC column connected to a BioLogic DuoFlow FPLC system (Bio-Rad Laboratories). 
The column was washed using Buffer A (50 mM Hepes (pH 8.0), 100 mM KCl, 1 mM 
TCEP, and 10 mM imidazole). The hexahistidine-tagged proteins were eluted using a 
linear gradient of imidazole (10 mM to 500 mM) in Buffer A. Fractions containing the 
highest OD280 fractions were analyzed by SDS-PAGE, pooled, and dialyzed against 
Buffer B (50 mM Hepes (pH 8.0), 100 mM KCl, 1 mM TCEP, and 15 % glycerol) 
followed by storage at – 20 °C.  
Analytical Ultracentrifugation  
Sedimentation velocity experiments performed
 
in a Beckman XL-I analytical 
ultracentrifuge with a four-place An-60Ti rotor. H6-EntA, H6-EntA (Q64A), H6-EntA 
(A68Q), and H6-EntA (Q64A/A68Q) were dialyzed into Buffer C (50 mM Tris buffer 
(pH 8.0), 150 mM NaCl and 0.5 mM TCEP) and adjusted to final concentrations of 2 µM 
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and 20 µM by dilution with Buffer C. Sedimentation velocity experiments were 
performed as described previously (206). Samples were centrifuged at 40,000 rpm for 
approximately 10 h at 20 °C; for each run a total of 250 absorbance scans were collected 
in which optical density at 280 nm was measured. Data were analyzed by fitting to the    
g(s*) and g^(s*) distributions using the computer program DCDT+ (v2.2.1) (220). 
Approximately 20 scans were selected from each run of 250 scans for analysis. Solvent 
density, viscosity, and protein partial specific volumes used as input parameters for 
DCDT+ were obtained using the program SEDNTERP (223). 
Chemical Crosslinking of Protein Complexes  
In this study, protein-protein complexes were covalently crosslinked using the 
Controlled Protein-Protein Crosslinking Kit (Pierce). The crosslinking reaction mixture 
contained 0.8 mg/ml of H6-EntA, H6-EntA (Q64A) or H6-EntA (A68Q)) and 50-fold 
molar excess of sulfo-SMCC prepared in phosphate-buffered saline (pH 7.2). The 
mixture was incubated for 30 minutes at room temperature, followed by removal of 
unreacted sulfo-SMCC using a D-salt
TM
 dextran desalting column. The highest OD280 
fractions containing maleimide-activated H6-EntA or H6-EntA variants were pooled (22 
µM), mixed with H6-EntE (2.5 µM) and incubated for 60 minutes at room temperature. 
Complex formation was analyzed by SDS-polyacrylamide gel electrophoresis. Bands 
corresponding to crosslinked species were excised and analyzed for protein content by 






Fluorescence Spectroscopy  
The interaction between H6-EntE and H6-EntA (wild-type or H6-EntA variants) 
was monitored by measuring the reduction in H6-EntE-bound 2,3-DHB FRET signal at 
440 nm (206). Fluorescence intensities were measured at 20 
o
C using a Varian Cary 
Eclipse spectrofluorimeter equipped with a Peltier temperature controller. Fluorescence 
intensity measurements (excitation wavelength: 280 nm; emission wavelength: 440 nm) 
of a mixture of H6-EntE solutions (2.5 μM) and 60 μM 2,3-DHB were collected in the 
presence and absence of each H6-EntA variant (Q64A, A68Q, Q64A/A68Q) at a 
concentration of 6 μM. Measurements were corrected for background, protein dilution, 
and the inner filter
 
effect as appropriate.  
Far-UV Circular Dichroism Spectroscopy  
Far-UV CD spectra of H6-EntE (1.25 µM), wild-type H6-EntA or H6-EntA 
variants (1.25 µM), and a mixture of H6-EntE with wild-type H6-EntA or H6-EntA 
variants (1.25 µM) were recorded over the range 200-260 nm
 
in 0.2-cm path-length 
rectangular cell. Proteins were exchanged
 
into a Tris buffer (pH 8.0, adjusted using 
H2SO4), 0.5 mM TCEP, 100 mM KCl, and 15% glycerol) and then diluted to the 
appropriate concentrations
 
in the same buffer. Spectra were recorded at 20°C by
 
averaging 5 wavelength scans (1 nm bandwidth)
 
in 0.2-nm steps at a rate of 100 nm/min, 
and 0.25 sec response.  
Near-UV Circular Dichroism Spectroscopy   
Near-UV CD spectra of H6-EntE (20µM), H6-EntA wild type or H6-EntA 
variants (20 µM), and a mixture of H6-EntE with wild-type H6-EntA or H6-EntA 
variants were recorded over the range 250-320 nm in 2-cm path-length rectangular cell. 
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Proteins used for near-UV CD experiments were dialyzed and diluted in buffer B. Spectra 
were recorded at 20°C by
 
averaging 3 wavelength scans (1 nm bandwidth)
 
in 0.2-nm 
steps at a rate of 20 nm/min, and 2 sec response. 
Growth Phenotype Assay  
Competent E. coli BW25113 (entA::kanR) cells (lacIq rrnBT14 ΔlacZWJ16 hsdR514 
ΔaraBADAH33 ΔrhaBADLD78) (244) were transformed with pCA24N-based expression 
constructs encoding H6-EntA (wild type), H6-EntA (Q64A), H6-EntA (A68Q), H6-EntA 
(Q64A/A68Q)). Cells were also transformed with empty pCA24N vector as a control. 
Cultures containing 5 ml LB with 30 μg/μl chlormophenicol were inoculated with one 
colony of each transformant and grown at 37 °C overnight with constant shaking at 225 
RPM. After overnight growth, cultures were diluted 1:60 in LB media containing 30 
μg/μl chlormophenicol and grown at 37 °C and 225 rpm until an OD600 ~ 0.4 was 
achieved. Log-phase cultures were then diluted 1:800 (all cultures having equivalent cell 
densities) in iron-free M63 minimal media containing 30 μg/μl chlormophenicol in the 
presence of 2,2‟-dipyridyl (65 µM). The strains were grown for 42 hours and cell 
densities were measured at 600 nm. Soluble whole cell lysates of each culture were 
prepared using BugBuster Master Mix lysis buffer (Novagen) followed by recovery of 
supernatants after centrifugation at 10,000g for 1 hr at 4
o
 C.  
Western Blot Analysis  
Western blot analysis was performed using the Immune-Blot Assay Kit (Bio-Rad 
Laboratories). Total protein (50 µg) of the clarified lysate prepared from each growth 
assay culture (see above) was applied to SDS-polyacrylamide gel (12%). After the 
electrophoresis, proteins were transferred to PVDF membrane at 4
o
 C for 1 hour at 100 
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Volt using the Bio-Rad Western Blotting system. The membrane was incubated in the 
blocking solution (TTBS containing 3 % BSA) overnight at 4 °C. Subsequently, the 
membrane was washed with TTBS and incubated overnight in the anti-His6 antibody 
(1:5000 dilution) solution. This was followed by two washing steps (each 10 minutes) 
using TTBS prior to incubation with the secondary antibody solution (Goat Anti-Mouse 
IgG/horseradish peroxidase conjugate (GAM-HRP)). After one hour incubation with 
GAM-HRP, the membrane was washed and resolved using colorimetric assay reagents 
supplied with the Bio-Rad Immune-Blot Assay kit.  
Results 
Identification of EntA Residues Involved in the Interaction with EntE Using Phage 
Display  
We used phage display in order to identify potential residues occurring at the 
EntA-EntE protein interaction interface. The Ph.D.-12
TM
 phage display peptide library 
was used to pan against immobilized H6-EntE to obtain a set of unique EntE-binding 
peptide sequences. Upon successive rounds of panning, we obtained 47 unique phage-
derived 12-mer peptides (Table 1). These peptides were used as inputs for the RELIC 
server program RELIC-MATCH (https://relic.bio.anl.gov/programs.aspx). RELIC-
MATCH analysis identified a subset of the 47-peptide set that aligned as a cluster to 
EntA primary amino acid sequence (Figure 1A). Such a cluster indicates a high 
probability that these peptide sequences reflect an EntE-binding site within the EntA 
sequence. Examination of the EntA crystal structure (PDB code: 2fwm) revealed that 
these residues occur on the EntA surface, specifically at the exterior face of EntA helix 
4 (Figure 1B). Residues within this cluster were compared and quantified using a 
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scoring function for the corresponding residues in EntA sequence (Table 2) (243). This 
method suggests a maximum similarity score at position 66 of EntA primary sequence 
(Leu 66), and approximately equal similarity scores at positions 64 and 68 (Gln64 and 
Ala68). We also found that some of our phage-derived EntE-binding peptide sequences 
aligned to the E. coli EntB primary sequence, suggesting potential EntB residues at the 
EntE interaction interface on that protein (data not shown).  
Table 1: Phage-derived 12-mer peptides isolated from H6-EntE-bound phage 
particles. 




























EntE phage peptide sequences (each 12 amino acids) obtained from a phage display 




























Table 2: Relic match analysis of EntE phage peptides. 

































Similarity scores in this table were obtained from the RELIC MATCH analysis of the 47 
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Figure 1: Identification of EntA-EntE interaction interface. 
(A) RELIC MATCH output showing alignment between phage-derived EntE-binding 
peptides and the E. coli EntA primary sequence. (B) EntA tetramer crystal structure 
(PDB code: 2fwm) with the predicted EntE interaction interface identified by phage 
display coloured in red. The red sticks show EntA residues which are selected for 
mutagenesis in this study (Gln64 and Ala68). EntA was crystalized as a dimer of dimers. 






Expression and Purification of EntA Variants 
 Based on our phage display results, we generated single-site and double-site 
EntA mutations at residues (Gln64, Ala68) predicted to interact with EntE. H6-EntA 
variants (Q64A, A68Q, and Q64A/A68Q) were purified by FPLC using immobilized 
metal affinity chromatography (Profinity IMAC column). According to SDS-PAGE 
analysis, all the purified variants have approximately the same subunit molecular weight 
~ 28 kDa and a purity of > 95% (Figure 2A).  
Circular Dichroism Spectroscopy of EntA Variants  
CD spectra in the far-UV and near-UV were collected in order to measure effects 
of H6-EntA amino acid conversions (Q64A, A68Q, Q64A/A68Q) on EntA secondary 
structure or tertiary structure. Far-UV spectra showed that wild-type H6-EntA in solution 
has major ellipticity minima at 210 nm and 222 nm (Figure 2B, black circles).  Far UV-
CD spectra also revealed a minor increase in the helicity of H6-EntA (Q64A) (Figure 2B, 
white circles) whereas a significant helicity increase was observed for the double mutant 
(Q64A/A68Q) relative to wild-type H6-EntA (Figure 2B, white triangles). H6-EntA 
(A68Q) far-UV spectrum is almost the same like that of wild-type EntA (Figure 2B, 
black triangles). Near-UV spectra demonstrated the same changes in the spectra of H6-
EntA (Q64A) (Figure 2C, white circles) and H6-EntA (A68Q) (Figure 2C, black 
triangles) relative to wild-type H6-EntA spectrum (Figure 2C, black circles). These 
changes likely reflect some conformational alteration in the environment of EntA 
chromophores upon amino acid replacement. No changes were observed in the near-UV 
spectrum of H6-EntA (Q64A/A68Q) compared to wild-type H6-EntA spectrum (Figure 










Figure 2: H6-EntA variants purification using IMAC and characterization using 
circular dichroism. 
A: Coomassie-stained 10 % SDS-polyacrylamide gel of EntA wild type and EntA variants 
purified by IMAC chromatography. The proteins were overexpressed in AG-1 cells grown 
in LB media. Protein marker (lane 1), EntA wild type (lane 2), EntA (Q64A) (lane 3), 
EntA (A68Q) (lane 4), and EntA (Q64A/A68Q) (lane 5). B and C: Far-UV and Near-UV 
spectra of wild-type EntA and variant proteins, respectively. EntA (black circles), EntA 






Analytical Ultracentrifugation of EntA Variants  
Sedimentation velocity analytical ultracentrifugation data of H6-EntA variants 
were analyzed using DCDT
+
. The sedimentation data were fitted to g^(s*) distributions, 
allowing for a model-independent estimation of sedimentation coefficients. In our 
previous work (Chapter 3), we demonstrated that EntA occurs in solution as a mixture of 
dimers and tetramers with shift toward the tetrameric form with increasing EntA 
concentration; dimeric EntA has an S20, W value of 4.23, and tetrameric EntA has an S20, W 
value of 6.71 (242). In this study, fits of sedimentation velocity data collected on EntA 
variants to the g^(s*) distribution using DCDT+ revealed that EntA mutations affect the 
distribution of dimers and tetramers in solution. While we did not see any significant 
change in the S20, W values of H6-EntA variants at 2 µM (Table 3, rows 1-4 and Figure 
3A), we did observe pronounced effects on S20, W values at an elevated concentration (20 
µM) (Table 3, rows 5-8 and Figure 3B). H6-EntA (A68Q) variant has S20, W value (6.81), 
indicating that this variant occurs mostly as tetramer as wild-type H6-EntA (Table 3, row 
6 and Figure 3B, blue squares). H6-EntA (Q64A) S20, W value (4.97) indicates that this 
variant has more dimer than tetramer at 20 µM (Table 3, rows 7 and Figure 3B, green 
diamonds). The double mutant H6-EntA (Q64A/A68Q) occurs mostly as dimer (S20, W 
value 3.95), even at a concentration (20 µM) at which wild-type H6-EntA is 
















Figure 3: g(s*) distribution fits of H6-EntA variants sedimentation velocity 
analytical ultracentrifugation data. 
EntA wild-type and variant protein concentrations are 2 µM (A) and 20 µM (B).  H6-
EntA (light blue triangles), H6-EntA (Q64A) (green diamonds), H6-EntA (A68Q) (blue 






Table 3: Sedimentation velocity analytical ultracentrifugation of purified H6-EntA 
variants. 
 


















3.87 ± 0.350 
4.26 ± 0.105 
3.90 ± 0.096 
3.60 ± 0.072 
6.60 ± 0.058 
6.81 ± 0.110 
4.97 ± 0.082 
3.96 ± 0.068 
 
Protein concentrations were measured by absorbance at 280 nm; all EntA concentrations 
were expressed for monomer subunits. Weight-average sedimentation coefficients (S20,W)  
were determined by g^(s*) distribution analysis using DCDT+.  
a 
wild-type H6-EntA S20,W value  determined at 2 µM in chapter three. 
 
Chemical Crosslinking  
We previously measured the H6-EntA-H6-EntE interaction using the 
heterobifunctional crosslinker sulfo-SMCC (242). In this report we used the same 
crosslinker in order to measure the interaction between H6-EntE and H6-EntA variants 
(Q64A and A68Q) (Figure 4). Maleimide-activated EntA variant proteins (22 µM) were 
mixed with H6-EntE (2.5 µM). When we used the maleimide-activated H6-EntA in the 
crosslinking mixture, we observed a conjugate band migrating according to a size greater 
than 250 kDa (Figure 4, lane 2). The protein contents of this band were found by LC-
MS/MS to contain EntE and EntA (data not shown). When maleimide-activated H6-EntA 
(Q64A) or (A68Q) was used in the crosslinking reaction mixture, the same conjugate 
band (> 250 kDa) was observed, but the densities of this band varied between the H6-
EntA variants. Mixture of H6-EntA (Q64A) with H6-EntE resulted in the formation of a 
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very faint conjugate band (Figure 4, lane 4). Mixture of H6-EntA (A68Q) and H6-EntE 
resulted in a conjugate band with a density approximately the same as that seen for wild-
type H6-EntA (Figure 4, lane 6). All conjugate bands in this experiment were found by 
LC-MS/MS to contain both EntE and EntA.  
 
 
Figure 4: The effect of EntA mutations on ability to crosslink with EntE in vitro. 
Protein size markers are represented by their molecular weight (kDa) on the right side of 
the gel. Lane 1: Wild-type H6-EntA mixed with H6-EntE in the absence of sulfo-SMCC. 
Lane 2: Wild-type H6-EntA mixed with H6-EntE in the presence of sulfo-SMCC. Lane 3: 
H6-EntA (Q64A) mixed with H6-EntE in the absence of sulfo-SMCC. Lane 4: H6-EntA 
(Q64A) mixed with H6-EntE in the presence of sulfo-SMCC. Lane 5: H6-EntA (A68Q) 
mixed with H6-EntE in the absence of sulfo-SMCC. Lane 6: H6-EntA (A68Q) mixed with 
H6-EntE in the presence of sulfo-SMCC.  
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Circular Dichroism Spectroscopy of Mixtures of H6-EntA and H6-EntE  
Circular dichroism spectra of protein mixtures (i.e., H6-EntE + H6-EntA (wild-
type or variants)) were collected, and spectra of corresponding individual proteins were 
subtracted from the protein mixture spectra in order to measure any observable alterations 
in the protein secondary or tertiary structure of individual proteins upon mixing with 
potential partner proteins. Using this approach, we observed increases in the near-UV 
spectra (260-320 nm) of H6-EntA and H6-EntA (A68Q) upon mixture with H6-EntE 
(Figure 5A and 5C). A corresponding change in the H6-EntE near-UV spectrum at the 
275 nm band was observed in the presence of H6-EntA or H6-EntA (A68Q) (Figure 6, 
white squares and white triangles). We did not see any changes in H6-EntE and H6-EntA 
(Q64A) or H6-EntA (Q64A/A68Q) spectra upon mixing (Figure 5B and 5D; Figure 6, 
black triangles and black squares). These results suggest that the EntA variant proteins 






Figure 5: Near-UV CD spectra of EntA variants upon mixing with EntE.  
Black circles: near-UV spectra of H6-EntA (or H6-EntA variants). White circles: near-
UV spectra of a mixture of H6-EntA (or H6-EntA variants) with H6-EntE in which H6-
EntE signal was subtracted. (A) H6-EntA wild type, (B) H6-EntA (Q64A), (C) H6-EntA 









Figure 6: Near-UV CD spectra of EntE upon mixing with EntA variants. 
 H6-EntE near-UV spectra (black diamonds). The remaining near-UV spectra are of H6-
EntE in the presence of wild-type H6-EntA or H6-EntA variants. H6-EntE spectra upon 
mixture with wild-type H6-EntA (white circles), H6-EntE spectra upon mixture with H6-
EntA (Q64A) (black triangles), H6-EntE spectra upon mixture with H6-EntA (A68Q) 










Fluorescence Spectroscopy  
We previously reported that 2,3-DHB when bound to H6-EntE results in a FRET  
signal at 440 nm upon excitation of EntE intrinsic fluorophores at 280 nm (Chapter 2) 
(206). We also used this FRET signal to measure EntE interaction with its upstream 
partner protein EntA (242). In both of those studies we found that addition of EntE 
partner proteins (EntB or EntA) reduces the H6-EntE-2,3-DHB FRET signal at 440 nm in 
a saturable manner. Here we used the H6-EntE-2,3-DHB FRET signal to measure the 
interaction between H6-EntE and H6-EntA variants (Figure 7). We expressed the 
reduction in the H6-EntE-2,3-DHB FRET signal at 440 nm as a percentage change in 
∆F/F0. ΔF = F0 - F (F0 is the fluorescence intensity of H6-EntE-2,3-DHB solution at 440 
nm in the absence of H6-EntA or H6-EntA variants, and F is the fluorescence intensity of 
H6-EntE-2,3-DHB solution at 440 nm in the presence of H6-EntA or H6-EntA variants). 
Addition of H6-EntA (A68Q) to H6-EntE plus 2,3-DHB solution resulted in a 
minor (approximately 10%) decrease in the ∆F/F0 value (Figure 7, light gray bar). This 
suggests that H6-EntA (A68Q) variant still efficiently interacts with H6-EntE, in 
agreement with our CD and crosslinking experiments.  An approximately 20% decrease 
in the ∆F/F0 value was observed upon addition of H6-EntA (Q64A) to the H6-EntE+2,3-
DHB mixture, reflecting a more pronounced negative effect of this mutation on the EntA-
EntE interaction (Figure 7, dark gray bar). The largest reduction in the ∆F/F0 value was 
observed upon addition of H6-EntA (Q64A/A68Q) to the H6-EntE+2,3-DHB solution 
(Figure 7, black bar), indicating that the Q64A/A68Q mutation had the most disruptive 






Figure 7: Effect of amino acid conversions in EntA on the interaction with 
EntE+DHB as measured by fluorescence spectroscopy. 
 The figure shows the reduction percent of the H6-EntE-bound 2,3-DHB FRET signal at 
440 nm upon mixing with 6 μM EntA or EntA variants. White bar: Reduction percent of 
H6-EntE-2,3-DHB FRET signal in the presence of wild-type H6-EntA. Light gray bar: 
Reduction percent of FRET signal in the presence of H6-EntA (A68Q). Dark gray bar: 
Reduction percent of FRET signal in the presence of H6-EntA (Q64A). Black bar: 
Reduction percent of FRET signal in the presence of H6-EntA (Q64A/A68Q). The 
reduction percent values are the average of three replicates and the error bars are the 
standard deviations of replicate values.  
 
Growth Phenotype Assays:  
In our previous study, we showed that addition of H6-EntA to an H6-EntE assay 
mixture resulted in a significant increase in EntE activity (Chapter 3) (242). These results 
suggested that EntA-EntE interaction could increase enterobactin biosynthesis efficiency 
in vivo, thus affecting bacterial growth under iron-limiting conditions.  Here we measured 
the effect of EntA amino acid conversions of residues predicted by phage display on E. 
coli cell growth under iron-limiting conditions. We transformed an entA
-
 E. coli strain 
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with constructs expressing H6-EntA mutations (Q64A, A68Q, Q64A/A68Q), and 
measured the ability of these transformants to grow in iron-restricted media containing 
2,2'-dipyridyl. In the absence of 2,2'-dipyridyl, entA
-
 cells expressing H6-EntA (A68Q) 
(Figure 8A, dark gray bar {-Dipyridyl}) exhibited growth similar to that of entA
-
 cells 
expressing wild-type H6-EntA (Figure 8A, black bar {-Dipyridyl}). In contrast, 
transformants expressing H6-EntA (Q64A) exhibited an approximately 25 % reduction in 
growth (Figure 8A, light gray bar {- Dipyridyl}), and transformants expressing H6-EntA 
(Q64A/A68Q) exhibited approximately 40 % reduction in cell growth (Figure 8A, white 
bar {- Dipyridyl}) relative to H6-EntA wild type. In agreement with the growth in the 
absence of 2,2-dipyridyl, cells expressing H6-EntA (A68Q) grew at levels similar to 
wild-type H6-EntA in the presence of 2,2'-dipyridyl (Figure 8A, dark gray bar {+ 
Dipyridyl}). EntA
-
 cells expressing H6-EntA (Q64A) and H6-EntA (Q64A/A68Q) 
exhibited an 80 % reduction in the growth in the presence of 2,2'-dipyridyl  (Figure 8A, 
light gray bar and white bar, respectively {+ Dipyridyl}). Western blot analysis revealed 
that all H6-EntA variants are similarly expressed in the transformants used in our growth 
experiments (Figure 8C). We did not observe any growth for entA
-
 cells transformed with 


























Figure 8: Monitoring the effect of amino acid conversions in EntA on EntA-EntE 
interaction in vivo through growth phenotype assays. 
 (A) Densities (OD600) of entA
-
 cells transformed with constructs expressing wild-type 
and variant EntA proteins after growth in M63 minimal media in the presence and 
absence of 65 μM 2,2'-Dipyridyl for 42 hours. H6-EntA wild type (black bars), H6-EntA 
(A68Q) (dark grey bars), H6-EntA (Q64A) (light grey bars), and H6-EntA (Q64A/A68Q) 
(white bars). (B) Coomassie-stained SDS-PAGE of E. coli BW25113 soluble whole-cell 
lysates (entA
-
 cells transformed with constructs expressing wild-type H6-EntA or H6-





were grown in M63 media for 42 hours. Lane 1: purified H6-EntA, 5 μg. Lanes 2-5: 
proteins recovered from soluble whole-cell lysates expressing wild-type or variant H6-
EntA proteins. Lane 2: wild-type H6-EntA, Lane 3: H6-EntA (Q64A), Lane 4: H6-EntA 
(A68A), Lane 5: H6-EntA (Q64A/A68Q).  (C) Western blot analysis of SDS-PAGE of E. 
coli BW25113 soluble whole-cell lysates. Lane 1: purified H6-EntA, 2.5 μg. Lanes 2-5: 
proteins recovered from soluble whole-cell lysates expressing wild-type or variant H6-
EntA proteins (50 µM each). Lane 2: H6-EntA wild type, Lane 3: H6-EntA (Q64A), Lane 
4: H6-EntA (A68A), Lane 5: H6-EntA (Q64A/A68Q).   
Discussion 
It is now known that the majority of proteins function in biochemical processes as 
proteins complexes (228-230). One function of protein-protein interactions is to enhance 
the process in which they involve. Such enhancement might occur indirectly through the 
sequestration of intermediates by direct channeling between the partner protein active 
sites without release into the bulk phase (231-233). Identification and characterization of 
residues occurring at protein-protein interaction interfaces are now recognized as active 
targets in the development and design of new drugs and antimicrobial agents (219). In the 
case of pathogenic bacteria infecting mammalian hosts, enterobactin is not itself a 
virulence factor due to its removal by circulating albumin in serum and by the innate 
immune system protein NGAL (132, 161). However, in bacteria harboring the iroA gene 
cluster, enterobactin can be glycosylated and secreted as salmochelin, which is not 
recognized by NGAL and has less hydrophobicity (166). Therefore inhibition of the 
growth of salmochelin-secreting pathogens can be targeted at stages prior to 
glycosylation starting at enterobactin biosynthesis. Protein-protein interactions have been 
established to play an important role in enterobactin biosynthesis (142, 144, 181, 206). 
The enterobactin biosynthetic enzyme EntE catalyzes the first reaction in the NRPS 
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module. In terms of overall enterobactin biosynthesis, EntE acts as a central enzyme that 
can form complexes both with its downstream partner EntB and its upstream partner 
EntA (206, 242), with the EntA-EntE interaction facilitating a direct physical link 
between the DHB and NRPS modules. Here we show through in vivo assays that this 
interaction is necessary for bacterial growth under iron-limiting conditions, likely through 
the enhancement of enterobactin biosynthesis in vivo. Therefore, disruption of the EntA-
EntE interaction appears to be a good target in the development of new antibiotics against 
bacteria that use enterobactin-based siderophores as virulence factors.  
In order to identify amino acid residues in the EntA-EntE interaction interface, we 
used phage display to pan random peptide sequences against immobilized H6-EntE. 
Using this approach, we obtained a set of unique peptides that aligned to the EntA 
primary sequence, suggesting a region on EntA potentially involved in a direct 
interaction with EntE. According to the EntA crystal structure (183), EntA residues 
Gln64 and Ala68, which we identified by phage display as being EntE-interacting 
residues, occur on the exterior face of the α4 helix, and proximal to the EntA 
physiological dimer interface (Figure 1B). We therefore targeted these residues for 
mutagenesis to investigate their role in the EntA-EntE interaction, both in vitro and in 
vivo. Our crosslinking experiments showed only a very faint conjugate band could be 
formed by mixing H6-EntE with maleimide-activated H6-EntA (Q64A), suggesting that 
the Q64A mutation diminishes the ability of EntA to interact with EntE. In contrast, 
crosslinking reactions containing H6-EntA (A68Q) resulted in the presence of an EntA-
EntE conjugate band at levels comparable to that seen when wild-type EntA was used.   
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Previously we showed that a reduction in H6-EntE-2,3-DHB FRET signal 
occurred in the presence of H6-EntA, presumably due to conformational alterations in the 
EntE active site upon EntA-EntE interaction (242). Here our H6-EntE-2,3-DHB FRET 
assay demonstrated a significant decrease in the FRET signal  reduction upon addition of 
H6-EntA (Q64A) compared to wild-type H6-EntA or H6-EntA (A68Q), indicating the 
pronounced negative effect of Q64A mutation on the EntA-EntE interaction, consistent 
with our crosslinking data. A further decrease in the H6-EntE-2,3-DHB FRET signal 
reduction was observed when the double mutant H6-EntA (Q64A/A68Q) was used, 
suggesting that multiple mutations in EntA helix α4 can completely abrogate the EntA-
EntE interaction. Our circular dichroism data indicated changes in the near-UV spectra of 
H6-EntE in the presence of H6-EntA or H6-EntA (A68Q). These spectral changes reflect 
conformational rearrangements of relevant chromophores occurring upon EntA-EntE 
interaction, and our results show that the EntA (A68Q) mutation does not significantly 
affect the interaction. In contrast, no CD spectral changes were observed upon mixing 
H6-EntE with H6-EntA (Q64A) or with H6-EntA (Q64A/A68Q), indicating that these 
variant proteins likely do not interact efficiently with H6-EntE. In support of our in vitro 
data, our in vivo growth studies revealed that attempted rescue of the entA
-
 phenotype by 
transformation with constructs expressing H6-EntA variants Q64A and Q64A/A68Q 
resulted in diminished bacterial growth under iron-limiting conditions. The similar levels 
of expression of EntA variants expressed in transformed entA
-
 BW25113 cells as revealed 
by our Western blot suggests that the observed effect on the bacterial growth is likely the 
result of amino acid substitutions at positions 64 and 68 in expressed EntA variants, and 
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not due to these conversions having a negative effect on protein expression at the 
transcriptional or translational level. 
The EntA crystal structure indicates that positions 64 and 68 occur on an alpha 
helix 4 near the dimer interface within the EntA biological subunit. Do the (Q64A) and 
(Q64A/A68Q) mutations of EntA therefore disrupt EntA-EntE interaction due to their 
participation in the interaction interface, or is the oligomeric state of EntA altered upon 
mutation at these positions? In our previous study of EntA oligomeric structure in 
solution, we found that EntA behaves in solution as a mixture of dimers and tetramers 
(242). EntA undergoes reversible conversion between the two oligomeric forms in a 
concentration-dependent manner. At low EntA concentrations, EntA dimers are the 
predominant form. Upon increasing EntA concentration, the distribution shifts towards 
the tetrameric form until EntA tetramers become predominant at high (> 18 µM) EntA 
concentrations. In this study, our sedimentation velocity analytical ultracentrifugation 
experiments on H6-EntA variants revealed that some of EntA mutations cause a shift in 
the distribution of EntA dimers and tetramers in solution. Since the EntA oligomeric 
structure is dependent on concentration, we maintained H6-EntA variant at constant 
concentrations in our AUC experiments. Thus any alteration in EntA quaternary structure 
would reflect the effect of the EntA conversions. H6-EntA (A68Q) in solution has S20,W 
value 6.81 at 20 µM, which is almost equal to that of wild-type H6-EntA (S20,W  = 6.6). 
This indicates that EntA tetramers are predominant in H6-EntA and H6-EntA (A68Q) 
solutions at this concentration, consistent with our results that H6-EntA (A68Q) is able to 
interact with EntE with similar efficiency as wild-type H6-EntA. However, the Q64A 
mutation of EntA shifts the distribution towards the dimeric form, resulting in an 
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observed S20,W value of 4.97. A pronounced shift toward the dimeric form was observed 
for the Q64A/A68Q mutation (S20, W value of 3.95).  
EntA was crystallized as a dimer of dimers, in which each physiological EntA 
dimer in the tetramer is composed of two EntA monomer subunits that interact strongly 
with each other (183) (Figure 1B, cyan and pink colored dimers). This EntA 
physiological dimer formation is supported by the four-helix bundle that contains α5 and 
α6 from each monomer. Formation of the four-helix bundle results in the burying of most 
of the residues that constitute the physiological dimer interface. The 'non-physiological 
dimer' in this structure is composed of the monomeric subunits at the dimer-tetramer 
interface (Figure 1B, cyan-colored subunit plus the corresponding pink-colored subunit). 
EntA subunits in the non-physiological dimer interact through the C-terminal loops and 
β7 from each subunit, giving less buried surface at the interaction interface compared to 
the physiological dimer.  
An explanation of the effect of Q64A and Q64A/A68Q conversions on EntA 
oligomeric structure is not immediately apparent. There are two possible reasons for the 
effects we observed. The EntA replacements studied in this report occur on the solvent-
exposed face of helix α4. The A68 side chain is completely exposed to the solvent while 
the Q64 side chain is partially facing α5 and the solvent (Figure 9, red sticks). The 
segment of α4 that is proximal to α5 is rich in hydrophobic residues (A56, A57, V59, 
A60, C63, Q64, L67, and A68) (Figure 9, yellow and red sticks). In contrast, the α5 
residues that face α4 are mostly polar (N109, L110, Q113, T114, Q117, and R120) 
(Figure 9, orange sticks). Since most of α5 residues facing α4 are hydrophilic, Q64 in α4 
might have the most important role in stabilizing α4-α5 interaction via a hydrogen bond 
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interaction with Q113 on α5. Thus there is the possibility that the transition to the dimeric 
forms upon amino acid conversions at these positions resulted from disruption of α4-α5 
interaction followed by diminishing the stability of α5 to participate in physiological 
dimer formation. Since the crystal structure of EntA indicates that the tetrameric form is a 
dimer of physiological dimers, this would mean that the dimeric forms of the EntA 
variants observed in our AUC experiments are due to non-physiological dimer formation 
(i.e. between subunits found normally at the dimer-tetramer interface). The EntA residue 
A68 might participate in the α4-α5 interaction stabilization to a lesser extent, which may 
also explain why we observed that H6-EntA (Q64A) was more predominantly dimeric 
than EntA (A68Q). This effect was also likely cumulative in the double mutant 
(Q64A/A68Q) such that non-physiological dimers occurred as the predominant form.  
 
Figure 9: EntA residues involved in the interaction between helix α4 and helix α5. 
Residues in helix α4 are shown as yellow sticks except residues selected for mutagenesis, 
which are shown as red sticks. Residues in helix α5 are shown as orange sticks. 
162 
 
The alternate possibility is that the observed increase in the helicity of both H6-
EntA (Q64A) and (Q64A/A68Q) resulted from changes in EntA folding caused by amino 
acid conversions at these positions. The small increase in the H6-EntA (Q64A) helicity 
correlated with a shift towards the dimeric form as revealed by our AUC experiments. 
The larger increase in helicity of the H6-EntA (Q64A/A68Q) variant correlated with 
almost a complete conversion to the dimeric form as observed by AUC. This suggests a 
direct relation between the observed increase in helicity content and the dimer-tetramer 
distribution in the solution for these EntA variants. This possible alteration in the variant 
EntA structure might bring residues 64 and 68 to closer to the tetramerization interface, 
causing a steric disruption of tetramer formation. In this case, the dimeric forms observed 
for the variant proteins in our AUC experiments would represent the physiological 
dimers.  
In summary, we have provided here initial evidence of EntA residues occurring at 
EntA-EntE interaction interface. Our fine-mapping has not only identified residues in 
EntA that are involved in EntE interaction, but as well EntA residues necessary for 
tetramer formation. In Chapter 3, we showed that EntE likely has a higher affinity for 
EntA in the tetrameric form compared to the dimeric form (242).  In this chapter, the 
negative effect of Q64A and Q64A/A68Q mutations on the EntA-EntE interaction are 
likely be due to (i) the participation of these residues at the EntA-EntE interaction 
interface, or (ii) to the conversion of EntA oligomeric structure to a dimeric form (either 
physiological or non-physiological), thus lowering the binding affinity of EntE to these 
variant proteins, or (iii) a combination of (i) and (ii). We also showed that EntA variants 
(Q64A and Q64A/A68Q) could not interact efficiently with EntE in vitro, and could also 
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not support bacterial growth under iron-limiting conditions in vivo when expressed in 
entA
-
 cells. These residues thus provide promising targets in the design new 
chemotherapeutic agents that could hinder the growth of enterobactin-dependent 











































The overall goal of this research project is to better understand the enterobactin 
biosynthetic enzyme EntE and its binding to its substrate 2,3-DHB as well as its 
interaction with the upstream and downstream partner proteins EntA and EntB, 
respectively. My thesis is divided into three research-related chapters:  
In the first research chapter (Chapter 2 in this thesis), biophysical techniques 
were used to study the interaction of EntE with its substrate 2,3-DHB, in addition to 
characterization its interaction with the downstream partner EntB in the presence and 
absence of 2,3-DHB. The results of this chapter showed that the EntE-EntB interaction is 
stimulated by 2,3-DHB. Furthermore, EntB undergoes significant conformational 
changes upon 2,3-DHB binding that allow it to interact efficiently with EntE. This study 
demonstrated the first reported detailed description of this interaction that is essential for 
enterobactin biosynthesis.  
In the second research chapter (Chapter 3 in this thesis), a novel protein-
protein interaction between EntE and EntA was characterized in vitro. Biophysical 
techniques and enzymatic assays were used in this chapter. The results of this chapter 
demonstrated that EntA quaternary structure is highly dependent on its concentration. 
Fluorescence and AUC experiments suggested that EntA quaternary structure likely plays 
a critical role in EntA-EntE interaction. Pull down assays provided additional evidence 
for EntE interactions with EntA and EntB. This suggests that EntE is a key enzyme in the 
enterobactin biosynthesis that is able to interact with more than one protein.  
The third research chapter (Chapter 4 in this thesis) focuses on identification 
and characterization of the EntE interaction interface on the EntA surface. Phage display 
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was used to determine EntA residues that constitute the interaction interface for EntE. 
Based on the phage display results, H6-EntA variants containing single-site and double-
site mutations were created. Here, in vitro studies showed that H6-EntA (Q64A) and H6-
EntA (Q64A/A68Q) variants exhibited a very weak binding to H6-EntE. Transformation 
of entA-knockout strains with entA genes encoding for those H6-EntA variants restricted 
their growth in iron-depleted media compared to entA-knockout strain transformed with 




















2,3-DHB Functions as a FRET Sensor in EntE Active Site 
EntE, 2,3-DHB-AMP ligase, is one of the key enzymes involved in enterobactin 
biosynthesis. It catalyzes 2,3-DHB adenylation, resulting in 2,3-DHB-AMP formation.  
EntE then catalyzes the transfer of 2,3-DHB to the holo-EntB  phosphopantetheine 
moiety, resulting in formation of acylated holo-EntB with release of AMP (139, 141). 
Adenylate forming enzymes are widely distributed in the biosynthesis of many 
siderophores. Some of them catalyze the adenylation of 2,3-DHB such as EntE in 
enterobactin biosynthesis by E. coli (141), and DhbE in bacillibactin biosynthesis by 
Bacillus subtilis (184). Altenatively, some of these enzymes adenylate salicylate instead 
of 2,3-DHB such as in the case of MbtA in mycobactin biosynthesis by Mycobacterium 
tuberculosis (245), PchD in pyochelin biosynthesis by Pseudomonas aeruginosa (246), 
and YbtE in yersiniabactin biosynthesis by Yersinia pestis (247). These enzymes have 
around 40-50 % sequence identity (206, 248). Recently, many studies have focused on 
the adenylate forming enzymes involved in different siderophore biosynthesis processes, 
revealing the attempts to inhibit these enzymes using small molecule product mimics 
(127, 248-249).  
In the second chapter, we characterized 2,3-DHB binding to H6-EntE using 
circular dichroism, fluorescence spectroscopy, and ITC. Here we found that apo-H6-EntE 
has an emission peak at 330 nm upon excitation the protein at 280 nm. In contrast, 2,3-
DHB has a very small emission peak at 440 nm when excited at 280 nm. Addition of 2,3-
DHB to H6-EntE solution resulted in a decrease in H6-EntE emission peak at 330 nm 
with a significant increase in the 2,3-DHB emission peak at 440 nm (Chapter 2, Figure 
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4A). As a result of the overlap between EntE tyrosine fluorophores emission maximum 
wavelength (305 nm) and 2,3-DHB excitation maximum wavelength (306 nm), we 
conclude that the peak at 440 nm resulted from fluorescence resonance energy transfer 
(FRET). This FRET occurred between EntE intrinsic fluorophores as donor and 2,3-DHB 
as acceptor (Chapter 2, Figure 2C).  
The increase at 440 nm was saturable with increasing 2,3-DHB concentrations 
and was fit to a hyperbolic single-site binding equation, giving EC50 value of 2,3-DHB 
binding to H6-EntE that agrees with the KD value (7.35 + 0.31  µM) determined by ITC 
(Chapter 2, Figure 3 and Figure 4C, 4D). This dissociation constant value reflects lower 
affinity of 2,3-DHB binding to H6-EntE than the expected affinity based on the reported 
EntE-2,3-DHB Km value (2.7 µM) by Rusnak, F. et al (141). The DhbE crystal structure 
determined by May et al revealed that 2,3-DHB binding is followed by ATP binding  at 
the entrance of the active site, and followed by P-loop closure at the top of the active site 
during the catalysis (184). Thus the lower affinity of 2,3-DHB binding in our 
fluorescence assay can be attributed to the absence of ATP. ATP binding would increase 
the 2,3-DHB affinity by preventing its dissociation from EntE active site. The affinity of 
EntE binding to its product 2,3-DHB-AMP has not been determined. However, adenylate 
product analogues were used as competitive inhibitors of EntE and DhbE with Ki values 
of 4.5 nM and 85 nM, respectively (186-187). This suggests a higher affinity of these 
adenylate forming enzymes for their products relative to their substrate. The higher 
affinity of these enzymes for their product is likely achieved by the P-loop closure as 
reported by May and coworkers (184). Thus, this higher affinity was a good target in the 
synthesis of inhibitors in order to hinder the siderophore biosynthesis processes that use 
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these enzymes (186-187). The high affinity of EntE binding to 2,3-DHB-AMP likely 
ensures the effective channeling of 2,3-DHB directly from EntE active site to holo-EntB 
active site without release to the cytoplasm. 
The Specificity of EntE Binding to 2,3-DHB 
An EntE homology model was generated using the Bacillus subtilis homologue 
DhbE (184). EntE has five tyrosine residues in the active site (Chapter 2, Figure 2C). The 
nearest tyrosine residue to 2,3-DHB is Y236, and this residue likely stabilizes 2,3-DHB 
via hydrophobic interactions, in agreement with DhbE crystal structure reported by May 
et al (184). In our EntE homology model, H233 and K519 are predicted to stabilize the 
DHB-carboxylate moiety. These residue side chains superimpose with the 2,3-DHB-
carboxylate stabilizing residues (H234 and K517) in DhbE active site, indicating their 
role in DHB binding. Our EntE model also anticipates the involvement of EntE active 
site residues N234 and S239 in 2,3-DHB binding via its C-2 and C-3 hydroxyl groups, 
respectively (Chapter 2, Figure 2D). In the second chapter, our data showed that the 
mixing of neither 2,5 DHB nor 3,5 DHB with EntE resulted in FRET (Chapter 2, Figure 
5B). These results revealed the selective binding of EntE to its natural substrate 2,3-DHB. 
Although most of catecholate siderophores use 2,3-DHB as iron-binding group (44), 
there are some siderophores that use other DHB isomers as iron-binding groups. For 
example, 3,4-DHB is found in petrobactin produced by Bacillus anthracis and Bacillus 
cereus (98), and 2,5-DHB is found in a mammalian siderophore produced by a 
mammalian cell (1). The hydroxyl group positions in the DHB moiety of these 
siderophores may play a role in the recognition of these DHB isomers by their enzymes 
or in siderophore recognition by their receptors. The specificity of 2,3-DHB binding to 
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EntE can be interpreted by the presence of N234 and S239 in the our EntE model active 
site close to the 2 and 3 hydroxyl groups of 2,3-DHB, respectively. This suggests the role 
of these residues in stabilizing 2,3-DHB binding by forming hydrogen bonds with the C-2 
and C-3 hydroxyl groups. In contrast, the hydroxyl group at C5 in 2,5 DHB or 3,5 DHB 
isomers would be proximal to a loop containing to V306, G307, G308. None of these 
residues can form hydrogen bond to stabilize 2,5 DHB or 3,5 DHB binding. Thus our 
data and EntE model predict the involvement of EntE active site residues N234 and S239 
in the binding of 2,3-DHB. 
The Role of 2,3-DHB in EntE-EntB Interaction 
Gehring and coworkers revealed that EntB is bifunctional enzyme with 
isochorismatase activity (ICL domain) that catalyzes the second reaction in the DHB 
module, and aryl carrier protein activity (Ar-CP domain) that catalyzes EntE downstream 
reaction (139). It has also been reported that holo-EntB stimulated EntE activity 
approximately 10-fold (144). This suggests that the EntE-EntB interaction likely 
stimulates the direct channeling of 2,3-DHB to holo-EntB active site, regenerating EntE 
for another round of catalysis. In the second chapter, we studied the 2,3-DHB binding to 
both EntE and EntB and its effect on the interaction between these proteins. All DHB 
isomers were able to quench EntB intrinsic fluorescence (Chapter 2, Figure 5A). 2,3-
DHB were found to have the most quenching effect on EntB emission spectra, suggesting 
that EntB favors the binding of this isomer. This is the first study to demonstrate 2,3-
DHB binding to EntB. Although 2,3-DHB is not the natural substrate of EntB, our data 
suggest that EntB might have an allosteric site to bind 2,3-DHB. EntC catalyzes a 
reversible reaction in the first step of enterobactin biosynthesis pathway (174) but the 
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EntB ICL domain catalyzes irreversible reaction in the second step of that pathway (139).  
This suggests that EntB ICL domain-catalyzed reaction is likely the first committed step 
of this pathway. Thus 2,3-DHB binding to EntB might have a regulatory role such as 
feedback inhibition of the DHB module in case of surplus production of  2,3-DHB.   
We found that H6-EntB is able to quench H6-EntE-bound 2,3-DHB FRET signal 
at 440 nm in a saturable manner with increasing H6-EntB concentrations. According to 
our FRET assay, H6-EntE and H6-EntB interact with EC50 value in the low micromolar 
range, suggesting the proteins interact transiently probably for substrate channeling 
(Chapter 2, Figure 6). The changes in the near-UV spectra of each protein upon mixing 
reflecting EntE-EntB interaction were observed only in the presence of 2,3-DHB 
(Chapter 2, Figure 7B and 7D).  We therefore conclude that 2,3-DHB binding to EntB is 
likely to induce conformational changes in EntB to ensure efficient interaction with EntE. 
This conclusion is consistent with studies reported by Drake et al (181). They showed 
that some mutations in the EntB Ar-CP domain increased the rate of EntB acylation by 
EntE, suggesting that EntB conformation alteration might be required to optimize the 
interaction interface for its interaction with EntE. Our pull-down assays support our CD 
and fluorescence data in this respect. We found that our purified H6-EntB was able to 
efficiently pull down E. coli EntE only in the presence of exogenous 2,3-DHB, revealing 
the essential role of 2,3-DHB in EntE-EntB interaction (Chapter 2, Figure 8). Studies in 
Chapter Two were the first-reported characterizations of EntE-2,3-DHB binding and the 





The Effect of the Protein Concentration on EntE and EntA Quaternary Structure 
EntA and EntE oligmeric structures were studied in the third chapter as a function 
of the protein concentration at 20 °C using AUC. Here we found that H6-EntE presents in 
solution as monomer independent on its concentration (Chapter 3, Figure 1A). In 
contrast, H6-EntA oligomeric structure is dependent on H6-EntA concentration in 
solution.  Here we found that H6-EntA behaves in solution as a mixture of dimer and 
tetramer. It was shown by Sundlov and coworkers that EntA crystallizes as a dimer of 
dimers (183). Our AUC analysis revealed that H6-EntA undergoes reversible conversion 
between the dimeric and tetrameric forms depending on its concentration (Chapter 3, 
Figure 1B). The dimer-tetramer distribution shifts toward the tetramer form upon 
increasing H6-EntA concentration gradually until H6-EntA tetramer becomes the 
predominant form (over 18 µM). The dependence of EntA oligomeric structure on its 
concentration might have a regulatory role in the enterobactin biosynthesis process. A 
similar example of self-association behavior affecting function is seen with tumor 
suppressor protein p53 oligomerization that described by Weinberg and coworkers (250). 
They found that a truncated form of p53 containing the oligomerization and DNA 
binding domains behaves as a mixture of dimers and tetramers. In that study, the dimeric 
form of p53 is predominant at submicromolar concentrations but the tetrameric form is 
predominant at high concentrations. The tetrameric form of p53 interacts with higher 




DHB Biosynthesis and NRPS Modules are Coordinated by the EntA-EntE 
Interaction  
It has been shown that protein-protein interactions play a crucial role in the 
enterobactin NRPS module (142, 181, 195, 197, 206). In the third chapter, for the first 
time we showed that enterobactin biosynthetic functional modules (DHB and NRPS 
modules) are directly linked through EntA-EntE interaction. EntA catalyzes the last 
reaction in the DHB module while EntE catalyzes the first reaction in the NRPS module 
(Chapter 3, Scheme 1B and 1C). The interaction between these enzymes is likely to 
facilitate enterobactin biosynthesis, probably by direct intermediate channeling. The role 
of protein-protein interactions in mediating substrate channeling between active sites has 
been identified in many processes. For example, it was shown by Tsuji and coworkers 
that protein-protein interactions between the modules of the polyketide synthase complex 
play a major role in intermediate channeling (251). It was also revealed by Winkel that 
intermediate channeling via protein-protein interactions plays an essential role in some of 
the plant metabolic processes (252). Moreover protein-protein interactions facilitate the 
substrate channeling between enzymes involved in the purine biosynthesis (253). Here 
we propose that EntA-EntE interaction will promote the growth of the bacteria that use 
enterobactin related siderophores inside the host. Such an interaction is a promising target 
for development of antimicrobial drugs. 
 In the third chapter of this thesis, H6-EntE activity was shown to be significantly 
enhanced upon H6-EntA addition to the H6-EntE reaction mixture (Chapter 3, Figure 4), 
supporting our assumption that this interaction will increase the efficiency of enterobactin 
biosynthesis. It has been reported by Ehmann et al that EntE activity is also stimulated by 
 174 
the holo-EntB Ar-CP domain (144). The increase in EntE activity might result from 
optimization of EntE active site upon conformational changes that occur during its 
interaction with EntA. This assumption is supported by the observed decrease in H6-
EntE-bound 2,3-DHB FRET upon EntA-EntE interaction. Here we assume that EntA-
EntE interaction alters the position of 2,3-DHB in the active site, such that 2,3-DHB 
moved away from the  FRET donors (resulted in the observed quenching of the FRET 
signal), and toward ATP (resulted in the observed increase in EntE activity) (Chapter 3, 
Scheme 2).   
Sulfo-SMCC crosslinking experiments gave us a direct evidence for EntA-EntE 
interaction at 20°C. Here, the sulfo-SMCC-activated H6-EntA was able to form a 
complex with H6-EntE with a molecular weight over 250 kDa (Chapter 3, Figure 3). In 
the crosslinking experiment, H6-EntA concentration was 22 µM, suggesting that EntA 
tetramers are the predominant forms based on the AUC analysis of EntA self-association.  
Thus the SDS-PAGE band containing crosslinked EntA and EntE probably reflects a 
complex of EntA tetramer with four EntE subunits (predicted mass ~360 kDa). Our pull 
down assays provide us with further direct evidence for EntA-EntE complex formation in 
situ in E. coli lysates.  H6-EntA bait was able to pull down chromosomally expressed E. 
coli EntE in a manner independent on 2,3-DHB (Chapter 3, Figure 2A {band a}). H6-
EntE bait was able to pull down chromosomally expressed E. coli EntA independent on 
the presence of exogenous 2,3-DHB (Chapter 3, Figure 2B {band e}). Moreover, H6-
EntE bait was also able to pull down E. coli EntB only in the presence of 2,3-DHB 
(Chapter 3, Figure 2B {band d}). This supports our observation in the second chapter that 
EntE and EntB interacts more efficiently in the presence of 2,3-DHB. There are two 
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possible explanations for pulling down both E. coli EntB and E. coli EntA by H6-EntE 
bait in the presence of 2,3-DHB.  The major explanation is that EntE forms discrete 
complexes with EntB and EntA. This possibility is supported by the ability of H6-EntA 
bait to pull down only E. coli EntE, and H6-EntB bait to pull down only E. coli EntE.  An 
alternate explanation is that formation of an EntA-EntE-EntB ternary complex can occur 
but we do not have further evidence for this.  
Characterization of the EntA-EntE Interaction 
In the second chapter of my thesis, we demonstrated that H6-EntE binding to 2,3-
DHB resulted in a FRET signal at 440 nm. The FRET signal was used to measure the 
EntE-EntB interaction, giving an EC50 value of ~ 1.5 µM (206). In the third chapter, we 
were able to use this fluorescence binding assay to measure the EntA-EntE interaction at 
20 °C. Here H6-EntA was able to decrease H6-EntE-2,3-DHB FRET signal in a manner 
dependent on H6-EntA concentration. Our anisotropy assay demonstrated that 2,3-DHB 
remains bound to H6-EntE upon H6-EntA interaction (Chapter 3, Figure 6). Thus the 
decrease in the H6-EntE-2,3-DHB FRET signal is likely due to a conformational change 
in EntE active site which alters the position and orientation of EntE FRET fluorophore 
donors and the acceptor 2,3-DHB.  The equilibrium binding data at 20 °C revealed a 
sigmoidal binding behavior with a Hill coefficient greater than one and a concave-down 
scatchard plot. Furthermore, the equilibrium binding curve of EntA-EntE interaction has 
biphasic behavior. At low H6-EntA concentrations, the equilibrium binding response 
exhibited a shallow reduction in the H6-EntE-2,3-DHB FRET signal. As we increased 
H6-EntA concentration, a steep reduction in the H6-EntE-bound 2,3-DHB FRET signal 
was observed, suggesting higher affinity of EntE toward EntA upon increasing EntA 
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concentration. Our AUC analysis showed that increasing EntA concentration 
accompanied by a transition from EntA dimer to EntA tetramer. Thus the higher 
reduction in the H6-EntE-bound 2,3-DHB FRET upon increasing H6-EntA concentration 
might reflect a higher affinity of EntE toward EntA in the tetrameric form. This suggests 
that the sigmoidicity and the high Hill coefficient are likely due to positive cooperativity 
in the interaction. The enhancement of protein-protein interaction by oligomerization has 
been shown in many systems. For example, it was demonstrated by Terawaki et al that 
the mammalian PD-L1 protein interaction with its receptor PD-1 was stimulated upon 
tetramerization as seen by approximately 100 fold increase in the association constant 
relative to that determined for interaction involved monomeric PD-L1 (254). The 
interaction between PD-L1 and its receptor PD1 play an essential role in the immune 
reactions (255). Another example is seen with p53-DNA binding as revealed by 
Weinberg and coworkers (250). They showed that p53 interaction with its DNA sequence 
is highly cooperative with a Hill coefficient greater than one, and enhanced by 
tetramerization. In that study, mutation affecting p53 oligomerization lowers the 
interaction affinity between the mutated p53 and DNA by approximately six-fold.  Our 
results do not rule out that EntE interaction with EntA in the dimeric form since our 
results showed stimulation in H6-EntE activity upon adding H6-EntA at 0.25 µM, where 
EntA would be predominantly as dimer according our analysis of EntA self-association. 
Taken together, our experiments revealed that EntE likely has higher affinity to EntA in 
the tetrameric form at 20°C. This suggests that EntA oligomeric state might play an 
important role in the regulation of enterobactin biosynthesis, such that the biosynthesis is 
enhanced upon EntA tetramerization. 
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Characterization of the EntA-EntE Interaction Interface 
Characterization of protein-protein interaction interfaces is the focus of much 
research.  Many studies have focused on identification of the interaction interfaces 
between enzymes involved in enterobactin biosynthesis (142, 181, 195, 197). Residues of 
acyl carrier protein domain (ACP) of polyketide synthase that comprise the interaction 
interface for phosphopantetheinyl transferse were studied by Weissman et al (256). It was 
also shown that that the bacterial chemotaxis mechanism is highly dependent on protein-
protein interactions (257). Moreover,  Carter and coworkers identified the E. coli TonB 
(cytoplasmic membrane protein) and FhuD (periplasmic protein) interaction interface 
(258). In that study, they showed the ternary complex formation of FhuA-TonB-FhuD, 
FhuD is a periplasmic protein that transports ferrichrome from the FhuA receptor to an 
ABC transporter for import of the ferric siderophore to the cytoplasm. 
Much research focuses on development of small molecules inhibitors in attempt 
to disrupt the protein interaction interfaces, providing useful targets for the development 
of antimicrobial and chemotherapeutic drugs (219, 259). For example, small peptide 
inhibitors have been used to disrupt the interaction between the pilus adhesin (FimH) and 
periplasmic chaperone (FimC) in Uropathogenic E. coli (260). A small molecule inhibitor 
of the interaction between cytokine interleulin-2 (IL-2) and its receptor IL-2R was 
studied by Arkin et al (261). Furthermore, small molecules inhibitors have been used to 
inhibit the antiapoptotic protein (BCL2) interaction with the proapoptotic protein BAK as 
reviewed by Arkin and Wells (262).  
Phage display was used to identify the interaction interface between EntA and 
EntE in the fourth chapter of this study. Here, a phage display library was used to pan 
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random peptide sequences against immobilized H6-EntE. This technique provides us 
with 47 unique peptide sequences that aligned with EntA primary sequence using RELIC 
MATCH program (Chapter 4, Table 1 and Figure 1A). EntA residues Gln64 and Ala68 
identified to be in the interaction interface for EntE were selected for mutagenesis in 
attempt to disrupt the interaction. Our crosslinking experiments showed that maleimide-
activated H6-EntA (Q64A) formed a very faint conjugate band with H6-EntE, suggesting 
a weak interaction between H6-EntE and H6-EntA (Q64A) (Chapter 4, Figure 4). In 
contrast, maleimide-activated H6-EntA (A68Q) formed a complex band with H6-EntE 
with a density almost the same like that seen when wild-type EntA was used (Chapter 4, 
Figure 4). Near-UV spectra changes reflecting EntA-EntE interaction were only observed 
upon mixing H6-EntE with wild-type H6-EntA or H6-EntA (A68Q) (Chapter 4, Figure 5 
and 6).  This suggests that A68Q mutation did not affect the ability of EntA to interact 
with EntE but Q64A and Q64A/A68Q mutations are likely disrupting the interaction. 
Moreover, our fluorescence binding assay showed that H6-EntA Q64A mutation had a 
negative effect on its interaction with H6-EntE. This assay also revealed that H6-EntA 
Q64A/A68Q mutation had a more pronounced effect than Q64A mutation on the 
interaction (Chapter 4, Figure 7), indicating that multiple mutations in the interaction 
interface can completely disrupt the interaction. Our in vivo growth assays support our in 
vitro studies, showing that entA
-
 BW25113 cells transformed with gene encoding for H6-
EntA (Q64A) and H6-EntA (Q64A/A68Q) were unable to grow under iron-limited 
condition (Chapter 4, Figure 8A). Taken together, our in vitro and in vivo studies in 
Chapter Four revealed that H6-EntA Q64A and Q64A/A68Q mutations have a 
pronounced effect on disrupting the EntA-EntE interaction. This suggests that the helix 
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containing EntA residues 64 and 68 would make a good target for the development of a 
small molecule inhibitor of the EntA-EntE interaction. 
EntA Mutations Interrupt EntA Tetramer Construction 
Wild-type H6-EntA behaves in solution as a mixture of dimer and tetramer with 
transition toward the tetramer forms upon increasing EntA concentration (Chapter 3, 
Figure 1B and Table 1, row 4-7). In the fourth chapter, we found H6-EntA (A68Q) has 
S20,W  value which almost equal to that of wild-type H6-EntA at 20 µM  (Chapter 4, 
Figure 3B and Table 3, row 6) , indicating that both H6-EntA (A68Q) and wild-type H6-
EntA present predominantly as tetramer. In contrast, the H6-EntA (Q64A) S20,W  value 
determined at 20 µM suggests that EntA of this variant has more dimers (Chapter 4, 
Figure 3B and Table 3, row 7). The H6-EntA (Q64A/A68Q) S20,W  value determined at 20 
µM indicates that EntA of this variant is predominantly dimer (Chapter 4, Figure 3B, 
Table 3, row 8). Thus the negative effect of Q64A and Q64A/A68Q mutations on EntA-
EntE interaction likely resulted from their position in the interaction interface and/or the 
dimer formation upon mutation. 
EntA was crystalized as a tetramer by Sundlov et al (183). This tetramer is 
composed of two physiological dimers as explained previously. The mechanism by which 
Q64A and Q64A/A68Q mutations interrupt the tetramerization of EntA is not obvious. 
However there are two possible interpretations for dimer formation in these variants. In 
the first interpretation, the non-physiological dimer is formed as a result of the 
physiological dimer interface disruption (Chapter 4, Figure 1B {one cyan colored subunit 
plus the corresponding pink colored subunit}). This effect likely resulted from the role of 
Gln64 and Ala68 that they might play in interaction between helices α4 and α5. In the 
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second interpretation, the physiological dimer is formed as a result of the tetramer 
interface disruption (Chapter 4, Figure 1B {cyan or pink colored dimers}). The observed 
change in the protein helicity of H6-EntA (Q64A) and H6-EntA (Q64A/A68Q) variants 
likely resulted from changes in the conformation of these variants upon mutation. The 
positions of Gln64 and Ala68 in these variants might be close to the tetramerization 
interface as a result of the conformation alteration, causing interruption of the tetramer 
interface.  
Thesis Studies in Context of What Have Been Currently Published 
Mechanistic studies on EntE by Sikora and coworkers revealed that EntE reaction 
divided into two half-reactions (189). The first half-reaction of EntE is 2,3-DHB 
adenylation (2,3-DHB-AMP formation) while the second half-reaction is acylation of 
holo-EntB by the activated 2,3-DHB with release of AMP. Sikora et al  also reported that 




-diadenosine-5'-tetraphosphate (Ap4A) in the 
absence of holo-EntB (188). 2,3-DHB-AMP, the product of the first half-reaction of 
EntE, is attacked by another molecule of ATP in the absence of holo-EntB, resulting in 
formation of Ap4A. In contrast in the presence of holo-EntB, 2,3-DHB-AMP is attacked 
by the phosphopantetheine group of holo-EntB, resulted in the formation of acylated 
holo-EntB.  
 Our findings, along with what is currently known about EntE (Chapter 5, Scheme 
1), suggest that EntE activity in the two half-reactions is only optimized by interactions 
with its protein partners. This likely occurs by conformational change of the EntE active 
site upon its interaction with both upstream and downstream protein partners. This is 
predicted by the observed quenching of the EntE bound 2,3-DHB FRET signal upon the 
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interaction with EntA and EntB (Chapter 2 and 3). Here we propose that the first half-
reaction of EntE is enhanced by its interaction with the upstream partner EntA (Chapter 
3). This likely resulted from stimulation of 2,3-DHB-AMP formation, probably by 
channeling of 2,3-DHB from EntA to EntE (Scheme 1A (I)). This interaction is likely 
dependent on EntA conformation, such that EntE interacts with higher affinity to EntA in 
the tetrameric form (Chapter 3 and 4).  
The second half-reaction of EntE is enhanced by its interaction with the 
downstream partner EntB as reported by Ehmann  et al (144). Consistent with our studies 
in the second chapter, some of the released 2,3-DHB likely binds  to an allosteric site on 
holo-EntB and primes it to interact with EntE (Scheme 1B). Our finding in Chapter Two 
that EntB needs to be optimized by conformational changes prior to its interaction with 
EntE is consistent with what reported by Drake et al  as (181). The EntE-EntB interaction 
occurs in the second half-reaction of EntE, probably to facilitate 2,3-DHB channeling to 
holo-EntB, consisting with what has been published (188-189). After holo-EntB is 
acylated by EntE (attach the 2,3-DHB moiety to PPant-Ser245 of holo-EntB), acylated 
holo-EntB will be released to interact with the downstream enzyme (EntF) in the 
pathway. Lai et al reported that mutations in EntB interaction interface for EntF did not 
disrupt its interaction with EntE, suggesting that EntB has separate interaction interfaces 
for each interaction (142). After EntB dissociates from EntE, EntE will be ready for 
another interaction with EntA and another cycle of the catalysis. Our studies in Chapter 
Four showed that EntA (Q64A) and EntA (Q64A/A68Q) variants demonstrated very 
weak interaction with EntE. The effect of these mutations might have resulted from their 
presence in the interaction interface and/or the conversion of EntA to the dimeric form 
 182 
upon the mutation, lowering the interaction affinity of EntE to these variants (Scheme1A 











Scheme 1: Proposed mechanism of EntE interaction with EntA and EntB in context 
of our studies, along with what have been reported about EntA, EntE, and EntB.  
A(I): Representation of the EntA-EntE interaction in the first half-reaction of EntE. EntA 
crystal structure revealed that EntA tetramer composed of two physiological homo-
dimers (light blue and dark blue dimers).  The third chapter studies revealed that EntA in 





also suggested that EntE interacts with higher affinity to EntA in the tetrameric form. 
This interaction is probably to mediate 2,3-DHB channeling from EntA active site to 
EntE active site as represented by orange arrows. A(II): Disruption of EntA-EntE 
interaction. The fourth chapter studies showed that EntA mutations (e.g. Q64A/A68Q) 
likely disrupt the interaction through promotion of dimer (physiological or non-
physiological) formation of EntA and/or disruption of the interaction interface. The 
mutagenized EntA residues (Gln64 and Ala68) were represented as orange squares. The 
dimer formation in these variants correlated with change in EntA conformation as 
predicted by our CD data. The change in EntA conformation upon the mutation might 
contribute to the weak interaction with EntE. EntA conformational change upon mutation 
was not represented in the diagram.  B: Representation of the EntE-EntB interaction in 
the second half-reaction of EntE. 2,3-DHB  (red squares) binds to EntB and prepares it 
to efficiently interact with EntE, probably by EntB conformational change as predicted  
by our studies in the second chapter.  EntE-EntB interaction likely facilitates 2,3-DHB-
AMP channeling from EntE active site to EntB active site as shown by the orange arrows. 
 
 Our studies in this report advance our knowledge about protein-protein 
interaction network involved in enterobactin biosynthesis. Furthermore our studies 
provide a rapid fluorescence assay for further exploration of EntE active site (Chapter 2). 
This assay has already proved useful in monitoring EntE interaction with EntB and EntA 
(Chapter 2 and 3). Moreover, studies in the fourth chapter demonstrated the essential role 
of Gln64 and Ala68 residues of EntA in the interaction with EntE as well as in EntA 
tetramer formation. Here, Q64A and Q64A/A68Q mutations of EntA were able to restrict 
the bacterial growth in iron free media. The studies in this chapter also suggest that 
inhibition of EntA tetramer formation might play an essential role in disruption of EntA-
EntE interaction. Hence this chapter identifies novel targets for development of 
antibacterial drug against bacteria that produce enterobactin-related siderophores. 
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Recently, Devireddy et al showed that the mammalian cell has a mammalian siderophore 
involved in the iron homeostasis (1). They found that the biosynthesis of this siderophore 
requires EntA and EntE homologues. Thus our findings provide insights not only into the 
related bacterial proteins involved in other sidrophores biosynthesis but also into the 
















































































































































































































































































































































































































































































































































 Band from SDS-polyacrylamide gel shown in Figure 2 of Chapter Three. Letter 
corresponds to letter label beside band in figure.  
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b
 Only LC-MS/MS data of peptides recovered from SDS-PAGE bands corresponding to 
pulled down prey proteins are shown in this table. 




















 Identified protein from band in SDS-polyacrylamide gel migrating with size > 250 kDa 
in +SMCC lane (Chapter 3, Figure 3). Non-crosslinked EntA and EntE peptides (i.e., 
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